<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?>
<?SourceDTD.Version 1.0?>
<?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
    <journal-id journal-id-type="iso-abbrev">Environ. Health Perspect</journal-id>
    <journal-id journal-id-type="publisher-id">EHP</journal-id>
    <journal-title-group>
      <journal-title>Environmental Health Perspectives</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0091-6765</issn>
    <issn pub-type="epub">1552-9924</issn>
    <publisher>
      <publisher-name>Environmental Health Perspectives</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6791490</article-id>
    <article-id pub-id-type="publisher-id">EHP5297</article-id>
    <article-id pub-id-type="doi">10.1289/EHP5297</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Commentary</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with <italic>in Vitro</italic> Testing and Adverse Outcome Pathway Approaches</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Noyes</surname>
          <given-names>Pamela D.</given-names>
        </name>
        <xref ref-type="aff" rid="a1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Friedman</surname>
          <given-names>Katie Paul</given-names>
        </name>
        <xref ref-type="aff" rid="a2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Browne</surname>
          <given-names>Patience</given-names>
        </name>
        <xref ref-type="aff" rid="a3">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Haselman</surname>
          <given-names>Jonathan T.</given-names>
        </name>
        <xref ref-type="aff" rid="a4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gilbert</surname>
          <given-names>Mary E.</given-names>
        </name>
        <xref ref-type="aff" rid="a5">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hornung</surname>
          <given-names>Michael W.</given-names>
        </name>
        <xref ref-type="aff" rid="a4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Barone</surname>
          <given-names>Stan</given-names>
          <suffix>Jr.</suffix>
        </name>
        <xref ref-type="aff" rid="a6">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Crofton</surname>
          <given-names>Kevin M.</given-names>
        </name>
        <xref ref-type="aff" rid="a2">
          <sup>2</sup>
        </xref>
        <xref ref-type="fn" rid="n1">
          <sup>†</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Laws</surname>
          <given-names>Susan C.</given-names>
        </name>
        <xref ref-type="aff" rid="a5">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stoker</surname>
          <given-names>Tammy E.</given-names>
        </name>
        <xref ref-type="aff" rid="a5">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Simmons</surname>
          <given-names>Steven O.</given-names>
        </name>
        <xref ref-type="aff" rid="a2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tietge</surname>
          <given-names>Joseph E.</given-names>
        </name>
        <xref ref-type="aff" rid="a4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Degitz</surname>
          <given-names>Sigmund J.</given-names>
        </name>
        <xref ref-type="aff" rid="a4">
          <sup>4</sup>
        </xref>
      </contrib>
      <aff id="a1"><label>1</label>National Center for Environmental Assessment, Office of Research and Development (ORD), <institution>U.S. Environmental Protection Agency (EPA)</institution>, Washington, DC, <country>USA</country></aff>
      <aff id="a2"><label>2</label>National Center for Computational Toxicology, ORD, <institution>U.S. EPA</institution>, <addr-line>Research Triangle Park</addr-line>, North Carolina, <country>USA</country></aff>
      <aff id="a3"><label>3</label>Environment Health and Safety Division, Environment Directorate, <institution>Organisation for Economic Co-operation and Development (OECD)</institution>, Paris, <country>France</country></aff>
      <aff id="a4"><label>4</label>Mid-Continent Ecology Division, National Health and Environmental Effects Research Laboratory (NHEERL), ORD, <institution>U.S. EPA</institution>, Duluth, Minnesota, <country>USA</country></aff>
      <aff id="a5"><label>5</label>Toxicity Assessment Division, NHEERL, ORD, <institution>U.S. EPA</institution>, <addr-line>Research Triangle Park</addr-line>, North Carolina, <country>USA</country></aff>
      <aff id="a6"><label>6</label>Office of Pollution Prevention and Toxics, Office of Chemical Safety and Pollution Prevention, <institution>U.S. EPA</institution>, Washington, DC, <country>USA</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1">Address correspondence to Pamela Noyes, U.S. EPA, 1300 Pennsylvania Ave., N.W. (Mail Code 7203M), Washington, DC 20460 USA. Telephone: (202) 564-8122. Email: <email>Noyes.pamela@epa.gov</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <volume>127</volume>
    <issue>9</issue>
    <elocation-id>095001</elocation-id>
    <history>
      <date date-type="received">
        <day>08</day>
        <month>3</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>01</day>
        <month>7</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>8</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <license license-type="open-access">
        <license-p><italic>EHP</italic> is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="ehp5297.pdf"/>
    <abstract>
      <sec>
        <title>Background:</title>
        <p>Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, <italic>in vitro</italic> assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented.</p>
      </sec>
      <sec>
        <title>Objectives:</title>
        <p>We present an adverse outcome pathway (AOP) network to link data derived from <italic>in vitro</italic> assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from <italic>in vivo</italic> testing. We examine the role of new <italic>in vitro</italic> technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism.</p>
      </sec>
      <sec>
        <title>Discussion:</title>
        <p>There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of <italic>in vitro</italic> assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/EHP5297">https://doi.org/10.1289/EHP5297</ext-link></p>
      </sec>
    </abstract>
  </article-meta>
</front>
<body>
  <sec id="s1">
    <title>Introduction</title>
    <p>Regulatory programs within the U.S. Environmental Protection Agency (EPA) are responsible for protecting public health and the environment from the potential hazards and risks of chemical exposures. To quickly and economically predict chemical hazard, and reduce laboratory animal testing, the U.S. EPA and many other government institutions and stakeholders are placing an emphasis on designing, validating, and implementing alternative approaches to whole animal toxicity testing to support chemical safety assessments and risk-based decisions (<xref rid="c63" ref-type="bibr">ECHA 2016</xref>; <xref rid="c123" ref-type="bibr">ICCVAM 2018</xref>; <xref rid="c181" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine 2007</xref>; <xref rid="c287" ref-type="bibr">U.S. EPA 2018</xref>). These alternative approaches, more recently termed new approach methodologies, may encompass any of a broad range of <italic>in vitro</italic> technologies [e.g., robotic-based higher-throughput screening (HTS), lower-throughput formats], omic approaches (e.g., microarray, RNA-sequencing, proteomics, genome editing), and <italic>in silico</italic> modeling (e.g., molecular docking to model interactions of small molecules and proteins, computational read-across to predict the toxicity of data poor substances using data rich sources).</p>
    <p>Coincident with the increasing availability of alternatives to traditional animal testing, government agencies have been seeking to adopt these new approach methodologies in chemical safety evaluations. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods recently finalized strategies for establishing new approaches in chemical safety evaluations for U.S. federal agencies (<xref rid="c123" ref-type="bibr">ICCVAM 2018</xref>). The U.S. EPA has published plans to promote the use of nonanimal alternative test strategies under the amended Toxic Substances Control Act (TSCA) (<xref rid="c287" ref-type="bibr">U.S. EPA 2018</xref>). Likewise, the U.S. EPA’s Endocrine Disruptor Screening Program (EDSP), which screens and tests chemicals for interference with estrogen, androgen, and thyroid hormone (TH) signaling, has been transitioning toward use of <italic>in vitro</italic> HTS to evaluate chemicals for endocrine activity (<xref rid="c285" ref-type="bibr">U.S. EPA 2015b</xref>, <xref rid="c286" ref-type="bibr">2017</xref>). <italic>In vitro</italic> HTS has been implemented under the EDSP to screen chemicals for interaction with estrogen and androgen receptors (<xref rid="c22" ref-type="bibr">Browne et al. 2015</xref>; <xref rid="c131" ref-type="bibr">Judson et al. 2015</xref>, <xref rid="c130" ref-type="bibr">2017</xref>; <xref rid="c139" ref-type="bibr">Kleinstreuer et al. 2017</xref>; <xref rid="c283" ref-type="bibr">U.S. EPA 2014</xref>), as well as steroidogenesis pathways (<xref rid="c14" ref-type="bibr">Botteri Principato et al. 2018</xref>; <xref rid="c98" ref-type="bibr">Haggard et al. 2018a</xref>; <xref rid="c133" ref-type="bibr">Karmaus et al. 2016</xref>). Several <italic>in vitro</italic> HTS assays for identification of thyroid active chemicals are now available, or under development, and the ToxCast and Tox21 programs have implemented <italic>in vitro</italic> HTS for targets in the thyroid pathway (<xref rid="c39" ref-type="bibr">Collins et al. 2008</xref>; <xref rid="c57" ref-type="bibr">Dix et al. 2007</xref>; <xref rid="c129" ref-type="bibr">Judson et al. 2010</xref>; <xref rid="c135" ref-type="bibr">Kavlock et al. 2008</xref>; <xref rid="c267" ref-type="bibr">Thomas et al. 2018</xref>). In Europe, the Joint Research Commission European Union Reference Laboratory for Alternatives to Animal Testing has been developing and validating <italic>in vitro</italic> thyroid assays for test guidelines (<xref rid="c66" ref-type="bibr">EU Science Hub 2017</xref>), following an Organisation for Economic Co-operation and Development (OECD) scoping document on the availability of <italic>in vitro</italic> methods to investigate modulators of TH signaling (<xref rid="c194" ref-type="bibr">OECD 2014</xref>). Efforts to develop new methods for evaluating chemical interactions with the thyroid pathway have been informed by recent initiatives to evaluate the empirical evidence of chemical mechanisms of thyroid disruption (e.g., <xref rid="c65" ref-type="bibr">EU 2017</xref>; <xref rid="c179" ref-type="bibr">Murk et al. 2013</xref>).</p>
    <p>To meet regulatory requirements for identifying potential endocrine disruptors, integration of a chemical’s toxicity mechanisms and apical effects is needed. To date, this has been challenging for identifying chemicals that perturb TH signaling due to the limited availability of mechanistic and thyroid-relevant end points used to evaluate chemical safety. The OECD’s recently updated Guidance Document 150 includes a revised conceptual framework and associated <italic>in vitro</italic> and <italic>in vivo</italic> test guidelines for evaluating endocrine disruption, including guidelines that have been updated to add thyroid end points (<xref rid="c204" ref-type="bibr">OECD 2018</xref>j). The European Chemicals Agency has adopted OECD Guidance Document 150 in its regulatory guidance for evaluating biocides and pesticides for endocrine disruption (<xref rid="c2" ref-type="bibr">Andersson et al. 2018</xref>).</p>
    <p>Despite these recent advances, the application of new technologies to identify chemicals that exert effects through a thyroid mechanism continues to be complicated by a lack of linkages between chemical effects detected at macromolecular levels of biological organization (e.g., protein, cellular) and end points (e.g., serum TH) and adverse outcomes (e.g., developmental neurotoxicity) traditionally used in hazard assessment. Moreover, apical developmental end points collected in current regulatory test guidelines (<xref rid="t1" ref-type="table">Table 1</xref>) are not thyroid-specific and may occur through a variety of mechanisms, making it difficult to infer biological relevance, dose– and time–response relationships, and associated uncertainties. Taken together, regulatory test guidelines, when required for chemical assessments and regulatory decisions, continue to rely on thyroid measurements derived from <italic>in vivo</italic> animal testing with uncertainty about the mechanisms underlying adverse outcomes when observed.</p>
    <table-wrap id="t1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>U.S. EPA and OECD test guidelines with required (X) and optional (opt) <italic>in vivo</italic> thyroid end points and potentially thyroid-responsive adverse outcomes; laid out according to the adverse outcome pathway (AOP) diagram in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p>
      </caption>
      <alt-text>Table 1 lists test guideline, study title, life stage, TSH, T4, T3, thyroid weight, thyroid histopathology, potential thyroid-related end points, potential thyroid-related adverse outcomes, and references.</alt-text>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
          <col align="left" valign="top" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th align="left" id="t1c1" scope="col" rowspan="1" colspan="1">Test guideline</th>
            <th align="center" id="t1c2" scope="col" rowspan="1" colspan="1">Study title</th>
            <th align="center" id="t1c3" scope="col" rowspan="1" colspan="1">Life stage</th>
            <th align="center" id="t1c4" scope="col" rowspan="1" colspan="1">TSH</th>
            <th align="center" id="t1c5" scope="col" rowspan="1" colspan="1">T4</th>
            <th align="center" id="t1c6" scope="col" rowspan="1" colspan="1">T3</th>
            <th align="center" id="t1c7" scope="col" rowspan="1" colspan="1">Thyroid weight</th>
            <th align="center" id="t1c8" scope="col" rowspan="1" colspan="1">Thyroid histopathology</th>
            <th align="center" id="t1c9" scope="col" rowspan="1" colspan="1">Potential thyroid-responsive end points</th>
            <th align="center" id="t1c10" scope="col" rowspan="1" colspan="1">Potential thyroid-responsive adverse outcomes</th>
            <th align="center" id="t1c11" scope="col" rowspan="1" colspan="1">References</th>
          </tr>
        </thead>
        <tbody valign="top">
          <tr>
            <th colspan="11" align="left" id="t1c12" scope="row" headers="t1c1" rowspan="1">Mammalian (rat) models</th>
          </tr>
          <tr>
            <td align="left" id="t1c13" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 890.1450/890.1500</td>
            <td align="left" headers="t1c2 t1c13" rowspan="1" colspan="1">Pubertal development (EDSP Tier 1)</td>
            <td align="left" headers="t1c3 t1c13" rowspan="1" colspan="1">Peripubertal</td>
            <td align="center" headers="t1c4 t1c13" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c5 t1c13" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c6 t1c13" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c13" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c8 t1c13" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c9 t1c13" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c10 t1c13" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c11 t1c13" rowspan="1" colspan="1">
              <xref rid="c282" ref-type="bibr">U.S. EPA 2009</xref>
            </td>
          </tr>
          <tr>
            <td align="left" id="t1c14" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 890.1400, OECD TG 441<xref ref-type="table-fn" rid="TF2"><sup><italic>a</italic></sup></xref></td>
            <td align="left" headers="t1c2 t1c14" rowspan="1" colspan="1">Hershberger (EDSP Tier 1)</td>
            <td align="left" headers="t1c3 t1c14" rowspan="1" colspan="1">Castrated-peripubertal</td>
            <td align="center" headers="t1c4 t1c14" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c5 t1c14" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c6 t1c14" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c7 t1c14" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c8 t1c14" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c9 t1c14" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c10 t1c14" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c11 t1c14" rowspan="1" colspan="1"><xref rid="c193" ref-type="bibr">OECD 2009</xref>; <xref rid="c282" ref-type="bibr">U.S. EPA 2009</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c15" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.3050, OECD TG 407</td>
            <td align="left" headers="t1c2 t1c15" rowspan="1" colspan="1">28-d oral toxicity<xref ref-type="table-fn" rid="TF3"><sup><italic>b</italic></sup></xref><sup>,</sup><xref ref-type="table-fn" rid="TF4"><sup><italic>c</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c15" rowspan="1" colspan="1">Young adult</td>
            <td align="center" headers="t1c4 t1c15" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c5 t1c15" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c6 t1c15" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c15" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c8 t1c15" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c9 t1c15" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c10 t1c15" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c11 t1c15" rowspan="1" colspan="1"><xref rid="c201" ref-type="bibr">OECD 2018g</xref>; <xref rid="c279" ref-type="bibr">U.S. EPA 2000a</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c16" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.3100, OECD TG 408</td>
            <td align="left" headers="t1c2 t1c16" rowspan="1" colspan="1">90-d oral toxicity<xref ref-type="table-fn" rid="TF3"><sup><italic>b</italic></sup></xref><sup>,</sup><xref ref-type="table-fn" rid="TF4"><sup><italic>c</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c16" rowspan="1" colspan="1">Young adult</td>
            <td align="center" headers="t1c4 t1c16" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c5 t1c16" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c6 t1c16" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c7 t1c16" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c8 t1c16" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c9 t1c16" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c10 t1c16" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c11 t1c16" rowspan="1" colspan="1"><xref rid="c202" ref-type="bibr">OECD 2018h</xref>; <xref rid="c275" ref-type="bibr">U.S. EPA 1998a</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c17" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP non-guideline</td>
            <td align="left" headers="t1c2 t1c17" rowspan="1" colspan="1">CDT assay<xref ref-type="table-fn" rid="TF5"><sup><italic>d</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c17" rowspan="1" colspan="1">Dam, offspring</td>
            <td align="center" headers="t1c4 t1c17" rowspan="1" colspan="1">F0 (♀), F1</td>
            <td align="center" headers="t1c5 t1c17" rowspan="1" colspan="1">F0 (♀), F1</td>
            <td align="center" headers="t1c6 t1c17" rowspan="1" colspan="1">F0 (♀), F1</td>
            <td align="center" headers="t1c7 t1c17" rowspan="1" colspan="1">F0 (♀), F1</td>
            <td align="center" headers="t1c8 t1c17" rowspan="1" colspan="1">F0 (♀), F1</td>
            <td align="center" headers="t1c9 t1c17" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c10 t1c17" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c11 t1c17" rowspan="1" colspan="1">
              <xref rid="c281" ref-type="bibr">U.S. EPA 2005</xref>
            </td>
          </tr>
          <tr>
            <td align="left" id="t1c18" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.3700, OECD TG 414</td>
            <td align="left" headers="t1c2 t1c18" rowspan="1" colspan="1">Prenatal developmental toxicity<xref ref-type="table-fn" rid="TF4"><sup><italic>c</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c18" rowspan="1" colspan="1">Dam, offspring</td>
            <td align="center" headers="t1c4 t1c18" rowspan="1" colspan="1">F0 (♀)</td>
            <td align="center" headers="t1c5 t1c18" rowspan="1" colspan="1">F0 (♀)</td>
            <td align="center" headers="t1c6 t1c18" rowspan="1" colspan="1">F0 (♀)</td>
            <td align="center" headers="t1c7 t1c18" rowspan="1" colspan="1">F0 (♀)</td>
            <td align="center" headers="t1c8 t1c18" rowspan="1" colspan="1">F0 (♀)</td>
            <td align="left" headers="t1c9 t1c18" rowspan="1" colspan="1">External, soft tissue, and skeletal malformations</td>
            <td align="left" headers="t1c10 t1c18" rowspan="1" colspan="1">Altered locomotor and sensory functioning in offspring (OECD only)</td>
            <td align="left" headers="t1c11 t1c18" rowspan="1" colspan="1"><xref rid="c200" ref-type="bibr">OECD 2018f</xref>; <xref rid="c276" ref-type="bibr">U.S. EPA 1998b</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c19" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.3650, OECD TG 421/422</td>
            <td align="left" headers="t1c2 t1c19" rowspan="1" colspan="1">Combined 28-d, repro/developmental toxicity<xref ref-type="table-fn" rid="TF4"><sup><italic>c</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c19" rowspan="1" colspan="1">Parent, offspring</td>
            <td align="center" headers="t1c4 t1c19" rowspan="1" colspan="1">opt</td>
            <td align="center" headers="t1c5 t1c19" rowspan="1" colspan="1">F0 (♂), F1 &amp; F0 (♀): “if relevant”</td>
            <td align="center" headers="t1c6 t1c19" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c19" rowspan="1" colspan="1">F0: opt, F1: X</td>
            <td align="center" headers="t1c8 t1c19" rowspan="1" colspan="1">F0: opt, F1: X</td>
            <td align="left" headers="t1c9 t1c19" rowspan="1" colspan="1">Gross developmental malformations</td>
            <td align="left" headers="t1c10 t1c19" rowspan="1" colspan="1">Altered locomotor and sensory functioning in offspring</td>
            <td align="left" headers="t1c11 t1c19" rowspan="1" colspan="1"><xref rid="c203" ref-type="bibr">OECD 2018</xref>i; <xref rid="c280" ref-type="bibr">U.S. EPA 2000b</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c20" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.3800, OECD TG 443/416</td>
            <td align="left" headers="t1c2 t1c20" rowspan="1" colspan="1">EOGRT/two-gen reproduction<xref ref-type="table-fn" rid="TF4"><sup><italic>c</italic></sup></xref></td>
            <td align="left" headers="t1c3 t1c20" rowspan="1" colspan="1">Parent, offspring</td>
            <td align="center" headers="t1c4 t1c20" rowspan="1" colspan="1">F0, F1</td>
            <td align="center" headers="t1c5 t1c20" rowspan="1" colspan="1">F0, F1</td>
            <td align="center" headers="t1c6 t1c20" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c20" rowspan="1" colspan="1">F0, F1</td>
            <td align="center" headers="t1c8 t1c20" rowspan="1" colspan="1">F0, F1</td>
            <td align="left" headers="t1c9 t1c20" rowspan="1" colspan="1">Brain, CNS, and PNS histology and morphology, startle response habituation</td>
            <td align="left" headers="t1c10 t1c20" rowspan="1" colspan="1">Altered locomotor and sensory functioning in offspring</td>
            <td align="left" headers="t1c11 t1c20" rowspan="1" colspan="1"><xref rid="c198" ref-type="bibr">OECD 2018d</xref>, <xref rid="c205" ref-type="bibr">2018k</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c21" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.6300, OECD TG 426</td>
            <td align="left" headers="t1c2 t1c21" rowspan="1" colspan="1">Developmental neurotoxicity</td>
            <td align="left" headers="t1c3 t1c21" rowspan="1" colspan="1">Parent, offspring</td>
            <td align="center" headers="t1c4 t1c21" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c5 t1c21" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c6 t1c21" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c21" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c8 t1c21" rowspan="1" colspan="1">—</td>
            <td align="left" headers="t1c9 t1c21" rowspan="1" colspan="1">Brain, CNS, PNS histology and morphology, startle response habituation, learning, and memory</td>
            <td align="left" headers="t1c10 t1c21" rowspan="1" colspan="1">Altered locomotor, sensory, and cognitive functioning in offspring</td>
            <td align="left" headers="t1c11 t1c21" rowspan="1" colspan="1"><xref rid="c197" ref-type="bibr">OECD 2018c</xref>; <xref rid="c277" ref-type="bibr">U.S. EPA 1998c</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c22" scope="row" headers="t1c1 t1c12" rowspan="1" colspan="1"> OCSPP 870.4100-4300, OECD TG 451-453</td>
            <td align="left" headers="t1c2 t1c22" rowspan="1" colspan="1">Chronic toxicity/ carcinogenicity</td>
            <td align="left" headers="t1c3 t1c22" rowspan="1" colspan="1">Young adult</td>
            <td align="center" headers="t1c4 t1c22" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c5 t1c22" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c6 t1c22" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c22" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c8 t1c22" rowspan="1" colspan="1">X</td>
            <td align="left" headers="t1c9 t1c22" rowspan="1" colspan="1">Thyroid gland hypertrophy and hyperplasia</td>
            <td align="left" headers="t1c10 t1c22" rowspan="1" colspan="1">Thyroid tumors (rodent)</td>
            <td align="left" headers="t1c11 t1c22" rowspan="1" colspan="1"><xref rid="c196" ref-type="bibr">OECD 2018b</xref>; <xref rid="c278" ref-type="bibr">U.S. EPA 1998d</xref></td>
          </tr>
          <tr>
            <th colspan="11" align="left" id="t1c23" scope="row" headers="t1c1" rowspan="1">Non-mammalian animal models</th>
          </tr>
          <tr>
            <td align="left" id="t1c24" scope="row" headers="t1c1 t1c23" rowspan="1" colspan="1"> OCSPP 890.1100, OECD TG 231<xref ref-type="table-fn" rid="TF2"><sup><italic>a</italic></sup></xref></td>
            <td align="left" headers="t1c2 t1c24" rowspan="1" colspan="1">AMA (EDSP Tier 1)</td>
            <td align="left" headers="t1c3 t1c24" rowspan="1" colspan="1">Metamorphosis</td>
            <td align="center" headers="t1c4 t1c24" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c5 t1c24" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c6 t1c24" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c24" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c8 t1c24" rowspan="1" colspan="1">X</td>
            <td align="left" headers="t1c9 t1c24" rowspan="1" colspan="1">Growth (e.g., BW, HLL, SVL), developmental progression</td>
            <td align="left" headers="t1c10 t1c24" rowspan="1" colspan="1">Reduced survival, arrested or impaired metamorphosis</td>
            <td align="left" headers="t1c11 t1c24" rowspan="1" colspan="1"><xref rid="c195" ref-type="bibr">OECD 2018a</xref>; <xref rid="c282" ref-type="bibr">U.S. EPA 2009</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c25" scope="row" headers="t1c1 t1c23" rowspan="1" colspan="1"> OCSPP 890.2300, OECD TG 241<xref ref-type="table-fn" rid="TF2"><sup><italic>a</italic></sup></xref></td>
            <td align="left" headers="t1c2 t1c25" rowspan="1" colspan="1">LAGDA (EDSP Tier 2)</td>
            <td align="left" headers="t1c3 t1c25" rowspan="1" colspan="1">Metamorphosis</td>
            <td align="center" headers="t1c4 t1c25" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c5 t1c25" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c6 t1c25" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c25" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c8 t1c25" rowspan="1" colspan="1">X</td>
            <td align="left" headers="t1c9 t1c25" rowspan="1" colspan="1">Growth (e.g., BW, SVL), developmental progression</td>
            <td align="left" headers="t1c10 t1c25" rowspan="1" colspan="1">Reduced survival, arrested or impaired metamorphosis</td>
            <td align="left" headers="t1c11 t1c25" rowspan="1" colspan="1"><xref rid="c199" ref-type="bibr">OECD 2018e</xref>; <xref rid="c282" ref-type="bibr">U.S. EPA 2009</xref></td>
          </tr>
          <tr>
            <td align="left" id="t1c26" scope="row" headers="t1c1 t1c23" rowspan="1" colspan="1"> OCSPP 890.2100</td>
            <td align="left" headers="t1c2 t1c26" rowspan="1" colspan="1">Avian two-gen toxicity test (EDSP Tier 2)</td>
            <td align="left" headers="t1c3 t1c26" rowspan="1" colspan="1">Parent, offspring</td>
            <td align="center" headers="t1c4 t1c26" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c5 t1c26" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c6 t1c26" rowspan="1" colspan="1">—</td>
            <td align="center" headers="t1c7 t1c26" rowspan="1" colspan="1">X</td>
            <td align="center" headers="t1c8 t1c26" rowspan="1" colspan="1">X</td>
            <td align="left" headers="t1c9 t1c26" rowspan="1" colspan="1">Embryonic, hatchling, and chick malformations</td>
            <td align="left" headers="t1c10 t1c26" rowspan="1" colspan="1">Reduced survival, impaired hatchling, chick development</td>
            <td align="left" headers="t1c11 t1c26" rowspan="1" colspan="1">
              <xref rid="c282" ref-type="bibr">U.S. EPA 2009</xref>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="TF1">
          <p>Note: <italic>In vivo</italic> data collected under regulatory test guidelines can be mapped along an adverse outcome pathway (AOP) from early key events that indicate thyroid activity with high specificity to downstream biological responses and adverse outcomes that may or may not occur via a thyroid mechanism. Currently, no <italic>in vitro</italic> regulatory guidelines test chemical interactions with molecular targets in thyroid axis. —, Not applicable; AMA, amphibian metamorphosis assay; BW, body weight; CDT, comparative developmental thyroid; CNS, central nervous system; EDSP, Endocrine Disruptor Screening Program; EOGRT, extended one-generation reproduction test; F0, parental generation; F1, offspring, first generation; HLL, hind leg length; LAGDA, larval amphibian growth and development assay; OCSPP, Office of Chemical Safety and Pollution Prevention; OECD, Organisation for Economic Co-operation and Development; opt, optional end point; PNS, peripheral nervous system; SVL, snout vent length; TG, test guideline; TSH, thyroid stimulating hormone; X, required end point.</p>
        </fn>
        <fn id="TF2">
          <label>a</label>
          <p>U.S EPA and OECD test guidelines harmonized with one another to minimize duplications and variations in test methodologies.</p>
        </fn>
        <fn id="TF3">
          <label>b</label>
          <p>The 90-d and 28-d repeated-dose toxicity studies include additional test methodologies for inhalation and dermal dosing of test animals, depending on observed or predicted routes of exposure.</p>
        </fn>
        <fn id="TF4">
          <label>c</label>
          <p>Under U.S. EPA test guidelines, specific hormone measures in serum are not required (OCSPP 870.3800, 3700) or recommended for consideration if the test chemical is known or suspected to have an effect (OCSPP 870.3050, .3100, .3650).</p>
        </fn>
        <fn id="TF5">
          <label>d</label>
          <p>CDT (comparative developmental thyroid) assay in rats is a non-guideline study that has been required by the U.S. EPA’s Office of Pesticide Programs to supplement reproductive toxicity testing with thyroid-related data in pregnant and nursing dams, their fetuses, and offspring (<xref rid="c281" ref-type="bibr">U.S. EPA 2005</xref>).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </sec>
  <sec id="s2">
    <title>Objectives and Overview of Challenges</title>
    <p>To facilitate the regulatory application of data derived from these new technologies, we present an adverse outcome pathway (AOP) network (<xref ref-type="fig" rid="f1">Figures 1</xref>–<xref ref-type="fig" rid="f2">2</xref>) that links well-known and putative chemical targets of thyroid activity to downstream adverse outcomes. We examine current regulatory and scientific challenges in screening chemicals for thyroid-related perturbations, and propose how new <italic>in vitro</italic> technologies in the context of the thyroid AOP network can serve as a screening tool to identify chemicals that interact with targets in the thyroid pathway. Measuring chemical interactions with thyroid-related molecular targets can help elucidate whether adverse outcomes are mediated through a TH signaling mechanism.</p>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>An adverse outcome pathway (AOP) begins with a molecular initiating event (MIE) and terminates in an adverse outcome that is linked by a series of intermediate key events (KEs) at increasing levels of biological organization. Adverse outcomes at the organism level are used in human health risk assessment and typically with plausible linkages to the population level for ecological risk assessment. A simplified example of an AOP network is presented whereby three MIEs shown in the first column (shaded green) elicit specific cellular responses in the next three columns (KE1, KE2, KE3; shaded orange) that converge in shared organ pathology (KE4) and mediate downstream organ system alterations (KE5) to produce divergent adverse outcomes at the organism (AO1, AO2) and population (AO3) levels as shown in the last two columns (shaded red).</p>
      </caption>
      <alt-text>Figure 1 is a tabular representation with three columns, namely, M I Es, key events, and adverse outcomes, comprises a flow chart. Molecular interaction leads to cellular response, which leads to responses at the organ, organ system, organism, and population levels. M I E 1 leads to K E 1, K E 4, K E 5 (connected to A O 2), A O 1, and A O 3. M I E 2 leads to K E 2, which is connected to K E 4. M I E 3 leads to K E 3, which is connected to K E 4.</alt-text>
      <graphic xlink:href="ehp-127-095001-g0001"/>
    </fig>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Adverse outcome pathway (AOP) network for chemically induced thyroid activity showing the integration of multiple individual AOPs under development and proposed. Biological linkages described may be informed by <italic>in vitro</italic>, <italic>in vivo</italic>, or computational data and may be causal, inferential, or putative, depending on the strength of the evidence. Boxes with thick, red borders represent <italic>in vivo</italic> end points that are targeted by U.S. EPA and OECD test guidelines. In the left-hand column, MIE boxes with solid borders (shaded green) represent current MIEs with <italic>in vitro</italic> high-throughput screening (HTS) assays that have demonstrated reliability and are available for use in thyroid activity screens, whereas those with dashed borders represent putative MIEs in the thyroid axis currently without <italic>in vitro</italic> HTS capabilities. In the key events (KEs) column, the box with the striped background (shaded yellow) depicts changes in serum TH as a KE node that represents a biomarker of thyroid disruption, whereas the trapezoids (shaded blue) represent additional potential KE nodes with limited data. Uppercase nomenclature denoting human protein is shown although present in differing species. Asterisks represent KEs being treated as MIEs. References and AOPs supporting the thyroid AOP network are identified in <xref rid="t2" ref-type="table">Table 2</xref>. AhR, aryl hydrocarbon receptor; BDNF, brain-derived neurotrophic factor; CAR, constitutive androstane receptor; DIO, iodothyronine deiodinase; DIO1, type 1 deiodinase; DIO2, type 2 deiodinase; DIO3, type 3 deiodinase; DUOX, dual oxidase; IYD, iodotyrosine deiodinase; LDL, low-density lipoprotein; MDR, multidrug resistance protein; MCT, monocarboxylate transporter; NIS, sodium–iodide symporter; OATP, organic anion transporter polypeptide; OECD, Organisation for Economic Co-operation and Development; PPAR, peroxisome proliferator-activated receptor; PXR, pregnane X receptor; rT3, reverse T3 (3,3ʹ,5ʹ-triiodothyronine); RXR, retinoid X receptor; SULT, sulfotransferase; T3, 3,3′,5-triiodothyronine; T4, thyroxine; TBG, thyroid binding globulin; TH, thyroid hormone; TPO, thyroperoxidase; TR, thyroid hormone receptor; TRHR, thyrotropin releasing hormone receptor; TSHR, thyroid stimulating hormone receptor; TTR, transthyretin; UDPGT, uridine diphosphate glucuronosyltransferase.</p>
      </caption>
      <alt-text>Figure 2 is a tabular representation with three columns, namely, M I Es, key events, and adverse outcomes, comprises a flow chart showing the connections in Hypothalamic-pituitary feedback, TH synthesis (Thyroid), Xenobiotic receptor activation (Liver), Serum TH transport, Peripheral TH metabolism, Cellular TH transport, and TR transactivation.</alt-text>
      <graphic xlink:href="ehp-127-095001-g0002"/>
    </fig>
    <p>TH signaling involves feedback interactions of the hypothalamic–pituitary–thyroid (HPT) axis, circulatory system, liver, and other tissues, collectively referred to here as the thyroid axis, that are critical to the maintenance of homeostasis and regulation of development and physiological functions (<xref rid="c10" ref-type="bibr">Bernal 2005</xref>; <xref rid="c52" ref-type="bibr">Denver 1998</xref>; <xref rid="c62" ref-type="bibr">Dussault and Ruel 1987</xref>; <xref rid="c211" ref-type="bibr">Oppenheimer and Schwartz 1997</xref>; <xref rid="c223" ref-type="bibr">Power et al. 2001</xref>; <xref rid="c256" ref-type="bibr">Silva 1995</xref>; <xref rid="c310" ref-type="bibr">Yen 2001</xref>; <xref rid="c316" ref-type="bibr">Zhang and Lazar 2000</xref>; <xref rid="c321" ref-type="bibr">Zoeller et al. 2005</xref>). In contrast to other endocrine pathways, evaluation of chemical impacts on the thyroid axis requires a more involved screening strategy because chemicals perturb TH signaling through several mechanisms other than the thyroid hormone receptor (TR) (<xref rid="c24" ref-type="bibr">Brucker-Davis 1998</xref>; <xref rid="c29" ref-type="bibr">Capen and Martin 1989</xref>; <xref rid="c28" ref-type="bibr">Capen 1997</xref>; <xref rid="c53" ref-type="bibr">DeVito et al. 1999</xref>; <xref rid="c121" ref-type="bibr">Hurley 1998</xref>; <xref rid="c284" ref-type="bibr">U.S. EPA 2015a</xref>). Clinical and experimental evidence describe receptor-independent disruption of TH signaling that can result in reduced serum and tissue concentrations of TH that can lead to abnormal brain development, irreversible cognitive deficits, and other impairments, depending on the severity and timing of the TH insufficiency (as reviewed by <xref rid="c24" ref-type="bibr">Brucker-Davis 1998</xref>; <xref rid="c29" ref-type="bibr">Capen and Martin 1989</xref>; <xref rid="c42" ref-type="bibr">Crofton 2008</xref>; <xref rid="c54" ref-type="bibr">Diamanti-Kandarakis et al. 2009</xref>; <xref rid="c89" ref-type="bibr">Gilbert and Zoeller 2010</xref>; <xref rid="c93" ref-type="bibr">Gore et al. 2015</xref>; <xref rid="c121" ref-type="bibr">Hurley 1998</xref>; <xref rid="c142" ref-type="bibr">Köhrle 2008</xref>; <xref rid="c179" ref-type="bibr">Murk et al. 2013</xref>; <xref rid="c319" ref-type="bibr">Zoeller 2005</xref>).</p>
    <p>To help link molecular targets that may mediate thyroid-dependent apical effects, AOPs can be integrated in an AOP network (<xref ref-type="fig" rid="f1">Figure 1</xref>) that includes multiple molecular initiating events (MIEs) sharing one or more key events (KEs) leading to one or more adverse outcomes (<xref rid="c3" ref-type="bibr">Ankley et al. 2010</xref>; <xref rid="c23" ref-type="bibr">Browne et al. 2017</xref>; <xref rid="c213" ref-type="bibr">Paul Friedman et al. 2016</xref>; <xref rid="c292" ref-type="bibr">Villeneuve et al. 2014</xref>; <xref rid="c291" ref-type="bibr">Villeneuve et al. 2018</xref>; <xref rid="c304" ref-type="bibr">Wittwehr et al. 2017</xref>). The thyroid AOP network herein (<xref ref-type="fig" rid="f2">Figure 2</xref>) provides a tool for mapping TH signaling data collected at multiple levels of biological organization and using differing study designs. It is intended to aide in evidence integration and determining if a chemical is exerting an adverse outcome by a thyroid mechanism.</p>
  </sec>
  <sec id="s3">
    <title>Discussion</title>
    <sec id="s3.1">
      <title>In Vitro HTS Assays Aimed at MIEs in the Thyroid Axis</title>
      <p>Over two dozen MIEs in the thyroid axis are demonstrated or hypothesized to be potential targets of chemicals (<xref rid="t2" ref-type="table">Table 2</xref>). These MIEs have been described at length in a recent review (<xref rid="c194" ref-type="bibr">OECD 2014</xref>) and workshop (<xref rid="c179" ref-type="bibr">Murk et al. 2013</xref>), so they will only be briefly summarized here. As a result of these and other collaborative efforts over the years, an increasing number of <italic>in vitro</italic> HTS assays and lower-/medium-throughput assays amenable to high-throughput platforms have been developed to measure chemical interactions with MIEs that may lead to perturbed TH synthesis, delivery, metabolism, and signaling. Perhaps two of the most well-characterized MIEs in the thyroid axis involve disruption of TH production by chemical interference with iodide uptake into thyroid follicular cells by inhibition of the Na<sup>+</sup>/I<sup>–</sup> symporter (NIS) (<xref rid="c36" ref-type="bibr">Clewell et al. 2004</xref>; <xref rid="c154" ref-type="bibr">Lecat-Guillet et al. 2008</xref>; <xref rid="c229" ref-type="bibr">Richards and Ingbar 1959</xref>; <xref rid="c272" ref-type="bibr">Tietge et al. 2005</xref>, <xref rid="c270" ref-type="bibr">2010</xref>; <xref rid="c305" ref-type="bibr">Wolff 1998</xref>; <xref rid="c307" ref-type="bibr">Wu et al. 2016</xref>) and by inhibition of thyroperoxidase (TPO) activity (<xref rid="c38" ref-type="bibr">Coady et al. 2010</xref>; <xref rid="c47" ref-type="bibr">Davidson et al. 1978</xref>; <xref rid="c49" ref-type="bibr">Degitz et al. 2005</xref>; <xref rid="c70" ref-type="bibr">Francis and Rennert 1980</xref>; <xref rid="c270" ref-type="bibr">Tietge et al. 2010</xref>). An <italic>in vitro</italic> radioactive iodide uptake assay coupled to a human NIS-expressing HEK293T cell line has been developed and adapted for use as an <italic>in vitro</italic> HTS assay to identify chemicals that may inhibit iodide uptake by NIS (<xref rid="c102" ref-type="bibr">Hallinger et al. 2017</xref>; <xref rid="c297" ref-type="bibr">Wang et al. 2018</xref>). Another <italic>in vitro</italic> HTS assay has been developed to use the commercially available fluorescent peroxidase substrate, Amplex UltraRed to detect TPO inhibition (the “AUR-TPO” assay), and was used to screen approximately 1,000 chemicals in the ToxCast phase 1 and 2 libraries (<xref rid="c213" ref-type="bibr">Paul Friedman et al. 2016</xref>; <xref rid="c216" ref-type="bibr">Paul et al. 2014</xref>).</p>
      <table-wrap id="t2" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p>Identification of known and putative molecular targets [i.e., molecular initiating events (MIEs) and key events (KEs) being treated as MIEs] of chemical-induced thyroid disruption.</p>
        </caption>
        <alt-text>Table 2 lists molecular initiating event in the first column and the corresponding toxicological mechanism, in vitro HTS assay readiness, potential adverse outcomes, and references in subsequent columns.</alt-text>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="top" span="1"/>
            <col align="left" valign="top" span="1"/>
            <col align="left" valign="top" span="1"/>
            <col align="left" valign="top" span="1"/>
            <col align="left" valign="top" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" id="t2c1" scope="col" rowspan="1" colspan="1">Molecular initiating event</th>
              <th align="center" id="t2c2" scope="col" rowspan="1" colspan="1">Toxicological mechanism<xref ref-type="table-fn" rid="TF7"><sup><italic>a</italic></sup></xref></th>
              <th align="center" id="t2c3" scope="col" rowspan="1" colspan="1"><italic>In vitro</italic> HTS assay readiness<xref ref-type="table-fn" rid="TF8"><sup><italic>b</italic></sup></xref></th>
              <th align="center" id="t2c4" scope="col" rowspan="1" colspan="1">Potential adverse outcomes<xref ref-type="table-fn" rid="TF9"><sup><italic>c</italic></sup></xref></th>
              <th align="center" id="t2c5" scope="col" rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <th colspan="5" align="left" id="t2c6" scope="row" headers="t2c1" rowspan="1">TH synthesis (thyroid gland)</th>
            </tr>
            <tr>
              <td align="left" rowspan="5" id="t2c7" scope="row" headers="t2c1 t2c6" colspan="1"> Sodium–iodide symporter (NIS)</td>
              <td align="left" rowspan="4" headers="t2c2 t2c7" colspan="1">Regulates serum iodide uptake into thyroid follicular cells and other tissues. Inhibition of NIS-iodide transport disrupts T4 and T3 synthesis. Well-characterized chemical target in thyroid pathway.</td>
              <td align="left" rowspan="5" headers="t2c3 t2c7" colspan="1"><italic>Existing:</italic><xref rid="c102" ref-type="bibr">Hallinger et al. 2017</xref>; <xref rid="c297" ref-type="bibr">Wang et al. 2018</xref></td>
              <td align="left" headers="t2c4 t2c7" rowspan="1" colspan="1">Mammals: Developmental neurotoxicity, cognitive defects</td>
              <td align="left" rowspan="3" headers="t2c5 t2c7" colspan="1"><italic>In vivo</italic> studies: <xref rid="c88" ref-type="bibr">Gilbert and Sui 2008</xref>; <xref rid="c91" ref-type="bibr">Goleman et al. 2002</xref>; <xref rid="c165" ref-type="bibr">McNabb et al. 2004</xref>; <xref rid="c272" ref-type="bibr">Tietge et al. 2005</xref>, <xref rid="c270" ref-type="bibr">2010</xref>; <xref rid="c312" ref-type="bibr">York et al. 2004</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c4 t2c7" rowspan="1" colspan="1">Amphibians: Impaired metamorphosis</td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c4 t2c7" colspan="1">Birds: Delayed hatching, increased mortality, decreased growth</td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c7" rowspan="1" colspan="1"><italic>In vitro</italic> studies: <xref rid="c32" ref-type="bibr">Chen et al. 2008</xref><break/>Reviews: <xref rid="c189" ref-type="bibr">NRC 2005</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c7" rowspan="1" colspan="1">
                <italic>Chemicals: perchlorate, chlorate, nitrate, thiocyanate, small ion drugs</italic>
              </td>
              <td align="left" headers="t2c4 t2c7" rowspan="1" colspan="1">
                <italic>AOPs 54, 110, 134, 176</italic>
              </td>
              <td align="left" headers="t2c5 t2c7" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="6" id="t2c8" scope="row" headers="t2c1 t2c6" colspan="1"> Thyroperoxidase (TPO)</td>
              <td align="left" rowspan="6" headers="t2c2 t2c8" colspan="1">Catalyzes oxidation of iodide, nonspecific iodination of tyrosyl residues of thyroglobulin (Tg), and coupling of iodotyrosyls to form Tg-bound T3 and T4. Inhibition of TPO activity disrupts TH synthesis. Well-characterized chemical target in thyroid pathway.<break/><italic>Chemicals: methimazole, PTU, pronamide, soy isoflavones, mancozeb, resorcinol, triclosan</italic></td>
              <td align="left" rowspan="6" headers="t2c3 t2c8" colspan="1">
                <italic>Existing:</italic>
                <xref rid="c213" ref-type="bibr">Paul Friedman et al. 2016</xref>
              </td>
              <td align="left" headers="t2c4 t2c8" rowspan="1" colspan="1">Mammals: Visual deficits, developmental neurotoxicity, cognitive defects; MOA/AOP developmental neurotoxicity in rat</td>
              <td align="left" rowspan="4" headers="t2c5 t2c8" colspan="1"><italic>In vivo</italic> studies: <xref rid="c4" ref-type="bibr">Ausó et al. 2004</xref>; <xref rid="c17" ref-type="bibr">Boyes et al. 2018</xref>; <xref rid="c49" ref-type="bibr">Degitz et al. 2005</xref>; <xref rid="c69" ref-type="bibr">Fort et al. 2000</xref>; <xref rid="c84" ref-type="bibr">Gilbert 2011</xref>; <xref rid="c86" ref-type="bibr">Gilbert et al. 2013</xref>, <xref rid="c87" ref-type="bibr">2016</xref>; <xref rid="c92" ref-type="bibr">Goodman and Gilbert 2007</xref>; <xref rid="c153" ref-type="bibr">Lasley and Gilbert 2011</xref>; <xref rid="c184" ref-type="bibr">Nelson et al. 2016</xref>; <xref rid="c190" ref-type="bibr">O’Shaughnessy et al. 2018a</xref>, <xref rid="c191" ref-type="bibr">2018b</xref>; <xref rid="c263" ref-type="bibr">Stinckens et al. 2016</xref>; <xref rid="c322" ref-type="bibr">Zoeller and Crofton 2005</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c4 t2c8" rowspan="1" colspan="1">Rat: Thyroid cancer</td>
            </tr>
            <tr>
              <td align="left" headers="t2c4 t2c8" rowspan="1" colspan="1">Amphibians: Impaired metamorphosis</td>
            </tr>
            <tr>
              <td align="left" rowspan="3" headers="t2c4 t2c8" colspan="1">Fish: Reduced swim bladder inflation<break/><italic>AOPs 42, 119, 159, 175, 271</italic></td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c8" rowspan="1" colspan="1"><italic>In vitro</italic> studies: <xref rid="c47" ref-type="bibr">Davidson et al. 1978</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c8" rowspan="1" colspan="1">Reviews: <xref rid="c50" ref-type="bibr">Dellarco et al. 2006</xref>; <xref rid="c121" ref-type="bibr">Hurley 1998</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="3" id="t2c9" scope="row" headers="t2c1 t2c6" colspan="1"> Iodotyrosine deiodinase (IYD)</td>
              <td align="left" rowspan="2" headers="t2c2 t2c9" colspan="1">Scavenges/recycles iodide in the thyroid by catalyzing deiodination to T1 and T2. Limited evidence of chemical inhibition.</td>
              <td align="left" rowspan="3" headers="t2c3 t2c9" colspan="1">Promising</td>
              <td align="left" rowspan="2" headers="t2c4 t2c9" colspan="1">Amphibians: Impaired metamorphosis<break/><italic>AOP 188</italic></td>
              <td align="left" headers="t2c5 t2c9" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c208" ref-type="bibr">Olker et al. 2018b</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c5 t2c9" colspan="1"><italic>In vitro</italic> studies: <xref rid="c254" ref-type="bibr">Shimizu et al. 2013</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c9" rowspan="1" colspan="1">
                <italic>Chemicals: 3-nitro-L-tyrosine, OH-PCBs, OH-PBDEs, rose bengal</italic>
              </td>
              <td align="left" headers="t2c4 t2c9" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c10" scope="row" headers="t2c1 t2c6" colspan="1"> Pendrin</td>
              <td align="left" headers="t2c2 t2c10" rowspan="1" colspan="1">Transports iodide from cytosol of thyroid follicular cell into lumen for organification. No reports of chemical interactions; research limited.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c10" colspan="1">Early</td>
              <td align="left" headers="t2c4 t2c10" rowspan="1" colspan="1">Not yet characterized<break/><italic>AOP 192</italic></td>
              <td align="left" rowspan="2" headers="t2c5 t2c10" colspan="1">—</td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c10" rowspan="1" colspan="1">
                <italic>Chemicals: Unknown</italic>
              </td>
              <td align="left" headers="t2c4 t2c10" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c11" scope="row" headers="t2c1 t2c6" colspan="1"> Dual oxidase (DUOX)</td>
              <td align="left" headers="t2c2 t2c11" rowspan="1" colspan="1">Generates peroxide necessary for TH synthesis. No reports of chemical interactions. Research limited.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c11" colspan="1">Early</td>
              <td align="left" headers="t2c4 t2c11" rowspan="1" colspan="1">Not yet characterized<break/><italic>AOP 193</italic></td>
              <td align="left" rowspan="2" headers="t2c5 t2c11" colspan="1">—</td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c11" rowspan="1" colspan="1">
                <italic>Chemicals: Unknown</italic>
              </td>
              <td align="left" headers="t2c4 t2c11" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th colspan="5" align="left" id="t2c12" scope="row" headers="t2c1" rowspan="1"> TH transport (serum)</th>
            </tr>
            <tr>
              <td align="left" rowspan="3" id="t2c13" scope="row" headers="t2c1 t2c12" colspan="1"> Transthyretin (TTR); Thyroid binding globulin (TBG); Albumin</td>
              <td align="left" headers="t2c2 t2c13" rowspan="1" colspan="1">Bind and distribute TH in circulation. TTR and TBG are known chemical targets. Albumin is the most abundant, but TH binding is nonspecific with low affinity.</td>
              <td align="left" rowspan="3" headers="t2c3 t2c13" colspan="1"><italic>Existing:</italic><xref rid="c160" ref-type="bibr">Marchesini et al. 2006</xref>; <xref rid="c171" ref-type="bibr">Montaño et al. 2012</xref></td>
              <td align="left" headers="t2c4 t2c13" rowspan="1" colspan="1">Not yet characterized<break/><italic>AOP 152</italic></td>
              <td align="left" headers="t2c5 t2c13" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c101" ref-type="bibr">Hallgren and Darnerud 2002</xref>; <xref rid="c107" ref-type="bibr">Hedge et al. 2009</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c2 t2c13" colspan="1">
                <italic>Chemicals: OH-PCBs, OH-BDEs, PFAS, TBBPA, TCBPA, genistein, dioxins</italic>
              </td>
              <td align="left" rowspan="2" headers="t2c4 t2c13" colspan="1"/>
              <td align="left" headers="t2c5 t2c13" rowspan="1" colspan="1"><italic>In vitro</italic> studies: <xref rid="c31" ref-type="bibr">Cheek et al. 1999</xref>; <xref rid="c103" ref-type="bibr">Hamers et al. 2006</xref>; <xref rid="c151" ref-type="bibr">Lans et al. 1994</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c13" rowspan="1" colspan="1">Reviews: <xref rid="c20" ref-type="bibr">Brouwer et al. 1998</xref></td>
            </tr>
            <tr>
              <th colspan="5" align="left" id="t2c14" scope="row" headers="t2c1" rowspan="1">TH metabolism and excretion (liver and other target tissues)</th>
            </tr>
            <tr>
              <td align="left" rowspan="3" id="t2c15" scope="row" headers="t2c1 t2c14" colspan="1"> Iodothyronine deiodinase(DIO) Type 1 (DIO1); DIO Type 2 (DIO2); DIO Type 3 (DIO3)</td>
              <td align="left" rowspan="2" headers="t2c2 t2c15" colspan="1">Control the activation and inactivation of T4 in a tissue-specific and temporal manner. With the exception of FD&amp;C red dye no. 3 that has been shown to induce thyroid tumors in rats, no studies to date have shown chemicals that exert effects on DIO expression and/or activity to directly manifest in adverse outcomes.</td>
              <td align="left" rowspan="3" headers="t2c3 t2c15" colspan="1"><italic>Existing:</italic> DIO1: <xref rid="c114" ref-type="bibr">Hornung et al. 2018</xref> DIO2, DIO3: <xref rid="c209" ref-type="bibr">Olker et al. 2019</xref></td>
              <td align="left" rowspan="2" headers="t2c4 t2c15" colspan="1">Not yet characterized<break/><italic>AOPs 156-158, 189-191</italic></td>
              <td align="left" headers="t2c5 t2c15" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c13" ref-type="bibr">Borzelleca et al. 1987</xref>; <xref rid="c113" ref-type="bibr">Hood and Klaassen 2000</xref>; <xref rid="c169" ref-type="bibr">Mol et al. 1999</xref>; <xref rid="c177" ref-type="bibr">Morse et al. 1993</xref>; <xref rid="c187" ref-type="bibr">Noyes et al. 2011</xref>, <xref rid="c188" ref-type="bibr">2013</xref>; <xref rid="c266" ref-type="bibr">Szabo et al. 2009</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c5 t2c15" colspan="1"><italic>In vitro</italic> studies: <xref rid="c27" ref-type="bibr">Butt et al. 2011</xref>; <xref rid="c29" ref-type="bibr">Capen and Martin 1989</xref>; <xref rid="c67" ref-type="bibr">Ferreira et al. 2002</xref>; <xref rid="c209" ref-type="bibr">Olker et al. 2019</xref>; <xref rid="c227" ref-type="bibr">Renko et al. 2015</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c15" rowspan="1" colspan="1">
                <italic>Chemicals: FD&amp;C red dye no. 3, phenobarbital, PCN PTU, PCBs, PBDEs</italic>
              </td>
              <td align="left" headers="t2c4 t2c15" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c16" scope="row" headers="t2c1 t2c14" colspan="1"> Constitutive androstane receptor (CAR); Pregnane X receptor (PXR); Aryl hydrocarbon receptor (AhR)</td>
              <td align="left" headers="t2c2 t2c16" rowspan="1" colspan="1">Xenobiotic nuclear receptors that up-regulate expression of phase I and II metabolic enzymes and phase III uptake and efflux transporters, some of which may accelerate TH catabolism and clearance.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c16" colspan="1"><italic>Existing:</italic> ToxCast/Tox21 <xref rid="c106" ref-type="bibr">He et al. 2011</xref>; <xref rid="c158" ref-type="bibr">Maglich et al. 2003</xref>; <xref rid="c233" ref-type="bibr">Romanov et al. 2008</xref>; <xref rid="c237" ref-type="bibr">Rosenfeld et al. 2003</xref></td>
              <td align="left" rowspan="2" headers="t2c4 t2c16" colspan="1">See UDPGTs and SULTs</td>
              <td align="left" rowspan="2" headers="t2c5 t2c16" colspan="1">See UDPGTs and SULTs</td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c16" rowspan="1" colspan="1"><italic>Chemicals: See</italic> UDPGTs and SULTs</td>
            </tr>
            <tr>
              <td align="left" rowspan="5" id="t2c17" scope="row" headers="t2c1 t2c14" colspan="1"> Uridine diphosphate glucuronosyltransferase (UDPGTs; e.g., UGT1A1, UGT1A6); sulfotransferases (SULTs; e.g., SULT2A1)</td>
              <td align="left" headers="t2c2 t2c17" rowspan="1" colspan="1">Major phase II chemical conjugation pathways that also regulate TH catabolism. Chemical up-regulation in the expression and activity of UDPGTs and SULTs increase T4 glucuronidation and sulfation, respectively. There are numerous isoforms of UDPGTs and SULTs, with UGT1A1, UGT1A6, and SULT2A1 having been shown to metabolize T4.</td>
              <td align="left" rowspan="5" headers="t2c3 t2c17" colspan="1">Promising</td>
              <td align="left" headers="t2c4 t2c17" rowspan="1" colspan="1">UDPGTs: Mammalian cochlear damage and hearing loss; MOA/AOP hearing deficits via up-regulated TH catabolism.<break/><italic>AOPs 8, 194</italic></td>
              <td align="left" rowspan="3" headers="t2c5 t2c17" colspan="1"><italic>In vivo</italic> studies: <xref rid="c6" ref-type="bibr">Barter and Klaassen 1992</xref>, <xref rid="c7" ref-type="bibr">1994</xref>; <xref rid="c100" ref-type="bibr">Haines et al. 2018</xref>; <xref rid="c138" ref-type="bibr">Klaassen and Hood 2001</xref>; <xref rid="c266" ref-type="bibr">Szabo et al. 2009</xref>; <xref rid="c289" ref-type="bibr">Vansell and Klaassen 2002</xref>; <xref rid="c295" ref-type="bibr">Visser et al. 1993</xref>; <xref rid="c306" ref-type="bibr">Wong et al. 2005</xref>; <xref rid="c315" ref-type="bibr">Yu et al. 2009</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="4" headers="t2c2 t2c17" colspan="1">
                <italic>Chemicals: OH-BDEs, OH-PCBs, PAHs, PFAS, BPA, triclosan, dioxins, propiconazole, phthalates, phenobarbital, rifampicin, PCN</italic>
              </td>
              <td align="left" headers="t2c4 t2c17" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="3" headers="t2c4 t2c17" colspan="1">SULTs: Not yet characterized</td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c17" rowspan="1" colspan="1"><italic>In vitro</italic> studies: <xref rid="c26" ref-type="bibr">Butt and Stapleton 2013</xref>; <xref rid="c152" ref-type="bibr">Larson et al. 2011</xref>; <xref rid="c238" ref-type="bibr">Rotroff et al. 2010</xref>; <xref rid="c249" ref-type="bibr">Schuur et al. 1998</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c17" rowspan="1" colspan="1">Reviews: <xref rid="c44" ref-type="bibr">Crofton and Zoeller 2005</xref>; <xref rid="c145" ref-type="bibr">Konno et al. 2008</xref>; <xref rid="c298" ref-type="bibr">Wang and James 2006</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c18" scope="row" headers="t2c1 t2c14" colspan="1"> Alanine side-chain reactions</td>
              <td align="left" headers="t2c2 t2c18" rowspan="1" colspan="1">T4 and T3 alanine side-chains can be metabolized by oxidative decarboxylation or deamination, producing thyroanimines and thyroacetic acids, respectively.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c18" colspan="1">Early</td>
              <td align="left" rowspan="2" headers="t2c4 t2c18" colspan="1">Not yet characterized</td>
              <td align="left" rowspan="2" headers="t2c5 t2c18" colspan="1">Reviews: <xref rid="c244" ref-type="bibr">Scanlan 2009</xref>; <xref rid="c308" ref-type="bibr">Wu et al. 2005</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c18" rowspan="1" colspan="1">
                <italic>Chemicals: Unknown</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="5" id="t2c19" scope="row" headers="t2c1 t2c14" colspan="1"> Peroxisome proliferator-activated receptor (PPARα, PPARβ/δ, PPARγ)</td>
              <td align="left" rowspan="3" headers="t2c2 t2c19" colspan="1">Key regulators controlling lipid and carbohydrate metabolism, as well as in mediating cellular differentiation and proliferation, and reproductive development. PPARs and TRs bind to DNA response elements as heterodimers with the RXR and other NRs and have been shown to compete for binding with RXR as well as for TR-transcriptional coactivators and corepressors.</td>
              <td align="left" rowspan="5" headers="t2c3 t2c19" colspan="1"><italic>Existing:</italic> ToxCast/Tox21: R <xref rid="c119" ref-type="bibr">Huang et al. 2016</xref>; <xref rid="c163" ref-type="bibr">Martin et al. 2010</xref>; <xref rid="c233" ref-type="bibr">Romanov et al. 2008</xref>; <xref rid="c288" ref-type="bibr">van Raalte et al. 2004</xref></td>
              <td align="left" rowspan="5" headers="t2c4 t2c19" colspan="1">Not yet characterized</td>
              <td align="left" headers="t2c5 t2c19" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c148" ref-type="bibr">Lake et al. 2016</xref>; <xref rid="c260" ref-type="bibr">Springer et al. 2012</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c19" rowspan="1" colspan="1"><italic>In vitro</italic> studies: <xref rid="c118" ref-type="bibr">Huang et al. 2011</xref>; <xref rid="c132" ref-type="bibr">Juge-Aubry et al. 1995</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c5 t2c19" colspan="1"><italic>In silico</italic> studies: <xref rid="c186" ref-type="bibr">Nolte et al. 1998</xref><break/>Reviews: <xref rid="c122" ref-type="bibr">Hyyti and Portman 2006</xref>; <xref rid="c157" ref-type="bibr">Lu and Cheng 2010</xref>; <xref rid="c168" ref-type="bibr">Miller et al. 2009</xref>; <xref rid="c301" ref-type="bibr">White et al. 2011</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c2 t2c19" colspan="1">
                <italic>Chemicals: PFAS, PBDEs, phthalates, BPA, TBBPA, TCBPA, organochlorine pesticides, EE2, fibrate drugs, Wy14,643, rosiglitazone, thiazolidinediones</italic>
              </td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c19" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th colspan="5" align="left" id="t2c20" scope="row" headers="t2c1" rowspan="1"> TH transport (cellular)</th>
            </tr>
            <tr>
              <td align="left" id="t2c21" scope="row" headers="t2c1 t2c20" rowspan="1" colspan="1"> Monocarboxylate transporter (MCT8, MCT10); organic anion transporter polypeptide (e.g., OATP1C1; OATP1A4);</td>
              <td align="left" headers="t2c2 t2c21" rowspan="1" colspan="1">MCT8 is a specific cellular transporter of TH, and MCT8 mutations produce hypothyroidism and severe neurological impairments. MCT10, OATP1C1, and OATP1A4 mediate transport TH and other ligands. There are numerous other transporters that have been shown to transport TH, including several other subtypes of OATPs and L-type amino acid transporter (LAT1, LAT2). Limited evidence that some chemicals may alter expression.<break/><italic>Chemicals: tyrosine kinase inhibitors, fenamate drugs, TRIAC, PBDEs</italic></td>
              <td align="left" headers="t2c3 t2c21" rowspan="1" colspan="1">Early</td>
              <td align="left" headers="t2c4 t2c21" rowspan="1" colspan="1">Not yet characterized</td>
              <td align="left" headers="t2c5 t2c21" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c18" ref-type="bibr">Braun et al. 2012</xref>; <xref rid="c109" ref-type="bibr">Heuer et al. 2005</xref>; <xref rid="c188" ref-type="bibr">Noyes et al. 2013</xref>; <xref rid="c230" ref-type="bibr">Richardson et al. 2008</xref>; <xref rid="c232" ref-type="bibr">Roberts et al. 2008</xref>; <xref rid="c252" ref-type="bibr">Sharlin et al. 2018</xref>; <xref rid="c259" ref-type="bibr">Song et al. 2016</xref>; <xref rid="c300" ref-type="bibr">Westholm et al. 2009</xref><break/><italic>In vitro</italic> studies: <xref rid="c59" ref-type="bibr">Dong and Wade 2017</xref>; <xref rid="c73" ref-type="bibr">Friesema et al. 2003</xref><break/>Reviews: <xref rid="c294" ref-type="bibr">Visser et al. 2011</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c22" scope="row" headers="t2c1 t2c20" colspan="1"> Multidrug resistance protein (MDR1); multidrug resistance associated protein (MRP2)</td>
              <td align="left" headers="t2c2 t2c22" rowspan="1" colspan="1">Phase III hepatic efflux transporters that mediate hepatobiliary efflux of xenobiotics and TH. Importance as a chemical target is unclear.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c22" colspan="1">Early</td>
              <td align="left" rowspan="2" headers="t2c4 t2c22" colspan="1">Not yet characterized</td>
              <td align="left" rowspan="2" headers="t2c5 t2c22" colspan="1"><italic>In vivo</italic> studies: <xref rid="c230" ref-type="bibr">Richardson et al. 2008</xref>; <xref rid="c266" ref-type="bibr">Szabo et al. 2009</xref>; <xref rid="c306" ref-type="bibr">Wong et al. 2005</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c22" rowspan="1" colspan="1">
                <italic>Chemicals: PBDEs, anxiolytic/antiepileptic drugs</italic>
              </td>
            </tr>
            <tr>
              <th colspan="5" align="left" id="t2c23" scope="row" headers="t2c1" rowspan="1"> Receptor–ligand binding</th>
            </tr>
            <tr>
              <td align="left" rowspan="3" id="t2c24" scope="row" headers="t2c1 t2c23" colspan="1"> TRH receptor</td>
              <td align="left" headers="t2c2 t2c24" rowspan="1" colspan="1">Controls synthesis and release of TSH; TRH mutations lead to hypothyroidism.</td>
              <td align="left" rowspan="3" headers="t2c3 t2c24" colspan="1">Promising: ToxCast/Tox21</td>
              <td align="left" rowspan="3" headers="t2c4 t2c24" colspan="1">Not yet characterized</td>
              <td align="left" rowspan="2" headers="t2c5 t2c24" colspan="1"><italic>In silico</italic> studies: <xref rid="c64" ref-type="bibr">Engel et al. 2008</xref>; <xref rid="c140" ref-type="bibr">Knudsen et al. 2011</xref>; <xref rid="c257" ref-type="bibr">Sipes et al. 2013</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" headers="t2c2 t2c24" colspan="1">
                <italic>Chemicals: Unknown</italic>
              </td>
            </tr>
            <tr>
              <td align="left" headers="t2c5 t2c24" rowspan="1" colspan="1">Reviews: <xref rid="c8" ref-type="bibr">Beck-Peccoz et al. 2006</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="2" id="t2c25" scope="row" headers="t2c1 t2c23" colspan="1"> TSH receptor</td>
              <td align="left" headers="t2c2 t2c25" rowspan="1" colspan="1">When activated, stimulates adenyl cyclase and formation of cAMP that increases iodide uptake and TH synthesis in thyroid follicular cells.</td>
              <td align="left" rowspan="2" headers="t2c3 t2c25" colspan="1">Promising: ToxCast/Tox21</td>
              <td align="left" rowspan="2" headers="t2c4 t2c25" colspan="1">Not yet characterized</td>
              <td align="left" rowspan="2" headers="t2c5 t2c25" colspan="1"><italic>In vitro</italic> studies: <xref rid="c128" ref-type="bibr">Jomaa et al. 2013</xref>; <xref rid="c185" ref-type="bibr">Neumann et al. 2009</xref>; <xref rid="c242" ref-type="bibr">Santini et al. 2003</xref>; <xref rid="c273" ref-type="bibr">Titus et al. 2008</xref><break/><italic>In silico</italic> studies: <xref rid="c214" ref-type="bibr">Paul Friedman et al. 2017</xref>; <xref rid="c255" ref-type="bibr">Shobair et al. 2019</xref><break/>Reviews: <xref rid="c82" ref-type="bibr">Gershengorn and Neumann 2012</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c25" rowspan="1" colspan="1">
                <italic>Chemicals: Unknown</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="5" id="t2c26" scope="row" headers="t2c1 t2c23" colspan="1"> TR binding and transactivation (TRα, TRβ)</td>
              <td align="left" rowspan="2" headers="t2c2 t2c26" colspan="1">Transcription factors that have ligand (T3)-dependent and -independent activity. In humans, THRA genes encode TRα1, TRα2, and TRα3 and truncated isoforms. THRB genes encode TRβ1, TRβ2, and TRβ3 (possibly rat only) and truncated isoforms. Only TRα1, TRβ1, TRβ2, and TRβ3 can bind T3 and TREs; TRβ1 and TRβ2 regulate TRH in the hypothalamus. Some chemicals bind TRs as antagonists and/or modify transcription; however, screens of chemical libraries suggest binding is restricted.</td>
              <td align="left" rowspan="5" headers="t2c3 t2c26" colspan="1"><italic>Existing:</italic> ToxCast/Tox21: <xref rid="c71" ref-type="bibr">Freitas et al. 2011</xref>, <xref rid="c72" ref-type="bibr">2014</xref></td>
              <td align="left" rowspan="5" headers="t2c4 t2c26" colspan="1">Not yet characterized</td>
              <td align="left" headers="t2c5 t2c26" rowspan="1" colspan="1"><italic>In vivo</italic> studies: <xref rid="c61" ref-type="bibr">Dupré et al. 2004</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="4" headers="t2c5 t2c26" colspan="1"><italic>In vitro</italic> studies: <xref rid="c31" ref-type="bibr">Cheek et al. 1999</xref>; <xref rid="c35" ref-type="bibr">Clerget-Froidevaux et al. 2004</xref>; <xref rid="c71" ref-type="bibr">Freitas et al. 2011</xref>, <xref rid="c72" ref-type="bibr">2014</xref>; <xref rid="c79" ref-type="bibr">Gauger et al. 2007</xref>; <xref rid="c111" ref-type="bibr">Hofmann et al. 2009</xref>; <xref rid="c118" ref-type="bibr">Huang et al. 2011</xref>; <xref rid="c136" ref-type="bibr">Kitamura et al. 2002</xref>, <xref rid="c137" ref-type="bibr">2005</xref>; <xref rid="c143" ref-type="bibr">Kojima et al. 2009</xref>; <xref rid="c172" ref-type="bibr">Moriyama et al. 2002</xref>; <xref rid="c248" ref-type="bibr">Schriks et al. 2006</xref>; <xref rid="c265" ref-type="bibr">Sun et al. 2009</xref>; <xref rid="c313" ref-type="bibr">You et al. 2006</xref><break/><italic>In silico</italic> studies: <xref rid="c140" ref-type="bibr">Knudsen et al. 2011</xref>; <xref rid="c219" ref-type="bibr">Politi et al. 2014</xref>; <xref rid="c233" ref-type="bibr">Romanov et al. 2008</xref>; <xref rid="c257" ref-type="bibr">Sipes et al. 2013</xref><break/>Reviews: <xref rid="c319" ref-type="bibr">Zoeller 2005</xref></td>
            </tr>
            <tr>
              <td align="left" headers="t2c2 t2c26" rowspan="1" colspan="1">
                <italic>Chemicals: TBBPA, TCBPA, BPA, OH-PCBs, OH-BDEs, triclosan</italic>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TF6">
            <p>Note: Table adapted from Murk et al. (<xref rid="c179" ref-type="bibr">2013</xref>) and OECD (<xref rid="c194" ref-type="bibr">2014</xref>). —, Not applicable; BPA, bisphenol A; EE2, 17α-ethinylestradiol (synthetic estrogen); MOA, mode of action; NR, nuclear receptor; OH-BDE, hydroxylated bromodiphenyl ether (PBDE metabolites); OH-PCB, hydroxylated polychlorinated biphenyl ether (PCB metabolites); PAH, polycyclic aromatic hydrocarbon; PBDE, polybrominated diphenyl ether; PCB, polychlorinated biphenyl ether; PCN, pregnenolone-16α-carbonitrile; PFAS, per- and polyfluoroalkyl substances; PTU, propylthiouracil; RXR, retinoid X receptor; T3, triiodothyronine; T4, thyroxine; TBBPA, tetrabromobisphenol A; TCBPA, tetrachlorobisphenol A; TRIAC, triiodothyroacetic acid; TR, thyroid hormone receptor; TRE, thyroid hormone response element; TRH, thyrotropin releasing hormone; TSH, thyroid stimulating hormone; UDPGT, uridine diphosphate glucuronosyltransferase.</p>
          </fn>
          <fn id="TF7">
            <label>a</label>
            <p>The toxicological mechanism column highlights the role of MIEs in thyroid hormone (TH) signaling along with chemicals shown to interact with them.</p>
          </fn>
          <fn id="TF8">
            <label>b</label>
            <p><italic>In vitro</italic> HTS assay development denoted as “promising” indicates MIEs in the thyroid axis for which there is interest and/or activity in developing <italic>in vitro</italic> HTS approaches, typically with supportive <italic>in vivo</italic> and slow- or medium-throughput <italic>in vitro</italic> toxicity studies indicating chemical interactions. <italic>In vitro</italic> HTS readiness denoted as “early” indicates putative MIEs but with limited toxicity evidence and with little current activity to develop high-throughput alternatives.</p>
          </fn>
          <fn id="TF9">
            <label>c</label>
            <p>MIEs in the thyroid axis with evidence of linkages to adverse outcomes. Additional information on individual AOPs in development and completed can be found at <ext-link ext-link-type="uri" xlink:href="https://aopwiki.org/">https://aopwiki.org/</ext-link>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Extrathyroidal targets involved in chemical perturbations of TH metabolism and transport have also been the focus of <italic>in vitro</italic> HTS development. Some chemicals have been shown to inhibit the activity of iodothyronine deiodinase (DIO) enzymes in different species, tissues, and life stages (<xref rid="c27" ref-type="bibr">Butt et al. 2011</xref>; <xref rid="c29" ref-type="bibr">Capen and Martin 1989</xref>; <xref rid="c67" ref-type="bibr">Ferreira et al. 2002</xref>; <xref rid="c113" ref-type="bibr">Hood and Klaassen 2000</xref>; <xref rid="c177" ref-type="bibr">Morse et al. 1993</xref>; <xref rid="c187" ref-type="bibr">Noyes et al. 2011</xref>, <xref rid="c188" ref-type="bibr">2013</xref>). The three DIO isoforms, Types I, II, and III (DIO1, DIO2, and DIO3, respectively) are differentially expressed and critical to the maintenance of TH in circulation and target tissues, such as brain (<xref rid="c51" ref-type="bibr">Dentice et al. 2013</xref>; <xref rid="c81" ref-type="bibr">Gereben et al. 2008</xref>; <xref rid="c141" ref-type="bibr">Köhrle 1999</xref>; <xref rid="c241" ref-type="bibr">Salvatore et al. 1996</xref>; <xref rid="c261" ref-type="bibr">St Germain et al. 1994</xref>). A low-throughput colorimetric assay (<xref rid="c226" ref-type="bibr">Renko et al. 2012</xref>) has been adapted recently to 96-well plate format using an adenovirus that expresses human DIO1, and was optimized to detect DIO1 inhibition by chemicals in the ToxCast phase 1 library (<xref rid="c114" ref-type="bibr">Hornung et al. 2018</xref>). This assay is currently being used to design <italic>in vitro</italic> HTS assays to evaluate chemical inhibition of DIO2 and DIO3 (<xref rid="c209" ref-type="bibr">Olker et al. 2019</xref>). Chemicals also may act as ligands that can bind TH distributor proteins, notably transthyretin (TTR), and to a lesser extent thyroid binding globulin (TBG), in serum and cerebrospinal fluid (CSF) to displace native thyroxine (T4) (<xref rid="c21" ref-type="bibr">Brouwer et al. 1986</xref>; <xref rid="c31" ref-type="bibr">Cheek et al. 1999</xref>; <xref rid="c124" ref-type="bibr">Ishihara et al. 2003</xref>; <xref rid="c166" ref-type="bibr">Meerts et al. 2000</xref>; <xref rid="c225" ref-type="bibr">Ren and Guo 2012</xref>; <xref rid="c299" ref-type="bibr">Weiss et al. 2009</xref>). Although the overall <italic>in vivo</italic> relevance of chemical interference with serum TH distributors remains unclear, a surface plasmon resonance–based biosensor assay for TTR and TBG is available that provides medium- to high-throughput testing capabilities with commercially available technologies (<xref rid="c160" ref-type="bibr">Marchesini et al. 2006</xref>, <xref rid="c159" ref-type="bibr">2008</xref>).</p>
      <p>Another mechanism by which chemicals decrease circulating concentrations of TH is by activation of hepatic xenobiotic nuclear receptors (NRs) leading to inductions of phase I, II, and III metabolic enzymes and transporters in the liver and other tissues. Enhanced phase II TH glucuronidation and sulfation catalyzed by uridine diphosphate glucuronosyltransferases (UDPGTs) and sulfotransferases (SULTs), respectively, can increase TH catabolism and reduce serum TH by accelerating clearance (<xref rid="c7" ref-type="bibr">Barter and Klaassen 1994</xref>; <xref rid="c112" ref-type="bibr">Hood et al. 2003</xref>; <xref rid="c315" ref-type="bibr">Yu et al. 2009</xref>; <xref rid="c318" ref-type="bibr">Zhou et al. 2002</xref>). <italic>In vitro</italic> HTS assays are available in ToxCast to assess chemical binding and activation of specific xenobiotic NRs [e.g., constitutive androstane receptor (CAR); pregnane X receptor (PXR); aryl hydrocarbon receptor (AhR)]. Once bound, activation of these NRs may up-regulate expression of phase I (CYP450s) and phase II [e.g., UDP glucuronosyltransferase family 1 member A1 and member A6 (<italic>UGT1A1 and UGT1A6</italic>, <italic>respectively</italic>), Sulfotransferase family 2A member 1 (<italic>SULT2A1</italic>)] genes encoding isoenzymes involved in T4 glucuronidation and sulfation. <italic>In vitro</italic> HTS assays measuring induction and/or inhibition of TH conjugating enzymes, as well as the transporters mediating cellular transport of TH, are under development.</p>
      <p>With regard to receptor–ligand interactions, screening of the Tox21 chemical library of 10,000 chemicals using transactivation assays aimed at TRα and TRβ indicate that binding is restricted to a limited number of chemicals (<xref rid="c71" ref-type="bibr">Freitas et al. 2011</xref>, <xref rid="c72" ref-type="bibr">2014</xref>; <xref rid="c116" ref-type="bibr">Houck et al. 2018</xref>; <xref rid="c284" ref-type="bibr">U.S. EPA 2015a</xref>). Likewise, chemical interactions with the thyrotropin releasing hormone receptor (TRHR) and thyroid stimulating hormone receptor (TSHR) do not appear to be prominent sites for chemical binding (<xref rid="c82" ref-type="bibr">Gershengorn and Neumann 2012</xref>; <xref rid="c179" ref-type="bibr">Murk et al. 2013</xref>); however, this is an area with limited research and analysis of the ToxCast/Tox21 screening data is underway (<xref rid="c214" ref-type="bibr">Paul Friedman et al. 2017</xref>; <xref rid="c255" ref-type="bibr">Shobair et al. 2019</xref>).</p>
    </sec>
    <sec id="s3.2">
      <title>Thyroid AOP Network as Framework for Chemical Screening and Assessment</title>
      <p>The thyroid AOP network in <xref ref-type="fig" rid="f2">Figure 2</xref> illustrates how <italic>in vitro</italic> HTS assays (under development or currently available) identified in <xref rid="t2" ref-type="table">Table 2</xref> can be mapped to this network of KEs that chart a progressive path to adverse outcomes. The thyroid AOP network serves as the foundation to organize and evaluate thyroid data, identify data gaps, and examine the evidence for causality between KEs in AOPs. These KE relationships connecting MIEs to KEs and adverse outcomes in <xref ref-type="fig" rid="f2">Figure 2</xref> may be considered hypothesized, correlative, or causal depending on the strength of the evidence (e.g., <xref rid="c37" ref-type="bibr">Coady et al. 2017</xref>; <xref rid="c44" ref-type="bibr">Crofton and Zoeller 2005</xref>; <xref rid="c49" ref-type="bibr">Degitz et al. 2005</xref>; <xref rid="c105" ref-type="bibr">Hassan et al. 2017</xref>; <xref rid="c168" ref-type="bibr">Miller et al. 2009</xref>; <xref rid="c179" ref-type="bibr">Murk et al. 2013</xref>; <xref rid="c218" ref-type="bibr">Perkins et al. 2013</xref>; <xref rid="c322" ref-type="bibr">Zoeller and Crofton 2005</xref>).</p>
      <p>Another important application of the thyroid AOP network is to clarify research needs for decision making. <italic>In vitro</italic> HTS assays currently available to measure MIEs are shown in <xref ref-type="fig" rid="f2">Figure 2</xref> with solid borders in the left-hand column (and also shaded green), and end points collected as part of U.S. EPA and OECD guidelines (<xref rid="t1" ref-type="table">Table 1</xref>) are shown with thick red borders. Several MIEs in <xref ref-type="fig" rid="f2">Figure 2</xref> and further summarized in <xref rid="t2" ref-type="table">Table 2</xref> do not yet have <italic>in vitro</italic> HTS assays even though in some instances lower-throughput <italic>in vitro</italic> assays are available (e.g., for UDPGT/SULT activity). In addition, results from studies published in peer-reviewed literature may be another source of data to further populate the AOP network. The peer reviewed literature may be particularly helpful in identifying and characterizing KEs downstream of serum TH and proximal to adverse outcomes as current regulatory test guidelines (<xref rid="t1" ref-type="table">Table 1</xref>) provide limited coverage.</p>
      <p>Advancements of methods for systematic review and evidence integration provide approaches to identify and evaluate peer-reviewed studies for relevance, performance, and reliability to support their inclusion in chemical assessment (<xref rid="c110" ref-type="bibr">Hoffmann et al. 2017</xref>; <xref rid="c180" ref-type="bibr">Rooney et al. 2014</xref>; <xref rid="c182" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine 2018</xref>). An increasing number of omic studies also describe chemical effects on genes (transcriptomics), proteins (proteomics), and low-molecular-weight biomolecules (metabolomics) in the thyroid gland and TH-responsive tissues, including several transcriptomic studies (<xref rid="c15" ref-type="bibr">Boucher et al. 2014</xref>; <xref rid="c45" ref-type="bibr">Crump et al. 2002</xref>; <xref rid="c118" ref-type="bibr">Huang et al. 2011</xref>; <xref rid="c99" ref-type="bibr">Haggard et al. 2018b</xref>; <xref rid="c206" ref-type="bibr">Ohara et al. 2018</xref>; <xref rid="c220" ref-type="bibr">Porreca et al. 2016</xref>; <xref rid="c239" ref-type="bibr">Royland et al. 2008</xref>). For example, chromatin immunoprecipitation with microarray (ChIP-on-chip) and DNA sequencing (ChIP-seq) have been used in genome-wide analyses to identify putative TR target genes in human cancer cell lines (<xref rid="c34" ref-type="bibr">Chung et al. 2016</xref>), mouse liver (<xref rid="c95" ref-type="bibr">Grøntved et al. 2015</xref>; <xref rid="c224" ref-type="bibr">Ramadoss et al. 2014</xref>), mouse brain (<xref rid="c40" ref-type="bibr">Compe et al. 2007</xref>; <xref rid="c60" ref-type="bibr">Dong et al. 2009</xref>), and frog intestine (<xref rid="c74" ref-type="bibr">Fu et al. 2017</xref>). There are now a handful of studies reporting chemical effects on thyroid-related proteomics (e.g., <xref rid="c303" ref-type="bibr">Williams et al. 2016</xref>; <xref rid="c155" ref-type="bibr">Lee et al. 2018</xref>; <xref rid="c251" ref-type="bibr">Serrano et al. 2010</xref>) and metabolomics (e.g., <xref rid="c120" ref-type="bibr">SSY Huang et al. 2016</xref>; <xref rid="c117" ref-type="bibr">Houten et al. 2016</xref>, <xref rid="c127" ref-type="bibr">Johnson et al. 2012</xref>). Cell-based assays and transgenic animal models have also been deployed to elucidate molecular targets, toxicity pathways, and chemical structure-activity relationships of thyroid disruption (<xref rid="c80" ref-type="bibr">Gentilcore et al. 2013</xref>; <xref rid="c125" ref-type="bibr">Jarque et al. 2018</xref>; <xref rid="c126" ref-type="bibr">Ji et al. 2012</xref>; <xref rid="c210" ref-type="bibr">Opitz et al. 2012</xref>; <xref rid="c236" ref-type="bibr">Rosenberg et al. 2017</xref>). To this end, recent advances in genome editing tools with toxicological applications, notably clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 technologies have been used to better understand TH signaling pathways (<xref rid="c147" ref-type="bibr">Kyono et al. 2016</xref>; <xref rid="c161" ref-type="bibr">Markossian et al. 2018</xref>; <xref rid="c240" ref-type="bibr">Sakane et al. 2018</xref>; <xref rid="c274" ref-type="bibr">Trubiroha et al. 2018</xref>; <xref rid="c309" ref-type="bibr">Yang et al. 2018</xref>). However, despite these advances, inclusion of <italic>in vitro</italic> genotyping studies in chemical assessment is still rare, and current efforts seek to standardize methods and link genetic outcomes to phenotypic anchors representing adverse outcomes (<xref rid="c25" ref-type="bibr">Buesen et al. 2017</xref>; <xref rid="c16" ref-type="bibr">Bourdon-Lacombe et al. 2015</xref>; <xref rid="c19" ref-type="bibr">Brazma et al. 2001</xref>; <xref rid="c48" ref-type="bibr">Dean et al. 2017</xref>; <xref rid="c268" ref-type="bibr">Thomas et al. 2013a</xref>, <xref rid="c269" ref-type="bibr">2013b</xref>; <xref rid="c293" ref-type="bibr">Villeneuve et al. 2012</xref>; <xref rid="c296" ref-type="bibr">Wang et al. 2016</xref>).</p>
      <p>Assembling and interpreting the scientific evidence measured in independent <italic>in vitro</italic>, <italic>in silico</italic>, and <italic>in vivo</italic> research efforts presents an enormous challenge for chemical assessment. The thyroid AOP network provides architecture to begin mapping and integrating diverse data to characterize chemical interactions with the thyroid axis. New <italic>in vitro</italic> technologies incorporated into pathway-based approaches are anticipated to help reduce uncertainties and resolve some of the major challenges that are examined below and presented by these evaluations.</p>
    </sec>
    <sec id="s3.3">
      <title>Regulatory Challenges in Evaluating and Linking Thyroid MIEs to Adverse Outcomes</title>
      <p>Currently, no U.S. EPA or OECD <italic>in vitro</italic> regulatory guidelines test chemical interactions with MIEs in the thyroid axis (<xref rid="t1" ref-type="table">Table 1</xref>). For most regulatory requirements, hazards are identified for individual chemicals and there are little to no data describing the combined effects of individual chemicals and chemical mixtures that interact with multiple MIEs in the thyroid axis. In addition, current guidelines can detect some thyroid-related disturbances (e.g., changes in serum TH) that have been used to derive hazard values for regulatory purposes, but it is not possible to attribute an adverse outcome to a mechanism. Neither have intermediate parameters (KE and KE relationships) linking an adverse outcome to an upstream MIE been empirically quantified in most cases.</p>
      <p>By depicting points where several MIEs converge at shared KEs, the AOP network helps to identify nodes around which assays can be developed to link MIEs to adverse outcomes and clarify data that would be most relevant for regulatory applications. For example, uncertainties continue as to dose–response relationships in chemical-induced changes in serum TH, particularly milder TH perturbations that result in adverse outcomes (<xref rid="c41" ref-type="bibr">Crofton 2004</xref>). For example, AOPs (<xref ref-type="fig" rid="f2">Figure 2</xref>; <xref rid="t2" ref-type="table">Table 2</xref>) describe chemical inhibition of NIS and TPO leading to reduced TH production and decreased serum T4 that culminate in delayed/arrested amphibian development (AOP 176, AOP 175, respectively) and impaired mammalian neurodevelopment (AOP 134, AOP 42, respectively). However, a quantitative understanding of KE relationships in the TPO- and NIS-related AOPs is limiting, although current efforts are beginning to quantify these interactions (<xref rid="c88" ref-type="bibr">Gilbert and Sui 2008</xref>; <xref rid="c105" ref-type="bibr">Hassan et al. 2017</xref>; <xref rid="c191" ref-type="bibr">O’Shaughnessy et al. 2018b</xref>). Decision makers can use the biological plausibility embedded in the thyroid AOP network to clarify linkages for characterization and identify gaps in available knowledge. From this information, KE relationships can be proposed for quantification to support predictive modeling and hazard assessment, as well as reduce data uncertainties.</p>
    </sec>
    <sec id="s3.4">
      <title>Differential Species and Life Stage Sensitivities; Interpreting Biomarkers</title>
      <p>Future work to expand and refine the thyroid AOP network can help to identify physiological similarities and differences between KEs and KE relationships spanning vertebrate classes. The characterization of shared toxicity mechanisms leading to divergent adverse outcomes across species can be useful in the translation of research between nonmammalian and mammalian species including humans. For example, chemical inhibition of thyroid gland TPO can reduce serum and tissue TH that alter tissue-specific genomic signaling and elicit species- and life stage–specific adverse outcomes [e.g., abnormal brain development in mammals (<xref rid="c322" ref-type="bibr">Zoeller and Crofton 2005</xref>); impaired metamorphosis in amphibians (<xref rid="c38" ref-type="bibr">Coady et al. 2010</xref>; <xref rid="c115" ref-type="bibr">Hornung et al. 2015</xref>; <xref rid="c270" ref-type="bibr">Tietge et al. 2010</xref>); reduced anterior swim bladder inflation in teleost fish (<xref rid="c184" ref-type="bibr">Nelson et al. 2016</xref>; <xref rid="c263" ref-type="bibr">Stinckens et al. 2016</xref>)]. Identification of shared KEs as integrative nodes facilitates characterization of diagnostic biomarkers across species that can be represented in predictive modeling and evaluated in organismal assays to further support mechanistic linkages between KEs and adverse outcomes (<xref rid="c42" ref-type="bibr">Crofton 2008</xref>; <xref rid="c168" ref-type="bibr">Miller et al. 2009</xref>; <xref rid="c215" ref-type="bibr">Paul et al. 2013</xref>; <xref rid="c218" ref-type="bibr">Perkins et al. 2013</xref>).</p>
      <p>Several MIEs in the thyroid AOP network may induce a cascade of KEs proceeding through decreased serum T4 and/or triiodothyronine (T3) (<xref ref-type="fig" rid="f2">Figure 2</xref>; box with striped background and shaded yellow). Changes in serum TH are a useful biomarker of thyroid perturbation and are usually correlated to changes in tissue TH (as reviewed by <xref rid="c211" ref-type="bibr">Oppenheimer and Schwartz 1997</xref>; <xref rid="c221" ref-type="bibr">Porterfield and Hendrich 1993</xref>). However, reliance on serum TH may oversimplify subsequent linkages to downstream KEs that drive adverse outcomes. Serum TH levels are not always aligned with tissue levels as tissue TH is regulated by DIO enzymes, cellular transporters, and regional TR expression. The disconnect between altered TH signaling in the fetal brain, neurodevelopmental consequences, and serum TH has been demonstrated using several gene knock-out (KO) mouse models with deficiencies in genes encoding DIO enzymes, TRs, monocarboxylate transporter (MCT)8, organic anion transporter polypeptide (OATP)1c1, and other TH transporters (as reviewed by <xref rid="c5" ref-type="bibr">Bárez-López et al. 2018</xref>; <xref rid="c11" ref-type="bibr">Bernal 2018</xref>; <xref rid="c108" ref-type="bibr">Hernandez et al. 2010</xref>; <xref rid="c228" ref-type="bibr">Richard and Flamant 2018</xref>). For example, considerable evidence describes the contribution of DIO enzymes, particularly DIO2 and DIO3, in the maintenance of T3 in TH-responsive regions of the developing brain [i.e., DIO2 predominantly in astrocytes; DIO3 predominantly in neurons; as reviewed by Bianco et al. (<xref rid="c12" ref-type="bibr">2002</xref>), Guadaño-Ferraz et al. (<xref rid="c96" ref-type="bibr">1997</xref>), Morreale de Escobar et al. (<xref rid="c174" ref-type="bibr">2008</xref>), Patel et al. (<xref rid="c212" ref-type="bibr">2011</xref>), and <xref rid="c320" ref-type="bibr">Zoeller (2010)</xref>]. However, studies show that <italic>Dio2</italic> and <italic>Dio1/Dio2</italic> KO mouse models with deficient tissue capacity to produce T3 do not experience substantial deficits in motor, learning, or memory functioning, although other deficits (e.g., impaired cochlear and visual development) do occur (<xref rid="c77" ref-type="bibr">Galton et al. 2007</xref>, <xref rid="c76" ref-type="bibr">2009</xref>, <xref rid="c75" ref-type="bibr">2014</xref>; <xref rid="c192" ref-type="bibr">Obregón et al. 1991</xref>; <xref rid="c245" ref-type="bibr">Schneider et al. 2001</xref>; <xref rid="c246" ref-type="bibr">Schneider et al. 2006</xref>). These <italic>Dio1/Dio2</italic> KO strains exhibit regionally specific reductions in brain T3 but normal serum T3, as well as elevated serum and tissue T4. In contrast, the <italic>Dio3</italic> KO fetus and newborn pup exhibit an initial hyperthyroidism followed by hypothyroidism, impaired growth and fertility, and reduced survival. Elevations in serum and brain T3 are accompanied by an initial acceleration and subsequent delay of T3-inducible gene expression in the brain (<xref rid="c108" ref-type="bibr">Hernandez et al. 2010</xref>). Subsequent experiments have shown that <italic>Dio</italic>3 KO mice with augmented brain TH exhibit hyperactivity and reduced anxiety-like behaviors despite systemic hypothyroidism as indicated by reduced serum T3 (<xref rid="c264" ref-type="bibr">Stohn et al. 2016</xref>).</p>
      <p>As these examples illustrate, the lack of change in serum TH is not a guarantee that TH effects in tissues are not occurring, and conversely changes in serum TH are not always predictive of adverse outcomes. Possible explanations for the lack of concordance between serum TH and adverse outcomes may relate to the not yet fully characterized age- and regional-specific responses of the brain to compensate to systemic TH insufficiency. Nonetheless, fetal and early postnatal susceptibilities to thyroid toxicants are heightened because their thyroid feedback systems are absent or incompletely formed and they have low TH reserves that are critical to neurological development (as reviewed by <xref rid="c175" ref-type="bibr">Morreale de Escobar et al. 2004a</xref>; <xref rid="c258" ref-type="bibr">Skeaff 2011</xref>; <xref rid="c302" ref-type="bibr">Williams 2008</xref>; and <xref rid="c323" ref-type="bibr">Zoeller and Rovet 2004</xref>). The thyroid AOP network provides a tool to map linkages and identify possible KEs for further characterization and quantification (e.g., trapezoid boxes also shaded blue in <xref ref-type="fig" rid="f2">Figure 2</xref>) to aide in predicting adversity. For purposes of decision making, changes in serum TH profiles are not proscriptive to either mechanisms or outcomes, but they nevertheless do provide clear indication of perturbed thyroid homeostasis with the potential to adversely affect development.</p>
      <p>The thyroid AOP network also can identify KEs that may not fall on the causative pathway leading to an adverse outcome, making these KEs potentially less relevant to decision making. One such example is the stimulation of the thyroid–pituitary feedback response (i.e., increased TSH). Although TSH increases often accompany exposure to a number of thyroid disrupting chemicals, TSH is not a causative KE in AOPs involving TPO inhibition that result in impaired hippocampal development and cognitive deficits (<xref rid="c322" ref-type="bibr">Zoeller and Crofton 2005</xref>) and up-regulated TH catabolism leading to ototoxicity (<xref rid="c44" ref-type="bibr">Crofton and Zoeller 2005</xref>) (<xref ref-type="fig" rid="f3">Figure 3</xref>). For example, rat offspring developmentally exposed to some polychlorinated biphenyls (PCBs) and dioxins experience mainly hypothyroxinemia (i.e., reduced serum T4 with TSH in reference control ranges) that culminate in impaired cochlear development and hearing loss (<xref rid="c43" ref-type="bibr">Crofton et al. 2000</xref>; <xref rid="c41" ref-type="bibr">Crofton 2004</xref>; <xref rid="c90" ref-type="bibr">Goldey et al. 1995</xref>; <xref rid="c177" ref-type="bibr">Morse et al. 1993</xref>; <xref rid="c253" ref-type="bibr">Sher et al. 1998</xref>). Elevated TSH in rodents leads to thyroid hypertrophy and potential thyroid cancer, an adverse outcome that has limited relevance to human thyroid cancer due to species differences in sensitivity (<xref rid="c29" ref-type="bibr">Capen and Martin 1989</xref>; <xref rid="c65" ref-type="bibr">EU 2017</xref>; <xref rid="c121" ref-type="bibr">Hurley 1998</xref>; <xref rid="c164" ref-type="bibr">McClain et al. 1988</xref>), although this too is an area of renewed interest (<xref rid="c65" ref-type="bibr">EU 2017</xref>). Thus, elevated TSH may not be a reliable KE biomarker for thyroid cancer in humans, but increased TSH in rodents does indicate a chemical capable of perturbing TH signaling in other species, including humans, and is involved in other thyroid-responsive outcomes, including neurodevelopment.</p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>Adverse outcome pathways (AOPs) for select chemical pathways of thyroid disruption, including (A) rat thyroid follicular cell tumors linked to chemical inhibition of TPO; (B) impaired cognitive functioning in mammals linked to chemical inhibition of TPO; and (C) hearing deficits in mammals linked to inductions of TH catabolic pathways. In the left-hand column, MIE boxes activated for a given pathway are shown with solid borders (shaded green) and KEs in the AOPs are shown as boxes with striped background (shaded orange). The causative KE in the formation of rat thyroid tumors (A) is increasing TSH (shown with thick borders and striped background and shaded orange) leading to hypothalamic–pituitary compensatory feedback responses shown in left-hand MIE boxes and downstream thyroid hypertrophy and hyperplasia with striped background (and also shaded orange). In contrast, elevated TSH (shown with a dashed border) has not been shown as a causative KE in chemical inhibition of TPO leading to cognitive impairments in mammals (B) or chemical activation of the hepatic xenobiotic NR response cascade leading to mammalian hearing deficits (C). References supporting these AOPs can be found in <xref rid="t2" ref-type="table">Table 2</xref>. ↔, no change from reference controls; AhR, aryl hydrocarbon receptor; CAR, constitutive androstane receptor; KE, key event; MIE, molecular initiating event; NR, nuclear receptor; PXR, pregnane X receptor; T3, 3,3ʹ,5-triiodothyronine; T4, thyroxine; TPO, thyroperoxidase; TH, thyroid hormone; TR, thyroid hormone receptor; TRH, thyrotropin releasing hormone; TRHR, thyrotropin releasing hormone receptor; TSH, thyroid stimulating hormone; TSHR, thyroid stimulating hormone receptor; UDPGT, uridine diphosphate glucuronosyltransferase.</p>
        </caption>
        <alt-text>Figure 3 is a tabular representation with three columns, namely, M I Es, key events, and adverse outcomes, comprises a flow chart showing the connections in Hypothalamic-pituitary feedback, TH synthesis (Thyroid), Xenobiotic receptor activation (Liver), Serum TH transport, Peripheral TH metabolism, Cellular TH transport, and TR transactivation for (a) rodent thyroid tumor AOP by inhibition of TPO activity, (b) mammalian neurodevelopmental AOP by inhibition of TPO activity, and (c) mammalian developmental hearing deficits AOP by activation of xenobiotic NRs.</alt-text>
        <graphic xlink:href="ehp-127-095001-g0003"/>
      </fig>
      <p>Understanding pathway conservation is critical for cross-species extrapolation and requires understanding the conservation of protein targets (e.g., MIEs) and resulting sensitivity to chemicals. Research efforts in this area range from <italic>in vivo</italic> exposures across phylogenetically disparate species, followed by toxicogenomic meta-analyses (<xref rid="c78" ref-type="bibr">Garcia-Reyero et al. 2011</xref>), to bioinformatics comparing amino acid sequences/functional domain similarity across species to identify putative functional orthologues (<xref rid="c149" ref-type="bibr">LaLone et al. 2013</xref>). For purposes of chemical screening and <italic>in vitro</italic> HTS assay development, a basic demonstration of cross-species concordance of chemical activity is sufficient to provide confidence that the representative <italic>in vitro</italic> system is reliable for generating screening-level data. For example, strong cross-species concordance in the activity of porcine and rat TPO has been shown despite only 75% amino acid similarity in the conserved peroxidase domain (<xref rid="c215" ref-type="bibr">Paul et al. 2013</xref>). Results from numerous <italic>in vivo</italic> exposures to select TPO-active chemicals in fish (<xref rid="c58" ref-type="bibr">Doerge et al. 1998</xref>; <xref rid="c184" ref-type="bibr">Nelson et al. 2016</xref>; <xref rid="c263" ref-type="bibr">Stinckens et al. 2016</xref>), amphibians (<xref rid="c38" ref-type="bibr">Coady et al. 2010</xref>; <xref rid="c115" ref-type="bibr">Hornung et al. 2015</xref>; <xref rid="c270" ref-type="bibr">Tietge et al. 2010</xref>, <xref rid="c271" ref-type="bibr">2013</xref>), birds (<xref rid="c94" ref-type="bibr">Grommen et al. 2011</xref>; <xref rid="c235" ref-type="bibr">Rosebrough et al. 2006</xref>), and mammals (<xref rid="c47" ref-type="bibr">Davidson et al. 1978</xref>; <xref rid="c56" ref-type="bibr">Divi and Doerge 1996</xref>; <xref rid="c70" ref-type="bibr">Francis and Rennert 1980</xref>) corroborate the conserved mechanistic linkages leading to species-specific adverse outcomes. Such information can define circumstances under which screens for thyroid activity can benefit from combining lines of evidence across species with shared KEs, as opposed to situations when species-specific data support being separated for regulatory use.</p>
    </sec>
    <sec id="s3.5">
      <title>Human Relevance of Hepatic- and Serum Distributor-Driven TH Effects in Rodents</title>
      <p>The observation of thyroid-related end point changes in rodents and their relevance to predicting adverse outcomes in humans continues to present research questions. One such data gap concerns interpreting the human applicability of chemical-induced TH reductions in rodents through activation of xenobiotic NRs, notably PXR and CAR, and up-regulation of hepatic TH catabolism (<xref ref-type="fig" rid="f2">Figures 2</xref>–<xref ref-type="fig" rid="f3">3</xref>; <xref rid="t2" ref-type="table">Table 2</xref>) (<xref rid="c65" ref-type="bibr">EU 2017</xref>; <xref rid="c63" ref-type="bibr">ECHA 2016</xref>). Although functionally conserved in many cases (e.g., CYP450s), hepatic drug metabolizing enzymes have differing isoform compositions, substrate selectivity, and catalytic activities depending on species, life stage, and genetics that may affect chemical and TH biotransformation (<xref rid="c9" ref-type="bibr">Benedetti et al. 2005</xref>; <xref rid="c46" ref-type="bibr">Curran and DeGroot 1991</xref>; <xref rid="c144" ref-type="bibr">Kondo et al. 2017</xref>; <xref rid="c162" ref-type="bibr">Martignoni et al. 2006</xref>; <xref rid="c183" ref-type="bibr">Nebert and Gonzalez 1987</xref>).</p>
      <p>Increased hepatic catabolism of TH, along with reductions in serum TH and elevated TSH, are well described in rodents (rat, mouse, hamster) exposed to hepatic enzyme-inducing chemicals such as phenobarbital, some PCBs (Aroclor 1254), pregnenolone-16α-carbonitrile, and 3-methylcholanthrene (<xref rid="c7" ref-type="bibr">Barter and Klaassen 1994</xref>; <xref rid="c100" ref-type="bibr">Haines et al. 2018</xref>; <xref rid="c112" ref-type="bibr">Hood et al. 2003</xref>; <xref rid="c134" ref-type="bibr">Kato et al. 2010</xref>; <xref rid="c138" ref-type="bibr">Klaassen and Hood 2001</xref>; <xref rid="c289" ref-type="bibr">Vansell and Klaassen 2002</xref>; <xref rid="c306" ref-type="bibr">Wong et al. 2005</xref>). Studies in human subjects also demonstrate the responsiveness of TH catabolic pathways to hepatic enzyme inducers (<xref rid="c9" ref-type="bibr">Benedetti et al. 2005</xref>; <xref rid="c33" ref-type="bibr">Christensen et al. 1989</xref>; <xref rid="c46" ref-type="bibr">Curran and DeGroot 1991</xref>; <xref rid="c207" ref-type="bibr">Ohnhaus et al. 1981</xref>; <xref rid="c234" ref-type="bibr">Rootwelt et al. 1978</xref>; <xref rid="c311" ref-type="bibr">Yeo et al. 1978</xref>; <xref rid="c317" ref-type="bibr">Zhang et al. 2016</xref>). In contrast with rodents, human serum T4 decrements reported in these studies are varied and typically not accompanied by changes in TSH, suggesting the possibility of milder responses in humans compared with rodents, although this may not be the case in sensitive subpopulations. For example, studies in healthy human test subjects receiving therapeutic doses of the human CAR activator phenobarbital and other antiepileptic drugs show unchanged or decreased serum TH, with generally no TSH alterations (as reviewed by <xref rid="c9" ref-type="bibr">Benedetti et al. 2005</xref>; <xref rid="c46" ref-type="bibr">Curran and DeGroot 1991</xref>). Similarly, healthy human subjects receiving therapeutic doses of the antibiotic and human PXR agonist rifampicin exhibit reduced serum T4, as well as increased T4 and rT3 clearance, with no change in TSH (<xref rid="c33" ref-type="bibr">Christensen et al. 1989</xref>; <xref rid="c207" ref-type="bibr">Ohnhaus et al. 1981</xref>). However, a meta-analysis of published clinical studies that examined TH end points in epileptic patients treated with phenobarbital and other antiepileptic drugs detected an overall decrease in serum T4 (no change in T3) and increase in TSH (<xref rid="c317" ref-type="bibr">Zhang et al. 2016</xref>), suggesting genetics and health status may influence sensitivity. The antibacterial triclosan, known to decrease serum TH in rats, has also been shown to activate human PXR, but not rat or mouse PXR, and to behave as an inverse agonist to human CAR1 and weak agonist of human CAR3 and rat/mouse CAR (<xref rid="c217" ref-type="bibr">Paul et al. 2013</xref>). Thus, current evidence supports that chemicals may induce hepatic TH catabolism in both humans and rodents, albeit by possibly differing metabolic pathways and potencies (an unknown at this time). Whether responses in humans extend to other chemicals as a general phenomenon is unclear, and differing exposure durations and responses between rodents and humans may be relevant to extrapolations from one species to another. Useful follow-up analyses of chemicals suspected of NR activation could involve evaluation of species selectivity of the NR response to the chemical itself.</p>
      <p>It has also been posited that TH metabolic clearance responses in rats are less relevant to humans because TBG, the major serum TH distributor protein in humans, is less prominent in the adult rat, although it does play an important role in thyroid homeostasis in newborn and neonatal rat pups (<xref rid="c243" ref-type="bibr">Savu et al. 1991</xref>; <xref rid="c314" ref-type="bibr">Young et al. 1988</xref>). In adult rodents, amphibians, birds, and fish, TTR appears to be the major serum TH distributor protein (<xref rid="c55" ref-type="bibr">Dickson et al. 1985</xref>; <xref rid="c104" ref-type="bibr">Harms et al. 1991</xref>; <xref rid="c222" ref-type="bibr">Power et al. 2000</xref>). TTR has a lower binding affinity for T4 than TBG, and this is thought to be responsible for the shorter T4 half-life in rats (∼12–24 h) than in humans (∼5 d) (<xref rid="c156" ref-type="bibr">Lewandowski et al. 2004</xref>). Unlike TBG, TTR is important in the transport of T4 across the blood–placental (<xref rid="c150" ref-type="bibr">Landers et al. 2009</xref>; <xref rid="c178" ref-type="bibr">Mortimer et al. 2012</xref>), blood–brain (<xref rid="c30" ref-type="bibr">Chanoine et al. 1992</xref>; <xref rid="c247" ref-type="bibr">Schreiber et al. 1990</xref>), and CSF–brain (<xref rid="c231" ref-type="bibr">Richardson et al. 2018</xref>) barriers. Thus, a role for human TTR in TH storage and transport appears critical during fetal development. Some researchers have also suggested that although TBG binds most TH in human circulation, TH dissociation rates from TTR and capillary transit times make TTR a significant distributor protein of TH in humans as well as in rodents (<xref rid="c1" ref-type="bibr">Alshehri et al. 2015</xref>; <xref rid="c167" ref-type="bibr">Mendel 1989</xref>). Taken together, current evidence supports the activation of putative MIEs and KEs in rats, encompassing xenobiotic NR activation, inductions of UDPGTs, SULTs, and TH distributor proteins are relevant pathways for consideration. In this regard, the rat serves as a conservative model for predicting human health effects. The thyroid AOP network allows for the integration of new <italic>in vitro</italic> mechanistic and interspecies scaling information to help relate rodent toxicity data to human-equivalent exposures and further populate the TH catabolic pathway for use in human health assessment.</p>
    </sec>
    <sec id="s3.6">
      <title>Building Predictive Models and Toxicokinetics</title>
      <p>Because of the diversity of known and putative molecular targets in the thyroid axis, using AOPs to develop predictive models of adverse outcomes from <italic>in vitro</italic> data will be challenging and require additional bioassay data for KEs in the network, particularly downstream of serum TH. Although there is qualitative evidence linking the MIEs listed in <xref rid="t2" ref-type="table">Table 2</xref> to altered serum TH, data to establish quantitative KE relationships helpful for regulatory application are lacking. Furthermore, the large diversity of genes regulated directly and indirectly by T3, the nongenomic effects of T4, and our limited knowledge of the functioning of TH during fetal development present a challenge for predicting chemical-induced adverse outcomes from <italic>in vitro</italic> data (as reviewed by <xref rid="c11" ref-type="bibr">Bernal 2018</xref>; <xref rid="c228" ref-type="bibr">Richard and Flamant 2018</xref>).</p>
      <p>In humans, detrimental effects of mild TH insufficiency on fetal cognitive development are recognized as an important public health concern, and some links to chemical exposures are described (<xref rid="c68" ref-type="bibr">Finken et al. 2013</xref>; <xref rid="c83" ref-type="bibr">Ghassabian et al. 2014</xref>; <xref rid="c97" ref-type="bibr">Haddow et al. 1999</xref>; <xref rid="c146" ref-type="bibr">Korevaar et al. 2016</xref>; <xref rid="c170" ref-type="bibr">Moleti et al. 2011</xref>; <xref rid="c173" ref-type="bibr">Morreale de Escobar et al. 2000</xref>; <xref rid="c262" ref-type="bibr">Steinmaus et al. 2016</xref>; <xref rid="c290" ref-type="bibr">Vermiglio et al. 2004</xref>). The observations in humans are supported by rodent studies where neurodevelopmental impairments result from moderate and transient reductions in serum TH induced by chemical exposures (<xref rid="c4" ref-type="bibr">Ausó et al. 2004</xref>; <xref rid="c17" ref-type="bibr">Boyes et al. 2018</xref>; <xref rid="c84" ref-type="bibr">Gilbert 2011</xref>; <xref rid="c86" ref-type="bibr">Gilbert et al. 2013</xref>, <xref rid="c87" ref-type="bibr">2016</xref>, <xref rid="c85" ref-type="bibr">2017</xref>; <xref rid="c176" ref-type="bibr">Morreale de Escobar et al. 2004b</xref>). As quantitative data become available for these types of sensitive developmental responses—likely from the use of bioassays of greater biological complexity that integrate multiple MIEs and KEs—additional modeling approaches to further characterize KE relationships could be implemented to predict thyroid-related adverse outcomes and characterize accompanying uncertainties. As a first step, models that integrate <italic>in vitro</italic> assay results for a single KE (when multiple assays exist) and models that integrate <italic>in vitro</italic> assay results for more than one KE in a target tissue (e.g., thyroid gland; TPO, NIS, DIO) could be used to prioritize chemicals for further assessment and targeted <italic>in vivo</italic> testing. Development of a computational systems biology model of thyroid function could help simulate the potential interactions of chemicals with activity at various MIEs. Such an effort will require an investment of research to parameterize and evaluate uncertainties.</p>
      <p>Another challenge is that chemical toxicokinetic considerations, and an understanding of potential differences among life stages and species, are not well accounted for by current <italic>in vitro</italic> test systems. These limitations can lead to both false positive and false negative calls in screening efforts. Developing <italic>in vitro</italic> predictions of thyroid perturbations is further complicated by the fact that most chemically induced effects on downstream KEs and adverse outcomes are indirect, secondary consequences to a chemically induced change in hormone regulation. We think predictions of <italic>in vivo</italic> adverse outcomes from <italic>in vitro</italic> HTS data and other new technologies will be greatly facilitated by <italic>a</italic>) incorporation of toxicokinetic tools to estimate metabolic bioactivation and better characterize potency and selectivity of chemicals for target tissues, and <italic>b</italic>) improved mechanistic and quantitative understanding of TH action on development of target organs, especially the brain.</p>
    </sec>
  </sec>
  <sec id="s4">
    <title>Conclusions</title>
    <p>Advancements in new <italic>in vitro</italic> technologies offer opportunities to screen chemicals for interactions with MIEs in the thyroid pathway and to anchor adverse outcomes to a thyroid mechanism. A substantial body of knowledge exists concerning the molecular and physiological regulation of TH signaling and responses of these systems to chemical exposures (including pharmaceuticals). The thyroid AOP network described in the present work is based on decades of research and multiple consortia to evaluate relevant KEs for chemical-induced thyroid disruption. At present, the use of <italic>in vitro</italic> data beyond screening and prioritization for thyroid bioactivity is challenged by the complexity of potential TH-related adverse outcomes and the limited knowledge of mechanistic processes controlling such responses. Despite these knowledge gaps, we propose that the thyroid AOP network provides the necessary biological structure to organize diverse data from differing test methods, thereby serving as a useful data integration tool to assist in hazard screening for large numbers of previously untested chemicals. As more data become available, the AOP network can be further populated to help bridge knowledge gaps and identify key nodes for assay development.</p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors are grateful to T. Bahadori, National Center for Environmental Assessment, ORD, U.S. EPA; S. Schappelle, Office of Science Coordination and Policy, Office of Chemical Safety and Pollution Prevention, U.S. EPA; and R. Thomas, National Center for Computational Toxicology, ORD, U.S. EPA for their input on early drafts of this paper.</p>
  </ack>
  <fn-group>
    <fn fn-type="equal" id="n1">
      <label>†</label>
      <p>Retired.</p>
    </fn>
    <fn fn-type="financial-disclosure">
      <p>The authors declare they have no actual or potential competing financial interests.</p>
    </fn>
    <fn fn-type="other">
      <p>The views expressed in this manuscript are those of the authors and do not necessarily reflect the views or policies of the U.S. EPA or OECD.</p>
    </fn>
    <fn fn-type="other" specific-use="pdf-only">
      <p><bold>Note to readers with disabilities:</bold><italic>EHP</italic> strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in <italic>EHP</italic> articles may not conform to <ext-link ext-link-type="uri" xlink:href="http://ehp.niehs.nih.gov/accessibility/">508 standards</ext-link> due to the complexity of the information being presented. If you need assistance accessing journal content, please contact <email>ehponline@niehs.nih.gov</email>. Our staff will work with you to assess and meet your accessibility needs within 3 working days.</p>
    </fn>
  </fn-group>
  <ref-list>
    <title>References</title>
    <ref id="c1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alshehri</surname><given-names>B</given-names></name>, <name name-style="western"><surname>D’Souza</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Petratos</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>SJ</given-names></name></person-group><year>2015</year>. <article-title>The diversity of mechanisms influenced by transthyretin in neurobiology: development, disease and endocrine disruption</article-title>. <source>J Neuroendocrinol</source><volume>27</volume>(<issue>5</issue>):<fpage>303</fpage>–<lpage>323</lpage>, PMID: 25737004, <pub-id pub-id-type="doi">10.1111/jne.12271</pub-id>.<?supplied-pmid 25737004?><pub-id pub-id-type="pmid">25737004</pub-id></mixed-citation>
    </ref>
    <ref id="c2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersson</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Arena</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Auteri</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Barmaz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grignard</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kienzler</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>2018</year><article-title>Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009</article-title>. <source>EFSA J</source><volume>16</volume>(<issue>6</issue>):<elocation-id>e05311</elocation-id>, <pub-id pub-id-type="doi">10.2903/j.efsa.2018.5311</pub-id>.</mixed-citation>
    </ref>
    <ref id="c3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ankley</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Erickson</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Hoff</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>RD</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment</article-title>. <source>Environ Toxicol Chem</source><volume>29</volume>(<issue>3</issue>):<fpage>730</fpage>–<lpage>741</lpage>, PMID: 20821501, <pub-id pub-id-type="doi">10.1002/etc.34</pub-id>.<?supplied-pmid 20821501?><pub-id pub-id-type="pmid">20821501</pub-id></mixed-citation>
    </ref>
    <ref id="c4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ausó</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lavado-Autric</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cuevas</surname><given-names>E</given-names></name>, <name name-style="western"><surname>del Rey</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>de Escobar</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Berbel</surname><given-names>P</given-names></name></person-group><year>2004</year>. <article-title>A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration</article-title>. <source>Endocrinology</source><volume>145</volume>(<issue>9</issue>):<fpage>4037</fpage>–<lpage>4047</lpage>, PMID: 15087434, <pub-id pub-id-type="doi">10.1210/en.2004-0274</pub-id>.<?supplied-pmid 15087434?><pub-id pub-id-type="pmid">15087434</pub-id></mixed-citation>
    </ref>
    <ref id="c5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bárez-López</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Obregon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bernal</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Guadaño-Ferraz</surname><given-names>A</given-names></name></person-group><year>2018</year>. <article-title>Thyroid hormone economy in the perinatal mouse brain: implications for cerebral cortex development</article-title>. <source>Cereb Cortex</source><volume>28</volume>(<issue>5</issue>):<fpage>1783</fpage>–<lpage>1793</lpage>, PMID: 28407057, <pub-id pub-id-type="doi">10.1093/cercor/bhx088</pub-id>.<?supplied-pmid 28407057?><pub-id pub-id-type="pmid">28407057</pub-id></mixed-citation>
    </ref>
    <ref id="c6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barter</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><year>1992</year>. <article-title>UDP-glucuronosyl transferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism</article-title>. <source>Toxicol Appl Pharmacol</source><volume>113</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>42</lpage>, PMID: 1553754, <pub-id pub-id-type="doi">10.1016/0041-008X(92)90006-E</pub-id>.<?supplied-pmid 1553754?><pub-id pub-id-type="pmid">1553754</pub-id></mixed-citation>
    </ref>
    <ref id="c7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barter</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><year>1994</year><article-title>Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats</article-title>. <source>Toxicol Appl Pharm</source><volume>128</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>17</lpage>, <pub-id pub-id-type="doi">10.1006/taap.1994.1174</pub-id>.</mixed-citation>
    </ref>
    <ref id="c8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck-Peccoz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Persani</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Calebiro</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bonomi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mannavola</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Campi</surname><given-names>I</given-names></name></person-group><year>2006</year>. <article-title>Syndromes of hormone resistance in the hypothalamic–pituitary–thyroid axis</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source><volume>20</volume>(<issue>4</issue>):<fpage>529</fpage>–<lpage>546</lpage>, PMID: 17161330, <pub-id pub-id-type="doi">10.1016/j.beem.2006.11.001</pub-id>.<?supplied-pmid 17161330?><pub-id pub-id-type="pmid">17161330</pub-id></mixed-citation>
    </ref>
    <ref id="c9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benedetti</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Whomsley</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Baltes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tonner</surname><given-names>F</given-names></name></person-group><year>2005</year>. <article-title>Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction</article-title>. <source>Eur J Clin Pharmacol</source><volume>61</volume>(<issue>12</issue>):<fpage>863</fpage>–<lpage>872</lpage>, PMID: 16307266, <pub-id pub-id-type="doi">10.1007/s00228-005-0056-0</pub-id>.<?supplied-pmid 16307266?><pub-id pub-id-type="pmid">16307266</pub-id></mixed-citation>
    </ref>
    <ref id="c10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernal</surname><given-names>J</given-names></name></person-group><year>2005</year>. <article-title>Thyroid hormones and brain development</article-title>. <source>Vitam Horm</source><volume>71</volume>:<fpage>95</fpage>–<lpage>122</lpage>, PMID: 16112266, <pub-id pub-id-type="doi">10.1016/S0083-6729(05)71004-9</pub-id>.<?supplied-pmid 16112266?><pub-id pub-id-type="pmid">16112266</pub-id></mixed-citation>
    </ref>
    <ref id="c11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernal</surname><given-names>J</given-names></name></person-group><year>2018</year><article-title>New insights on thyroid hormone and the brain</article-title>. <source>Curr Opin Endocr Metab Res</source><volume>2</volume>:<fpage>24</fpage>–<lpage>28</lpage>, <pub-id pub-id-type="doi">10.1016/j.coemr.2017.12.001</pub-id>.</mixed-citation>
    </ref>
    <ref id="c12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bianco</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Salvatore</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gereben</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Berry</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>PR</given-names></name></person-group><year>2002</year>. <article-title>Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases</article-title>. <source>Endocr Rev</source><volume>23</volume>(<issue>1</issue>):<fpage>38</fpage>–<lpage>89</lpage>, PMID: 11844744, <pub-id pub-id-type="doi">10.1210/edrv.23.1.0455</pub-id>.<?supplied-pmid 11844744?><pub-id pub-id-type="pmid">11844744</pub-id></mixed-citation>
    </ref>
    <ref id="c13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borzelleca</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Capen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Hallagan</surname><given-names>JB</given-names></name></person-group><year>1987</year>. <article-title>Lifetime toxicity/carcinogenicity study of FD &amp; C Red No. 3 (erythrosine) in rats</article-title>. <source>Food Chem Toxicol</source><volume>25</volume>(<issue>10</issue>):<fpage>723</fpage>–<lpage>733</lpage>, PMID: 2824305, <pub-id pub-id-type="doi">10.1016/0278-6915(87)90227-4</pub-id>.<?supplied-pmid 2824305?><pub-id pub-id-type="pmid">2824305</pub-id></mixed-citation>
    </ref>
    <ref id="c14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botteri Principato</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Suarez</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Klinefelter</surname><given-names>GR</given-names></name></person-group><year>2018</year>. <article-title>The use of purified rat Leydig cells complements the H295R screen to detect chemical-induced alterations in testosterone production</article-title>. <source>Biol Reprod</source><volume>98</volume>(<issue>2</issue>):<fpage>239</fpage>–<lpage>249</lpage>, PMID: 29272331, <pub-id pub-id-type="doi">10.1093/biolre/iox177</pub-id>.<?supplied-pmid 29272331?><pub-id pub-id-type="pmid">29272331</pub-id></mixed-citation>
    </ref>
    <ref id="c15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boucher</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Husain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rowan-Carroll</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yauk</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Atlas</surname><given-names>E</given-names></name></person-group><year>2014</year>. <article-title>Identification of mechanisms of action of bisphenol A-induced human preadipocyte differentiation by transcriptional profiling</article-title>. <source>Obesity (Silver Spring)</source><volume>22</volume>(<issue>11</issue>):<fpage>2333</fpage>–<lpage>2343</lpage>, PMID: 25047013, <pub-id pub-id-type="doi">10.1002/oby.20848</pub-id>.<?supplied-pmid 25047013?><pub-id pub-id-type="pmid">25047013</pub-id></mixed-citation>
    </ref>
    <ref id="c16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourdon-Lacombe</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Moffat</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Deveau</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Husain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Auerbach</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Krewski</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title>Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals</article-title>. <source>Regul Toxicol Pharmacol</source><volume>72</volume>(<issue>2</issue>):<fpage>292</fpage>–<lpage>309</lpage>, PMID: 25944780, <pub-id pub-id-type="doi">10.1016/j.yrtph.2015.04.010</pub-id>.<?supplied-pmid 25944780?><pub-id pub-id-type="pmid">25944780</pub-id></mixed-citation>
    </ref>
    <ref id="c17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyes</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Degn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>George</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2018</year>. <article-title>Moderate perinatal thyroid hormone insufficiency alters visual system function in adult rats</article-title>. <source>Neurotoxicology</source><volume>67</volume>:<fpage>73</fpage>–<lpage>83</lpage>, PMID: 29684405, <pub-id pub-id-type="doi">10.1016/j.neuro.2018.04.013</pub-id>.<?supplied-pmid 29684405?><pub-id pub-id-type="pmid">29684405</pub-id></mixed-citation>
    </ref>
    <ref id="c18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Le Coutre</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Köhrle</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hershman</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>U</given-names></name></person-group><year>2012</year>. <article-title>Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport</article-title>. <source>J Clin Endocrinol Metab</source><volume>97</volume>(<issue>1</issue>):<fpage>E100</fpage>–<lpage>E105</lpage>, PMID: 22031512, <pub-id pub-id-type="doi">10.1210/jc.2011-1837</pub-id>.<?supplied-pmid 22031512?><pub-id pub-id-type="pmid">22031512</pub-id></mixed-citation>
    </ref>
    <ref id="c19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brazma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hingamp</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Quackenbush</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sherlock</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Spellman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Stoeckert</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2001</year>. <article-title>Minimum information about a microarray experiment (MIAME)—toward standards for microarray data</article-title>. <source>Nat Genet</source><volume>29</volume>(<issue>4</issue>):<fpage>365</fpage>–<lpage>371</lpage>, PMID: 11726920, <pub-id pub-id-type="doi">10.1038/ng1201-365</pub-id>.<?supplied-pmid 11726920?><pub-id pub-id-type="pmid">11726920</pub-id></mixed-citation>
    </ref>
    <ref id="c20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouwer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morse</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Lans</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Schuur</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Klasson-Wehler</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group><year>1998</year>. <article-title>Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health</article-title>. <source>Toxicol Ind Health</source><volume>14</volume>(<issue>1–2</issue>):<fpage>59</fpage>–<lpage>84</lpage>, PMID: 9460170, <pub-id pub-id-type="doi">10.1177/074823379801400107</pub-id>.<?supplied-pmid 9460170?><pub-id pub-id-type="pmid">9460170</pub-id></mixed-citation>
    </ref>
    <ref id="c21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brouwer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van den Berg</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Blaner</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>DS</given-names></name></person-group><year>1986</year><article-title>Transthyretin (prealbumin) binding of PCBS, a model for the mechanism of interference with vitamin A and thryoid-hormone metabolism</article-title>. <source>Chemosphere</source><volume>15</volume>(<issue>9–12</issue>):<fpage>1699</fpage>–<lpage>1706</lpage>, <pub-id pub-id-type="doi">10.1016/0045-6535(86)90457-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="c22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Kleinstreuer</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name></person-group><year>2015</year>. <article-title>Screening chemicals for estrogen receptor bioactivity using a computational model</article-title>. <source>Environ Sci Technol</source><volume>49</volume>(<issue>14</issue>):<fpage>8804</fpage>–<lpage>8814</lpage>, PMID: 26066997, <pub-id pub-id-type="doi">10.1021/acs.est.5b02641</pub-id>.<?supplied-pmid 26066997?><pub-id pub-id-type="pmid">26066997</pub-id></mixed-citation>
    </ref>
    <ref id="c23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Noyes</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Dix</surname><given-names>DJ</given-names></name></person-group><year>2017</year>. <article-title>Application of adverse outcome pathways to U.S. EPA’s endocrine disruptor screening program</article-title>. <source>Environ Health Perspect</source><volume>125</volume>(<issue>9</issue>):<elocation-id>096001</elocation-id>, PMID: 28934726, <pub-id pub-id-type="doi">10.1289/EHP1304</pub-id>.<?supplied-pmid 28934726?><pub-id pub-id-type="pmid">28934726</pub-id></mixed-citation>
    </ref>
    <ref id="c24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brucker-Davis</surname><given-names>F</given-names></name></person-group><year>1998</year>. <article-title>Effects of environmental synthetic chemicals on thyroid function</article-title>. <source>Thyroid</source><volume>8</volume>(<issue>9</issue>):<fpage>827</fpage>–<lpage>856</lpage>, PMID: 9777756, <pub-id pub-id-type="doi">10.1089/thy.1998.8.827</pub-id>.<?supplied-pmid 9777756?><pub-id pub-id-type="pmid">9777756</pub-id></mixed-citation>
    </ref>
    <ref id="c25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buesen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chorley</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>da Silva Lima</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Daston</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Deferme</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ebbels</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>Applying ’omics technologies in chemicals risk assessment: report of an ECETOC workshop</article-title>. <source>Regul Toxicol Pharmacol</source><volume>91</volume>(<issue>Suppl 1</issue>):<fpage>S3</fpage>–<lpage>S13</lpage>, PMID: 28958911, <pub-id pub-id-type="doi">10.1016/j.yrtph.2017.09.002</pub-id>.<?supplied-pmid 28958911?><pub-id pub-id-type="pmid">28958911</pub-id></mixed-citation>
    </ref>
    <ref id="c26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butt</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Stapleton</surname><given-names>HM</given-names></name></person-group><year>2013</year>. <article-title>Inhibition of thyroid hormone sulfotransferase activity by brominated flame retardants and halogenated phenolics</article-title>. <source>Chem Res Toxicol</source><volume>26</volume>(<issue>11</issue>):<fpage>1692</fpage>–<lpage>1702</lpage>, PMID: 24089703, <pub-id pub-id-type="doi">10.1021/tx400342k</pub-id>.<?supplied-pmid 24089703?><pub-id pub-id-type="pmid">24089703</pub-id></mixed-citation>
    </ref>
    <ref id="c27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butt</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Stapleton</surname><given-names>HM</given-names></name></person-group><year>2011</year>. <article-title>Halogenated phenolic contaminants inhibit the <italic>in vitro</italic> activity of the thyroid-regulating deiodinases in human liver</article-title>. <source>Toxicol Sci</source><volume>124</volume>(<issue>2</issue>):<fpage>339</fpage>–<lpage>347</lpage>, PMID: 21565810, <pub-id pub-id-type="doi">10.1093/toxsci/kfr117</pub-id>.<?supplied-pmid 21565810?><pub-id pub-id-type="pmid">21565810</pub-id></mixed-citation>
    </ref>
    <ref id="c28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capen</surname><given-names>CC</given-names></name></person-group><year>1997</year>. <article-title>Mechanistic data and risk assessment of selected toxic end points of the thyroid gland</article-title>. <source>Toxicol Pathol</source><volume>25</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>48</lpage>, PMID: 9061850, <pub-id pub-id-type="doi">10.1177/019262339702500109</pub-id>.<?supplied-pmid 9061850?><pub-id pub-id-type="pmid">9061850</pub-id></mixed-citation>
    </ref>
    <ref id="c29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>SL</given-names></name></person-group><year>1989</year>. <article-title>The effects of xenobiotics on the structure and function of thyroid follicular and C-cells</article-title>. <source>Toxicol Pathol</source><volume>17</volume>(<issue>2</issue>):<fpage>266</fpage>–<lpage>293</lpage>, PMID: 2675279, <pub-id pub-id-type="doi">10.1177/019262338901700205</pub-id>.<?supplied-pmid 2675279?><pub-id pub-id-type="pmid">2675279</pub-id></mixed-citation>
    </ref>
    <ref id="c30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chanoine</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Alex</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Leonard</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Körhle</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>1992</year>. <article-title>Role of transthyretin in the transport of thyroxine from the blood to the choroid-plexus, the cerebrospinal fluid, and the brain</article-title>. <source>Endocrinology</source><volume>130</volume>(<issue>2</issue>):<fpage>933</fpage>–<lpage>938</lpage>, PMID: 1733735, <pub-id pub-id-type="doi">10.1210/endo.130.2.1733735</pub-id>.<?supplied-pmid 1733735?><pub-id pub-id-type="pmid">1733735</pub-id></mixed-citation>
    </ref>
    <ref id="c31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheek</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Kow</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McLachlan</surname><given-names>JA</given-names></name></person-group><year>1999</year>. <article-title>Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin</article-title>. <source>Environ Health Perspect</source><volume>107</volume>(<issue>4</issue>):<fpage>273</fpage>–<lpage>278</lpage>, PMID: 10090705, <pub-id pub-id-type="doi">10.1289/ehp.99107273</pub-id>.<?supplied-pmid 10090705?><pub-id pub-id-type="pmid">10090705</pub-id></mixed-citation>
    </ref>
    <ref id="c32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sible</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>McNabb</surname><given-names>F</given-names></name></person-group><year>2008</year>. <article-title>Effects of maternal exposure to ammonium perchlorate on thyroid function and the expression of thyroid-responsive genes in Japanese quail embryos</article-title>. <source>Gen Comp Endocrinol</source><volume>159</volume>(<issue>2–3</issue>):<fpage>196</fpage>–<lpage>207</lpage>, PMID: 18804473, <pub-id pub-id-type="doi">10.1016/j.ygcen.2008.08.014</pub-id>.<?supplied-pmid 18804473?><pub-id pub-id-type="pmid">18804473</pub-id></mixed-citation>
    </ref>
    <ref id="c33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Simonsen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hegedüs</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Døssing</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kampmamn</surname><given-names>JP</given-names></name>, <etal>et al.</etal></person-group><year>1989</year>. <article-title>Influence of rifampicin on thyroid gland volume, thyroid hormones, and antipyrine metabolism</article-title>. <source>Acta Endocrinol (Copenh)</source><volume>121</volume>(<issue>3</issue>):<fpage>406</fpage>–<lpage>410</lpage>, PMID: 2800919, <pub-id pub-id-type="doi">10.1530/acta.0.1210406</pub-id>.<?supplied-pmid 2800919?><pub-id pub-id-type="pmid">2800919</pub-id></mixed-citation>
    </ref>
    <ref id="c34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y-H</given-names></name>, <name name-style="western"><surname>Chi</surname><given-names>H-C</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y-H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>C-C</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance</article-title>. <source>Oncotarget</source><volume>7</volume>(<issue>16</issue>):<fpage>22448</fpage>–<lpage>22459</lpage>, PMID: 26968954, <pub-id pub-id-type="doi">10.18632/oncotarget.7988</pub-id>.<?supplied-pmid 26968954?><pub-id pub-id-type="pmid">26968954</pub-id></mixed-citation>
    </ref>
    <ref id="c35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clerget-Froidevaux</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Seugnet</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Demeneix</surname><given-names>BA</given-names></name></person-group><year>2004</year>. <article-title>Thyroid status co-regulates thyroid hormone receptor and co-modulator genes specifically in the hypothalamus</article-title>. <source>FEBS Lett</source><volume>569</volume>(<issue>1–3</issue>):<fpage>341</fpage>–<lpage>345</lpage>, PMID: 15225659, <pub-id pub-id-type="doi">10.1016/j.febslet.2004.05.076</pub-id>.<?supplied-pmid 15225659?><pub-id pub-id-type="pmid">15225659</pub-id></mixed-citation>
    </ref>
    <ref id="c36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clewell</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Merrill</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Narayanan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gearhart</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>PJ</given-names></name></person-group><year>2004</year>. <article-title>Evidence for competitive inhibition of iodide uptake by perchlorate and translocation of perchlorate into the thyroid</article-title>. <source>Int J Toxicol</source><volume>23</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>23</lpage>, PMID: 15162843, <pub-id pub-id-type="doi">10.1080/10915810490275044</pub-id>.<?supplied-pmid 15162843?><pub-id pub-id-type="pmid">15162843</pub-id></mixed-citation>
    </ref>
    <ref id="c37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coady</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Biever</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Denslow</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Guiney</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Holbech</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances</article-title>. <source>Integr Environ Assess Manag</source><volume>13</volume>(<issue>2</issue>):<fpage>302</fpage>–<lpage>316</lpage>, PMID: 27791330, <pub-id pub-id-type="doi">10.1002/ieam.1862</pub-id>.<?supplied-pmid 27791330?><pub-id pub-id-type="pmid">27791330</pub-id></mixed-citation>
    </ref>
    <ref id="c38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coady</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Marino</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Currie</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Crofoot</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>Evaluation of the amphibian metamorphosis assay: exposure to the goitrogen methimazole and the endogenous thyroid hormone L-thyroxine</article-title>. <source>Environ Toxicol Chem</source><volume>29</volume>(<issue>4</issue>):<fpage>869</fpage>–<lpage>880</lpage>, PMID: 20821516, <pub-id pub-id-type="doi">10.1002/etc.74</pub-id>.<?supplied-pmid 20821516?><pub-id pub-id-type="pmid">20821516</pub-id></mixed-citation>
    </ref>
    <ref id="c39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Bucher</surname><given-names>JR</given-names></name></person-group><year>2008</year>. <article-title>Toxicology. Transforming environmental health protection</article-title>. <source>Science</source><volume>319</volume>(<issue>5865</issue>):<fpage>906</fpage>–<lpage>907</lpage>, PMID: 18276874, <pub-id pub-id-type="doi">10.1126/science.1154619</pub-id>.<?supplied-pmid 18276874?><pub-id pub-id-type="pmid">18276874</pub-id></mixed-citation>
    </ref>
    <ref id="c40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Compe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Malerba</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Soler</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Marescaux</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Borrelli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Egly</surname><given-names>J-M</given-names></name></person-group><year>2007</year>. <article-title>Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH</article-title>. <source>Nat Neurosci</source><volume>10</volume>(<issue>11</issue>):<fpage>1414</fpage>–<lpage>1422</lpage>, PMID: 17952069, <pub-id pub-id-type="doi">10.1038/nn1990</pub-id>.<?supplied-pmid 17952069?><pub-id pub-id-type="pmid">17952069</pub-id></mixed-citation>
    </ref>
    <ref id="c41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>2004</year>. <article-title>Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats</article-title>. <source>Risk Anal</source><volume>24</volume>(<issue>6</issue>):<fpage>1665</fpage>–<lpage>1671</lpage>, PMID: 15660619, <pub-id pub-id-type="doi">10.1111/j.0272-4332.2004.00557.x</pub-id>.<?supplied-pmid 15660619?><pub-id pub-id-type="pmid">15660619</pub-id></mixed-citation>
    </ref>
    <ref id="c42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>2008</year>. <article-title>Thyroid disrupting chemicals: mechanisms and mixtures</article-title>. <source>Int J Androl</source><volume>31</volume>(<issue>2</issue>):<fpage>209</fpage>–<lpage>222</lpage>, PMID: 18217984, <pub-id pub-id-type="doi">10.1111/j.1365-2605.2007.00857.x</pub-id>.<?supplied-pmid 18217984?><pub-id pub-id-type="pmid">18217984</pub-id></mixed-citation>
    </ref>
    <ref id="c43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kodavanti</surname><given-names>PRS</given-names></name>, <name name-style="western"><surname>Derr-Yellin</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Kehn</surname><given-names>LS</given-names></name></person-group><year>2000</year>. <article-title>PCBs, thyroid hormones, and ototoxicity in rats: cross-fostering experiments demonstrate the impact of postnatal lactation exposure</article-title>. <source>Toxicol Sci</source><volume>57</volume>(<issue>1</issue>):<fpage>131</fpage>–<lpage>140</lpage>, PMID: 10966519, <pub-id pub-id-type="doi">10.1093/toxsci/57.1.131</pub-id>.<?supplied-pmid 10966519?><pub-id pub-id-type="pmid">10966519</pub-id></mixed-citation>
    </ref>
    <ref id="c44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2005</year>. <article-title>Mode of action: neurotoxicity induced by thyroid hormone disruption during development—hearing loss resulting from exposure to PHAHs</article-title>. <source>Crit Rev Toxicol</source><volume>35</volume>(<issue>8–9</issue>):<fpage>757</fpage>–<lpage>769</lpage>, PMID: 16417043, <pub-id pub-id-type="doi">10.1080/10408440591007304</pub-id>.<?supplied-pmid 16417043?><pub-id pub-id-type="pmid">16417043</pub-id></mixed-citation>
    </ref>
    <ref id="c45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crump</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Werry</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Veldhoen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Van Aggelen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Helbing</surname><given-names>CC</given-names></name></person-group><year>2002</year>. <article-title>Exposure to the herbicide acetochlor alters thyroid hormone-dependent gene expression and metamorphosis in <italic>Xenopus laevis</italic></article-title>. <source>Environ Health Perspect</source><volume>110</volume>(<issue>12</issue>):<fpage>1199</fpage>–<lpage>1205</lpage>, PMID: 12460798, <pub-id pub-id-type="doi">10.1289/ehp.021101199</pub-id>.<?supplied-pmid 12460798?><pub-id pub-id-type="pmid">12460798</pub-id></mixed-citation>
    </ref>
    <ref id="c46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curran</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>DeGroot</surname><given-names>LJ</given-names></name></person-group><year>1991</year>. <article-title>The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland</article-title>. <source>Endocr Rev</source><volume>12</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>150</lpage>, PMID: 2070777, <pub-id pub-id-type="doi">10.1210/edrv-12-2-135</pub-id>.<?supplied-pmid 2070777?><pub-id pub-id-type="pmid">2070777</pub-id></mixed-citation>
    </ref>
    <ref id="c47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Soodak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Neary</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Strout</surname><given-names>HV</given-names></name>, <name name-style="western"><surname>Kieffer</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Mover</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group><year>1978</year>. <article-title>The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings</article-title>. <source>Endocrinology</source><volume>103</volume>(<issue>3</issue>):<fpage>871</fpage>–<lpage>882</lpage>, PMID: 744122, <pub-id pub-id-type="doi">10.1210/endo-103-3-871</pub-id>.<?supplied-pmid 744122?><pub-id pub-id-type="pmid">744122</pub-id></mixed-citation>
    </ref>
    <ref id="c48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dean</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Wesselkamper</surname><given-names>SC</given-names></name></person-group><year>2017</year>. <article-title>Editor’s highlight: application of gene set enrichment analysis for identification of chemically induced, biologically relevant transcriptomic networks and potential utilization in human health risk assessment</article-title>. <source>Toxicol Sci</source><volume>157</volume>(<issue>1</issue>):<fpage>85</fpage>–<lpage>99</lpage>, PMID: 28123101, <pub-id pub-id-type="doi">10.1093/toxsci/kfx021</pub-id>.<?supplied-pmid 28123101?><pub-id pub-id-type="pmid">28123101</pub-id></mixed-citation>
    </ref>
    <ref id="c49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Holcombe</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Tietge</surname><given-names>JE</given-names></name></person-group><year>2005</year>. <article-title>Progress towards development of an amphibian-based thyroid screening assay using <italic>Xenopus laevis</italic>. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine</article-title>. <source>Toxicol Sci</source><volume>87</volume>(<issue>2</issue>):<fpage>353</fpage>–<lpage>364</lpage>, PMID: 16002479, <pub-id pub-id-type="doi">10.1093/toxsci/kfi246</pub-id>.<?supplied-pmid 16002479?><pub-id pub-id-type="pmid">16002479</pub-id></mixed-citation>
    </ref>
    <ref id="c50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dellarco</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>McGregor</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Berry</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Boobis</surname><given-names>AR</given-names></name></person-group><year>2006</year>. <article-title>Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action</article-title>. <source>Crit Rev Toxicol</source><volume>36</volume>(<issue>10</issue>):<fpage>793</fpage>–<lpage>801</lpage>, PMID: 17118729, <pub-id pub-id-type="doi">10.1080/10408440600975242</pub-id>.<?supplied-pmid 17118729?><pub-id pub-id-type="pmid">17118729</pub-id></mixed-citation>
    </ref>
    <ref id="c51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dentice</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Marsili</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zavacki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Salvatore</surname><given-names>D</given-names></name></person-group><year>2013</year>. <article-title>The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation</article-title>. <source>Biochim Biophys Acta</source><volume>1830</volume>(<issue>7</issue>):<fpage>3937</fpage>–<lpage>3945</lpage>, PMID: 22634734, <pub-id pub-id-type="doi">10.1016/j.bbagen.2012.05.007</pub-id>.<?supplied-pmid 22634734?><pub-id pub-id-type="pmid">22634734</pub-id></mixed-citation>
    </ref>
    <ref id="c52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denver</surname><given-names>RJ</given-names></name></person-group><year>1998</year>. <article-title>The molecular basis of thyroid hormone-dependent central nervous system remodeling during amphibian metamorphosis</article-title>. <source>Comp Biochem Physiol C Pharmacol Toxicol Endocrinol</source><volume>119</volume>(<issue>3</issue>):<fpage>219</fpage>–<lpage>228</lpage>, PMID: 9826995, <pub-id pub-id-type="doi">10.1016/S0742-8413(98)00011-5</pub-id>.<?supplied-pmid 9826995?><pub-id pub-id-type="pmid">9826995</pub-id></mixed-citation>
    </ref>
    <ref id="c53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeVito</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Biegel</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Brouwer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brucker-Davis</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cheek</surname><given-names>AO</given-names></name>, <etal>et al.</etal></person-group><year>1999</year>. <article-title>Screening methods for thyroid hormone disruptors</article-title>. <source>Environ Health Perspect</source><volume>107</volume>(<issue>5</issue>):<fpage>407</fpage>–<lpage>415</lpage>, PMID: 10210697, <pub-id pub-id-type="doi">10.1289/ehp.99107407</pub-id>.<?supplied-pmid 10210697?><pub-id pub-id-type="pmid">10210697</pub-id></mixed-citation>
    </ref>
    <ref id="c54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diamanti-Kandarakis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bourguignon</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Giudice</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Hauser</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Soto</surname><given-names>AM</given-names></name>, <etal>et al.</etal></person-group><year>2009</year>. <article-title>Endocrine-disrupting chemicals: an Endocrine Society scientific statement</article-title>. <source>Endocr Rev</source><volume>30</volume>(<issue>4</issue>):<fpage>293</fpage>–<lpage>342</lpage>, PMID: 19502515, <pub-id pub-id-type="doi">10.1210/er.2009-0002</pub-id>.<?supplied-pmid 19502515?><pub-id pub-id-type="pmid">19502515</pub-id></mixed-citation>
    </ref>
    <ref id="c55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dickson</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Howlett</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>G</given-names></name></person-group><year>1985</year>. <article-title>Rat transthyretin (prealbumin). Molecular cloning, nucleotide sequence, and gene expression in liver and brain</article-title>. <source>J Biol Chem</source><volume>260</volume>(<issue>13</issue>):<fpage>8214</fpage>–<lpage>8219</lpage>, PMID: 3839240.<?supplied-pmid 3839240?><pub-id pub-id-type="pmid">3839240</pub-id></mixed-citation>
    </ref>
    <ref id="c56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Divi</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Doerge</surname><given-names>DR</given-names></name></person-group><year>1996</year>. <article-title>Inhibition of thyroid peroxidase by dietary flavonoids</article-title>. <source>Chem Res Toxicol</source><volume>9</volume>(<issue>1</issue>):<fpage>16</fpage>–<lpage>23</lpage>, PMID: 8924586, <pub-id pub-id-type="doi">10.1021/tx950076m</pub-id>.<?supplied-pmid 8924586?><pub-id pub-id-type="pmid">8924586</pub-id></mixed-citation>
    </ref>
    <ref id="c57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dix</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Setzer</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Kavlock</surname><given-names>RJ</given-names></name></person-group><year>2007</year>. <article-title>The ToxCast program for prioritizing toxicity testing of environmental chemicals</article-title>. <source>Toxicol Sci</source><volume>95</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>12</lpage>, PMID: 16963515, <pub-id pub-id-type="doi">10.1093/toxsci/kfl103</pub-id>.<?supplied-pmid 16963515?><pub-id pub-id-type="pmid">16963515</pub-id></mixed-citation>
    </ref>
    <ref id="c58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doerge</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Divi</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Churchwell</surname><given-names>MI</given-names></name></person-group><year>1998</year>. <article-title>Mechanism for inhibition of thyroid peroxidase by leucomalachite green</article-title>. <source>Chem Res Toxicol</source><volume>11</volume>(<issue>9</issue>):<fpage>1098</fpage>–<lpage>1104</lpage>, PMID: 9760285, <pub-id pub-id-type="doi">10.1021/tx970226o</pub-id>.<?supplied-pmid 9760285?><pub-id pub-id-type="pmid">9760285</pub-id></mixed-citation>
    </ref>
    <ref id="c59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wade</surname><given-names>MG</given-names></name></person-group><year>2017</year>. <article-title>Application of a nonradioactive assay for high throughput screening for inhibition of thyroid hormone uptake via the transmembrane transporter MCT8</article-title>. <source>Toxicol In Vitro</source><volume>40</volume>:<fpage>234</fpage>–<lpage>242</lpage>, PMID: 28119167, <pub-id pub-id-type="doi">10.1016/j.tiv.2017.01.014</pub-id>.<?supplied-pmid 28119167?><pub-id pub-id-type="pmid">28119167</pub-id></mixed-citation>
    </ref>
    <ref id="c60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yauk</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Rowan-Carroll</surname><given-names>A</given-names></name>, <name name-style="western"><surname>You</surname><given-names>S-H</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>I</given-names></name>, <etal>et al.</etal></person-group><year>2009</year>. <article-title>Identification of thyroid hormone receptor binding sites and target genes using ChIP-on-chip in developing mouse cerebellum</article-title>. <source>PLoS One</source><volume>4</volume>(<issue>2</issue>):<elocation-id>e4610</elocation-id>, PMID: 19240802, <pub-id pub-id-type="doi">10.1371/journal.pone.0004610</pub-id>.<?supplied-pmid 19240802?><pub-id pub-id-type="pmid">19240802</pub-id></mixed-citation>
    </ref>
    <ref id="c61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dupré</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Guissouma</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Flamant</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Seugnet</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Scanlan</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Baxter</surname><given-names>JD</given-names></name>, <etal>et al.</etal></person-group><year>2004</year>. <article-title>Both thyroid hormone receptor (TR)β1 and TRβ2 isoforms contribute to the regulation of hypothalamic <italic>thyrotropin-releasing hormone</italic></article-title>. <source>Endocrinology</source><volume>145</volume>(<issue>5</issue>):<fpage>2337</fpage>–<lpage>2345</lpage>, PMID: 14726446, <pub-id pub-id-type="doi">10.1210/en.2003-1209</pub-id>.<?supplied-pmid 14726446?><pub-id pub-id-type="pmid">14726446</pub-id></mixed-citation>
    </ref>
    <ref id="c62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dussault</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Ruel</surname><given-names>J</given-names></name></person-group><year>1987</year>. <article-title>Thyroid hormones and brain development</article-title>. <source>Annu Rev Physiol</source><volume>49</volume>:<fpage>321</fpage>–<lpage>324</lpage>, PMID: 3551803, <pub-id pub-id-type="doi">10.1146/annurev.ph.49.030187.001541</pub-id>.<?supplied-pmid 3551803?><pub-id pub-id-type="pmid">3551803</pub-id></mixed-citation>
    </ref>
    <ref id="c63">
      <mixed-citation publication-type="web"><collab>ECHA (European Chemicals Agency)</collab>. <year>2016</year><article-title><italic>New Approach Methodologies in Regulatory Science</italic>. Proceedings of a Scientific Workshop, 19–20 April 2016 2016, Helsinki, Finland</article-title>. <ext-link ext-link-type="uri" xlink:href="https://echa.europa.eu/documents/10162/22816069/scientific_ws_proceedings_en.pdf/a2087434-0407-4705-9057-95d9c2c2cc57">https://echa.europa.eu/documents/10162/22816069/scientific_ws_proceedings_en.pdf/a2087434-0407-4705-9057-95d9c2c2cc57</ext-link> [accessed <date-in-citation content-type="access-date">5 October 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Skoumbourdis</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Childress</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Neumann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deschamps</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>CJ</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists</article-title>. <source>J Am Chem Soc</source><volume>130</volume>(<issue>15</issue>):<fpage>5115</fpage>–<lpage>5123</lpage>, PMID: 18357984, <pub-id pub-id-type="doi">10.1021/ja077620l</pub-id>.<?supplied-pmid 18357984?><pub-id pub-id-type="pmid">18357984</pub-id></mixed-citation>
    </ref>
    <ref id="c65">
      <mixed-citation publication-type="report"><collab>EU</collab>. <year>2017</year><source>Supporting the Organisation of a Workshop on Thyroid Disruption—Final Report. European Commission, Framework Contract ENV.A.3/FRA/2014/0029 on implementation of the Community strategy on Endocrine Disrupters</source>. <ext-link ext-link-type="uri" xlink:href="https://publications.europa.eu/en/publication-detail/-/publication/472d2c88-a8b1-11e7-837e-01aa75ed71a1/language-en">https://publications.europa.eu/en/publication-detail/-/publication/472d2c88-a8b1-11e7-837e-01aa75ed71a1/language-en</ext-link> [accessed <date-in-citation content-type="access-date">15 July 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c66">
      <mixed-citation publication-type="web"><collab>EU Science Hub</collab>. <year>2017</year><article-title>European drive to validate in vitro methods for the detection of thyroid disruptors</article-title>. <italic>EU Science Hub</italic> News and Events section. 4 July 2017. <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/jrc/en/science-update/vitro-methods-detection-thyroid-disruptors">https://ec.europa.eu/jrc/en/science-update/vitro-methods-detection-thyroid-disruptors</ext-link> [accessed <date-in-citation content-type="access-date">1 August 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>ACF</given-names></name>, <name name-style="western"><surname>Lisboa</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>Barros</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>DP</given-names></name></person-group><year>2002</year>. <article-title>Inhibition of thyroid type 1 deiodinase activity by flavonoids</article-title>. <source>Food Chem Toxicol</source><volume>40</volume>(<issue>7</issue>):<fpage>913</fpage>–<lpage>917</lpage>, PMID: 12065212, <pub-id pub-id-type="doi">10.1016/S0278-6915(02)00064-9</pub-id>.<?supplied-pmid 12065212?><pub-id pub-id-type="pmid">12065212</pub-id></mixed-citation>
    </ref>
    <ref id="c68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finken</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>van Eijsden</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Loomans</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Vrijkotte</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Rotteveel</surname><given-names>J</given-names></name></person-group><year>2013</year>. <article-title>Maternal hypothyroxinemia in early pregnancy predicts reduced performance in reaction time tests in 5- to 6-year-old offspring</article-title>. <source>J Clin Endocrinol Metab</source><volume>98</volume>(<issue>4</issue>):<fpage>1417</fpage>–<lpage>1426</lpage>, PMID: 23408575, <pub-id pub-id-type="doi">10.1210/jc.2012-3389</pub-id>.<?supplied-pmid 23408575?><pub-id pub-id-type="pmid">23408575</pub-id></mixed-citation>
    </ref>
    <ref id="c69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fort</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>White</surname><given-names>JA</given-names></name>, <etal>et al.</etal></person-group><year>2000</year>. <article-title>Preliminary validation of a short-term morphological assay to evaluate adverse effects on amphibian metamorphosis and thyroid function using <italic>Xenopus laevis</italic></article-title>. <source>J Appl Toxicol</source><volume>20</volume>(<issue>5</issue>):<fpage>419</fpage>–<lpage>425</lpage>, PMID: 11139173, <pub-id pub-id-type="doi">10.1002/1099-1263(200009/10)20:5&lt;419::AID-JAT708&gt;3.0.CO;2-A</pub-id>.<?supplied-pmid 11139173?><pub-id pub-id-type="pmid">11139173</pub-id></mixed-citation>
    </ref>
    <ref id="c70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francis</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Rennert</surname><given-names>OM</given-names></name></person-group><year>1980</year>. <article-title>Correlation of plasma propylthiouracil levels with inhibition of thyroid hormone synthesis in the rat</article-title>. <source>Metabolism</source><volume>29</volume>(<issue>5</issue>):<fpage>410</fpage>–<lpage>414</lpage>, PMID: 7374447, <pub-id pub-id-type="doi">10.1016/0026-0495(80)90164-x</pub-id>.<?supplied-pmid 7374447?><pub-id pub-id-type="pmid">7374447</pub-id></mixed-citation>
    </ref>
    <ref id="c71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cano</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Craig-Veit</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Goodson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Furlow</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name></person-group><year>2011</year>. <article-title>Detection of thyroid hormone receptor disruptors by a novel stable <italic>in vitro</italic> reporter gene assay</article-title>. <source>Toxicol In Vitro</source><volume>25</volume>(<issue>1</issue>):<fpage>257</fpage>–<lpage>266</lpage>, PMID: 20732405, <pub-id pub-id-type="doi">10.1016/j.tiv.2010.08.013</pub-id>.<?supplied-pmid 20732405?><pub-id pub-id-type="pmid">20732405</pub-id></mixed-citation>
    </ref>
    <ref id="c72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mengeling</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group><year>2014</year>. <article-title>Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform</article-title>. <source>Curr Chem Genom Transl Med</source><volume>8</volume>:<fpage>36</fpage>–<lpage>46</lpage>, PMID: 24772387, <pub-id pub-id-type="doi">10.2174/2213988501408010036</pub-id>.<?supplied-pmid 24772387?><pub-id pub-id-type="pmid">24772387</pub-id></mixed-citation>
    </ref>
    <ref id="c73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friesema</surname><given-names>ECH</given-names></name>, <name name-style="western"><surname>Ganguly</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Abdalla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>JEM</given-names></name>, <name name-style="western"><surname>Halestrap</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>TJ</given-names></name></person-group><year>2003</year>. <article-title>Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter</article-title>. <source>J Biol Chem</source><volume>278</volume>(<issue>41</issue>):<fpage>40128</fpage>–<lpage>40135</lpage>, PMID: 12871948, <pub-id pub-id-type="doi">10.1074/jbc.M300909200</pub-id>.<?supplied-pmid 12871948?><pub-id pub-id-type="pmid">12871948</pub-id></mixed-citation>
    </ref>
    <ref id="c74">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Matsuura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Heimeier</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Y-B</given-names></name></person-group><year>2017</year>. <article-title>Genome-wide identification of thyroid hormone receptor targets in the remodeling intestine during <italic>Xenopus tropicalis</italic> metamorphosis</article-title>. <source>Sci Rep</source><volume>7</volume>(<issue>1</issue>):<fpage>6414</fpage>, PMID: 28743885, <pub-id pub-id-type="doi">10.1038/s41598-017-06679-x</pub-id>.<?supplied-pmid 28743885?><pub-id pub-id-type="pmid">28743885</pub-id></mixed-citation>
    </ref>
    <ref id="c75">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galton</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>de Waard</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parlow</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>A</given-names></name></person-group><year>2014</year>. <article-title>Life without the iodothyronine deiodinases</article-title>. <source>Endocrinology</source><volume>155</volume>(<issue>10</issue>):<fpage>4081</fpage>–<lpage>4087</lpage>, PMID: 24949664, <pub-id pub-id-type="doi">10.1210/en.2014-1184</pub-id>.<?supplied-pmid 24949664?><pub-id pub-id-type="pmid">24949664</pub-id></mixed-citation>
    </ref>
    <ref id="c76">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galton</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name></person-group><year>2009</year>. <article-title>Life without thyroxine to 3,5,3ʹ-triiodothyronine conversion: studies in mice devoid of the 5ʹ-deiodinases</article-title>. <source>Endocrinology</source><volume>150</volume>(<issue>6</issue>):<fpage>2957</fpage>–<lpage>2963</lpage>, PMID: 19196796, <pub-id pub-id-type="doi">10.1210/en.2008-1572</pub-id>.<?supplied-pmid 19196796?><pub-id pub-id-type="pmid">19196796</pub-id></mixed-citation>
    </ref>
    <ref id="c77">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galton</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Withrow</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>G</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>GM</given-names></name>, <etal>et al.</etal></person-group><year>2007</year>. <article-title>Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development</article-title>. <source>Endocrinology</source><volume>148</volume>(<issue>7</issue>):<fpage>3080</fpage>–<lpage>3088</lpage>, PMID: 17332058, <pub-id pub-id-type="doi">10.1210/en.2006-1727</pub-id>.<?supplied-pmid 17332058?><pub-id pub-id-type="pmid">17332058</pub-id></mixed-citation>
    </ref>
    <ref id="c78">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Reyero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Habib</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pirooznia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gust</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Warner</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2011</year>. <article-title>Conserved toxic responses across divergent phylogenetic lineages: a meta-analysis of the neurotoxic effects of RDX among multiple species using toxicogenomics</article-title>. <source>Ecotoxicology</source><volume>20</volume>(<issue>3</issue>):<fpage>580</fpage>–<lpage>594</lpage>, PMID: 21516383, <pub-id pub-id-type="doi">10.1007/s10646-011-0623-3</pub-id>.<?supplied-pmid 21516383?><pub-id pub-id-type="pmid">21516383</pub-id></mixed-citation>
    </ref>
    <ref id="c79">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gauger</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Giera</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sharlin</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Bansal</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Iannacone</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2007</year>. <article-title>Polychlorinated biphenyls 105 and 118 form thyroid hormone receptor agonists after cytochrome P4501A1 activation in rat pituitary GH3 cells</article-title>. <source>Environ Health Perspect</source><volume>115</volume>(<issue>11</issue>):<fpage>1623</fpage>–<lpage>1630</lpage>, PMID: 18007995, <pub-id pub-id-type="doi">10.1289/ehp.10328</pub-id>.<?supplied-pmid 18007995?><pub-id pub-id-type="pmid">18007995</pub-id></mixed-citation>
    </ref>
    <ref id="c80">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gentilcore</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Porreca</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Rizzo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ganbaatar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carchia</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mallardo</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Bisphenol A interferes with thyroid specific gene expression</article-title>. <source>Toxicology</source><volume>304</volume>:<fpage>21</fpage>–<lpage>31</lpage>, PMID: 23238275, <pub-id pub-id-type="doi">10.1016/j.tox.2012.12.001</pub-id>.<?supplied-pmid 23238275?><pub-id pub-id-type="pmid">23238275</pub-id></mixed-citation>
    </ref>
    <ref id="c81">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gereben</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zavacki</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ribich</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Simonides</surname><given-names>WS</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling</article-title>. <source>Endocr Rev</source><volume>29</volume>(<issue>7</issue>):<fpage>898</fpage>–<lpage>938</lpage>, PMID: 18815314, <pub-id pub-id-type="doi">10.1210/er.2008-0019</pub-id>.<?supplied-pmid 18815314?><pub-id pub-id-type="pmid">18815314</pub-id></mixed-citation>
    </ref>
    <ref id="c82">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gershengorn</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Neumann</surname><given-names>S</given-names></name></person-group><year>2012</year>. <article-title>Update in TSH receptor agonists and antagonists</article-title>. <source>J Clin Endocrinol Metab</source><volume>97</volume>(<issue>12</issue>):<fpage>4287</fpage>–<lpage>4292</lpage>, PMID: 23019348, <pub-id pub-id-type="doi">10.1210/jc.2012-3080</pub-id>.<?supplied-pmid 23019348?><pub-id pub-id-type="pmid">23019348</pub-id></mixed-citation>
    </ref>
    <ref id="c83">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghassabian</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Henrichs</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tiemeier</surname><given-names>H</given-names></name></person-group><year>2014</year>. <article-title>Impact of mild thyroid hormone deficiency in pregnancy on cognitive function in children: lessons from the Generation R Study</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source><volume>28</volume>(<issue>2</issue>):<fpage>221</fpage>–<lpage>232</lpage>, PMID: 24629863, <pub-id pub-id-type="doi">10.1016/j.beem.2013.04.008</pub-id>.<?supplied-pmid 24629863?><pub-id pub-id-type="pmid">24629863</pub-id></mixed-citation>
    </ref>
    <ref id="c84">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2011</year>. <article-title>Impact of low-level thyroid hormone disruption induced by propylthiouracil on brain development and function</article-title>. <source>Toxicol Sci</source><volume>124</volume>(<issue>2</issue>):<fpage>432</fpage>–<lpage>445</lpage>, PMID: 21964421, <pub-id pub-id-type="doi">10.1093/toxsci/kfr244</pub-id>.<?supplied-pmid 21964421?><pub-id pub-id-type="pmid">21964421</pub-id></mixed-citation>
    </ref>
    <ref id="c85">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Johnstone</surname><given-names>AFM</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>RL</given-names></name></person-group><year>2017</year>. <article-title>Adult hippocampal neurogenesis is impaired by transient and moderate developmental thyroid hormone disruption</article-title>. <source>Neurotoxicology</source><volume>59</volume>:<fpage>9</fpage>–<lpage>21</lpage>, PMID: 28048979, <pub-id pub-id-type="doi">10.1016/j.neuro.2016.12.009</pub-id>.<?supplied-pmid 28048979?><pub-id pub-id-type="pmid">28048979</pub-id></mixed-citation>
    </ref>
    <ref id="c86">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hedge</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Valentin-Blasini</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Blount</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Kannan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tietge</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome</article-title>. <source>Toxicol Sci</source><volume>132</volume>(<issue>1</issue>):<fpage>177</fpage>–<lpage>195</lpage>, PMID: 23288053, <pub-id pub-id-type="doi">10.1093/toxsci/kfs335</pub-id>.<?supplied-pmid 23288053?><pub-id pub-id-type="pmid">23288053</pub-id></mixed-citation>
    </ref>
    <ref id="c87">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Sanchez-Huerta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>C</given-names></name></person-group><year>2016</year>. <article-title>Mild thyroid hormone insufficiency during development compromises activity-dependent neuroplasticity in the hippocampus of adult male rats</article-title>. <source>Endocrinology</source><volume>157</volume>(<issue>2</issue>):<fpage>774</fpage>–<lpage>787</lpage>, PMID: 26606422, <pub-id pub-id-type="doi">10.1210/en.2015-1643</pub-id>.<?supplied-pmid 26606422?><pub-id pub-id-type="pmid">26606422</pub-id></mixed-citation>
    </ref>
    <ref id="c88">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Sui</surname><given-names>L</given-names></name></person-group><year>2008</year>. <article-title>Developmental exposure to perchlorate alters synaptic transmission in hippocampus of the adult rat</article-title>. <source>Environ Health Perspect</source><volume>116</volume>(<issue>6</issue>):<fpage>752</fpage>–<lpage>760</lpage>, PMID: 18560531, <pub-id pub-id-type="doi">10.1289/ehp.11089</pub-id>.<?supplied-pmid 18560531?><pub-id pub-id-type="pmid">18560531</pub-id></mixed-citation>
    </ref>
    <ref id="c89">
      <mixed-citation publication-type="book"><string-name><surname>Gilbert</surname><given-names>M</given-names></string-name>, <string-name><surname>Zoeller</surname><given-names>RT.</given-names></string-name><year>2010</year><article-title>Thyroid hormones—impact on the developing brain: possible mechanisms of neurotoxicity</article-title>. In: <source>Neurotoxicology</source>. <person-group person-group-type="editor"><name name-style="western"><surname>Harry</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Tillson</surname><given-names>HA</given-names></name></person-group>, eds. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press</publisher-name>, <fpage>79</fpage>–<lpage>111</lpage>.</mixed-citation>
    </ref>
    <ref id="c90">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldey</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Kehn</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rehnberg</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>1995</year>. <article-title>Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats</article-title>. <source>Toxicol Appl Pharmacol</source><volume>135</volume>(<issue>1</issue>):<fpage>77</fpage>–<lpage>88</lpage>, PMID: 7482542, <pub-id pub-id-type="doi">10.1006/taap.1995.1210</pub-id>.<?supplied-pmid 7482542?><pub-id pub-id-type="pmid">7482542</pub-id></mixed-citation>
    </ref>
    <ref id="c91">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goleman</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>TA</given-names></name></person-group><year>2002</year>. <article-title>Environmentally relevant concentrations of ammonium perchlorate inhibit thyroid function and alter sex ratios in developing <italic>Xenopus laevis</italic></article-title>. <source>Environ Toxicol Chem</source><volume>21</volume>(<issue>3</issue>):<fpage>590</fpage>–<lpage>597</lpage>, PMID: 11878472, <pub-id pub-id-type="doi">10.1002/etc.5620210318</pub-id>.<?supplied-pmid 11878472?><pub-id pub-id-type="pmid">11878472</pub-id></mixed-citation>
    </ref>
    <ref id="c92">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodman</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2007</year>. <article-title>Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: a model of cortical dysplasia</article-title>. <source>Endocrinology</source><volume>148</volume>(<issue>6</issue>):<fpage>2593</fpage>–<lpage>2597</lpage>, PMID: 17317780, <pub-id pub-id-type="doi">10.1210/en.2006-1276</pub-id>.<?supplied-pmid 17317780?><pub-id pub-id-type="pmid">17317780</pub-id></mixed-citation>
    </ref>
    <ref id="c93">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gore</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Chappell</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Fenton</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Flaws</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Nadal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Prins</surname><given-names>GS</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title>EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals</article-title>. <source>Endocr Rev</source><volume>36</volume>(<issue>6</issue>):<fpage>E1</fpage>–<lpage>E150</lpage>, PMID: 26544531, <pub-id pub-id-type="doi">10.1210/er.2015-1010</pub-id>.<?supplied-pmid 26544531?><pub-id pub-id-type="pmid">26544531</pub-id></mixed-citation>
    </ref>
    <ref id="c94">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grommen</surname><given-names>SVH</given-names></name>, <name name-style="western"><surname>Iwasawa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Darras</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>De Groef</surname><given-names>B</given-names></name></person-group><year>2011</year>. <article-title>Ontogenic expression profiles of thyroid-specific genes in embryonic and hatching chicks</article-title>. <source>Domest Anim Endocrinol</source><volume>40</volume>(<issue>1</issue>):<fpage>10</fpage>–<lpage>18</lpage>, PMID: 20926227, <pub-id pub-id-type="doi">10.1016/j.domaniend.2010.08.002</pub-id>.<?supplied-pmid 20926227?><pub-id pub-id-type="pmid">20926227</pub-id></mixed-citation>
    </ref>
    <ref id="c95">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grøntved</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Waterfall</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Baek</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>M-H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title>Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling</article-title>. <source>Nat Commun</source><volume>6</volume>:<fpage>7048</fpage>, PMID: 25916672, <pub-id pub-id-type="doi">10.1038/ncomms8048</pub-id>.<?supplied-pmid 25916672?><pub-id pub-id-type="pmid">25916672</pub-id></mixed-citation>
    </ref>
    <ref id="c96">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guadaño-Ferraz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Obregón</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Bernal</surname><given-names>J</given-names></name></person-group><year>1997</year>. <article-title>The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>94</volume>(<issue>19</issue>):<fpage>10391</fpage>–<lpage>10396</lpage>, PMID: 9294221, <pub-id pub-id-type="doi">10.1073/pnas.94.19.10391</pub-id>.<?supplied-pmid 9294221?><pub-id pub-id-type="pmid">9294221</pub-id></mixed-citation>
    </ref>
    <ref id="c97">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haddow</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Palomaki</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Allan</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Gagnon</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>1999</year>. <article-title>Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child</article-title>. <source>N Engl J Med</source><volume>341</volume>(<issue>8</issue>):<fpage>549</fpage>–<lpage>555</lpage>, PMID: 10451459, <pub-id pub-id-type="doi">10.1056/NEJM199908193410801</pub-id>.<?supplied-pmid 10451459?><pub-id pub-id-type="pmid">10451459</pub-id></mixed-citation>
    </ref>
    <ref id="c98">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haggard</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Karmaus</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Setzer</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Paul Friedman</surname><given-names>K</given-names></name></person-group><year>2018a</year>. <article-title>High-throughput H295R steroidogenesis assay: utility as an alternative and a statistical approach to characterize effects on steroidogenesis</article-title>. <source>Toxicol Sci</source><volume>162</volume>(<issue>2</issue>):<fpage>509</fpage>–<lpage>534</lpage>, PMID: 29216406, <pub-id pub-id-type="doi">10.1093/toxsci/kfx274</pub-id>.<?supplied-pmid 29216406?><pub-id pub-id-type="pmid">29216406</pub-id></mixed-citation>
    </ref>
    <ref id="c99">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haggard</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Noyes</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Waters</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Tanguay</surname><given-names>RL</given-names></name></person-group><year>2018b</year>. <article-title>Transcriptomic and phenotypic profiling in developing zebrafish exposed to thyroid hormone receptor agonists</article-title>. <source>Reprod Toxicol</source><volume>77</volume>:<fpage>80</fpage>–<lpage>93</lpage>, PMID: 29458080, <pub-id pub-id-type="doi">10.1016/j.reprotox.2018.02.006</pub-id>.<?supplied-pmid 29458080?><pub-id pub-id-type="pmid">29458080</pub-id></mixed-citation>
    </ref>
    <ref id="c100">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haines</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chatham</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Vardy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Elcombe</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Lake</surname><given-names>BG</given-names></name></person-group><year>2018</year>. <article-title>Comparison of the hepatic and thyroid gland effects of sodium phenobarbital in wild type and constitutive androstane receptor (CAR) knockout rats and pregnenolone-16α-carbonitrile in wild type and pregnane X receptor (PXR) knockout rats</article-title>. <source>Toxicology</source><volume>400–401</volume>:<fpage>20</fpage>–<lpage>27</lpage>, PMID: 29548889, <pub-id pub-id-type="doi">10.1016/j.tox.2018.03.002</pub-id>.<?supplied-pmid 29548889?><pub-id pub-id-type="pmid">29548889</pub-id></mixed-citation>
    </ref>
    <ref id="c101">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hallgren</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Darnerud</surname><given-names>PO</given-names></name></person-group><year>2002</year>. <article-title>Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats—testing interactions and mechanisms for thyroid hormone effects</article-title>. <source>Toxicology</source><volume>177</volume>(<issue>2–3</issue>):<fpage>227</fpage>–<lpage>243</lpage>, PMID: 12135626, <pub-id pub-id-type="doi">10.1016/S0300-483X(02)00222-6</pub-id>.<?supplied-pmid 12135626?><pub-id pub-id-type="pmid">12135626</pub-id></mixed-citation>
    </ref>
    <ref id="c102">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hallinger</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Murr</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Buckalew</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Stoker</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>SC</given-names></name></person-group><year>2017</year>. <article-title>Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS)</article-title>. <source>Toxicol In Vitro</source><volume>40</volume>:<fpage>66</fpage>–<lpage>78</lpage>, PMID: 27979590, <pub-id pub-id-type="doi">10.1016/j.tiv.2016.12.006</pub-id>.<?supplied-pmid 27979590?><pub-id pub-id-type="pmid">27979590</pub-id></mixed-citation>
    </ref>
    <ref id="c103">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamers</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kamstra</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Sonneveld</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Kester</surname><given-names>MHA</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>PL</given-names></name>, <etal>et al.</etal></person-group><year>2006</year>. <article-title><italic>In vitro</italic> profiling of the endocrine-disrupting potency of brominated flame retardants</article-title>. <source>Toxicol Sci</source><volume>92</volume>(<issue>1</issue>):<fpage>157</fpage>–<lpage>173</lpage>, PMID: 16601080, <pub-id pub-id-type="doi">10.1093/toxsci/kfj187</pub-id>.<?supplied-pmid 16601080?><pub-id pub-id-type="pmid">16601080</pub-id></mixed-citation>
    </ref>
    <ref id="c104">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harms</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Aldred</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Jaworowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>G</given-names></name></person-group><year>1991</year>. <article-title>Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates</article-title>. <source>Comp Biochem Phys B</source><volume>99</volume>(<issue>1</issue>):<fpage>239</fpage>–<lpage>249</lpage>, PMID: 1959330, <pub-id pub-id-type="doi">10.1016/0305-0491(91)90035-C</pub-id>.<?supplied-pmid 1959330?><pub-id pub-id-type="pmid">1959330</pub-id></mixed-citation>
    </ref>
    <ref id="c105">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hassan</surname><given-names>I</given-names></name>, <name name-style="western"><surname>El-Masri</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2017</year>. <article-title>Neurodevelopment and thyroid hormone synthesis inhibition in the rat: quantitative understanding within the adverse outcome pathway framework</article-title>. <source>Toxicol Sci</source><volume>160</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>73</lpage>, PMID: 28973696, <pub-id pub-id-type="doi">10.1093/toxsci/kfx163</pub-id>.<?supplied-pmid 28973696?><pub-id pub-id-type="pmid">28973696</pub-id></mixed-citation>
    </ref>
    <ref id="c106">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tsutsumi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Baston</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heath-Pagliuso</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><year>2011</year>. <article-title>Third-generation Ah receptor–responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness</article-title>. <source>Toxicol Sci</source><volume>123</volume>(<issue>2</issue>):<fpage>511</fpage>–<lpage>522</lpage>, PMID: 21775728, <pub-id pub-id-type="doi">10.1093/toxsci/kfr189</pub-id>.<?supplied-pmid 21775728?><pub-id pub-id-type="pmid">21775728</pub-id></mixed-citation>
    </ref>
    <ref id="c107">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedge</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>DeVito</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>2009</year>. <article-title>In vivo acute exposure to polychlorinated biphenyls: effects on free and total thyroxine in rats</article-title>. <source>Int J Toxicol</source><volume>28</volume>(<issue>5</issue>):<fpage>382</fpage>–<lpage>391</lpage>, PMID: 19815845, <pub-id pub-id-type="doi">10.1177/1091581809344631</pub-id>.<?supplied-pmid 19815845?><pub-id pub-id-type="pmid">19815845</pub-id></mixed-citation>
    </ref>
    <ref id="c108">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Quignodon</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Flamant</surname><given-names>F</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name></person-group><year>2010</year>. <article-title>Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T<sub>3</sub> signaling that are dissociated from serum thyroid hormone levels</article-title>. <source>Endocrinology</source><volume>151</volume>(<issue>11</issue>):<fpage>5550</fpage>–<lpage>5558</lpage>, PMID: 20719855, <pub-id pub-id-type="doi">10.1210/en.2010-0450</pub-id>.<?supplied-pmid 20719855?><pub-id pub-id-type="pmid">20719855</pub-id></mixed-citation>
    </ref>
    <ref id="c109">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heuer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Maier</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Iden</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mittag</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Friesema</surname><given-names>ECH</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>TJ</given-names></name>, <etal>et al.</etal></person-group><year>2005</year>. <article-title>The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations</article-title>. <source>Endocrinology</source><volume>146</volume>(<issue>4</issue>):<fpage>1701</fpage>–<lpage>1706</lpage>, PMID: 15661862, <pub-id pub-id-type="doi">10.1210/en.2004-1179</pub-id>.<?supplied-pmid 15661862?><pub-id pub-id-type="pmid">15661862</pub-id></mixed-citation>
    </ref>
    <ref id="c110">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>de Vries</surname><given-names>RBM</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>NB</given-names></name>, <name name-style="western"><surname>Dirven</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fowle</surname><given-names>JR</given-names><suffix>III</suffix></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>A primer on systematic reviews in toxicology</article-title>. <source>Arch Toxicol</source><volume>91</volume>(<issue>7</issue>):<fpage>2551</fpage>–<lpage>2575</lpage>, PMID: 28501917, <pub-id pub-id-type="doi">10.1007/s00204-017-1980-3</pub-id>.<?supplied-pmid 28501917?><pub-id pub-id-type="pmid">28501917</pub-id></mixed-citation>
    </ref>
    <ref id="c111">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hofmann</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Schomburg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Köhrle</surname><given-names>J</given-names></name></person-group><year>2009</year>. <article-title>Interference of endocrine disrupters with thyroid hormone receptor-dependent transactivation</article-title>. <source>Toxicol Sci</source><volume>110</volume>(<issue>1</issue>):<fpage>125</fpage>–<lpage>137</lpage>, PMID: 19403856, <pub-id pub-id-type="doi">10.1093/toxsci/kfp086</pub-id>.<?supplied-pmid 19403856?><pub-id pub-id-type="pmid">19403856</pub-id></mixed-citation>
    </ref>
    <ref id="c112">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><year>2003</year>. <article-title>Induction of T<sub>4</sub> UDP-GT activity, serum thyroid stimulating hormone, and thyroid follicular cell proliferation in mice treated with microsomal enzyme inducers</article-title>. <source>Toxicol Appl Pharmacol</source><volume>188</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>13</lpage>, PMID: 12668117, <pub-id pub-id-type="doi">10.1016/S0041-008X(02)00071-6</pub-id>.<?supplied-pmid 12668117?><pub-id pub-id-type="pmid">12668117</pub-id></mixed-citation>
    </ref>
    <ref id="c113">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><year>2000</year>. <article-title>Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues</article-title>. <source>Toxicol Appl Pharm</source><volume>163</volume>(<issue>3</issue>):<fpage>240</fpage>–<lpage>248</lpage>, PMID: 10702363, <pub-id pub-id-type="doi">10.1006/taap.1999.8883</pub-id>.<?supplied-pmid 10702363?><pub-id pub-id-type="pmid">10702363</pub-id></mixed-citation>
    </ref>
    <ref id="c114">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Olker</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Denny</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Knutsen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hartig</surname><given-names>PC</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Screening the ToxCast phase 1 chemical library for inhibition of deiodinase type 1 activity</article-title>. <source>Toxicol Sci</source><volume>162</volume>(<issue>2</issue>):<fpage>570</fpage>–<lpage>581</lpage>, PMID: 29228274, <pub-id pub-id-type="doi">10.1093/toxsci/kfx279</pub-id>.<?supplied-pmid 29228274?><pub-id pub-id-type="pmid">29228274</pub-id></mixed-citation>
    </ref>
    <ref id="c115">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Haselman</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Challis</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Macherla</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title><italic>In vitro</italic>, <italic>ex vivo</italic>, and <italic>in vivo</italic> determination of thyroid hormone modulating activity of benzothiazoles</article-title>. <source>Toxicol Sci</source><volume>146</volume>(<issue>2</issue>):<fpage>254</fpage>–<lpage>264</lpage>, PMID: 25953703, <pub-id pub-id-type="doi">10.1093/toxsci/kfv090</pub-id>.<?supplied-pmid 25953703?><pub-id pub-id-type="pmid">25953703</pub-id></mixed-citation>
    </ref>
    <ref id="c116">
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Houck</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bone</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Paul-Friedman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sakamuru</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2018</year><article-title>Screening the 10K Tox21 chemical library for thyroid hormone receptor modulators [Abstract #1844]</article-title>. In: <conf-name>SOT Annual Meeting</conf-name>, <comment>11–15 March 2018</comment>, <publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Society of Toxicology</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c117">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houten</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Belpoggi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Manservisi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sánchez-Guijo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wudy</surname><given-names>SA</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Changes in the metabolome in response to low-dose exposure to environmental chemicals used in personal care products during different windows of susceptibility</article-title>. <source>PLoS One</source><volume>11</volume>(<issue>7</issue>):<elocation-id>e0159919</elocation-id>, PMID: 27467775, <pub-id pub-id-type="doi">10.1371/journal.pone.0159919</pub-id>.<?supplied-pmid 27467775?><pub-id pub-id-type="pmid">27467775</pub-id></mixed-citation>
    </ref>
    <ref id="c118">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Sakamuru</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shinn</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <etal>et al.</etal></person-group><year>2011</year>. <article-title>Chemical genomics profiling of environmental chemical modulation of human nuclear receptors</article-title>. <source>Environ Health Perspect</source><volume>119</volume>(<issue>8</issue>):<fpage>1142</fpage>–<lpage>1148</lpage>, PMID: 21543282, <pub-id pub-id-type="doi">10.1289/ehp.1002952</pub-id>.<?supplied-pmid 21543282?><pub-id pub-id-type="pmid">21543282</pub-id></mixed-citation>
    </ref>
    <ref id="c119">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sakamuru</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shahane</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Attene-Ramos</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Modelling the Tox21 10 K chemical profiles for <italic>in vivo</italic> toxicity prediction and mechanism characterization</article-title>. <source>Nat Commun</source><volume>7</volume>:<elocation-id>10425</elocation-id>, PMID: 26811972, <pub-id pub-id-type="doi">10.1038/ncomms10425</pub-id>.<?supplied-pmid 26811972?><pub-id pub-id-type="pmid">26811972</pub-id></mixed-citation>
    </ref>
    <ref id="c120">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>SSY</given-names></name>, <name name-style="western"><surname>Benskin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chandramouli</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Helbing</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Cosgrove</surname><given-names>JR</given-names></name></person-group><year>2016</year>. <article-title>Xenobiotics produce distinct metabolomic responses in zebrafish larvae (<italic>Danio rerio</italic>)</article-title>. <source>Environ Sci Technol</source><volume>50</volume>(<issue>12</issue>):<fpage>6526</fpage>–<lpage>6535</lpage>, PMID: 27232715, <pub-id pub-id-type="doi">10.1021/acs.est.6b01128</pub-id>.<?supplied-pmid 27232715?><pub-id pub-id-type="pmid">27232715</pub-id></mixed-citation>
    </ref>
    <ref id="c121">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hurley</surname><given-names>PM</given-names></name></person-group><year>1998</year>. <article-title>Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents</article-title>. <source>Environ Health Perspect</source><volume>106</volume>(<issue>8</issue>):<fpage>437</fpage>–<lpage>445</lpage>, PMID: 9681970, <pub-id pub-id-type="doi">10.1289/ehp.98106437</pub-id>.<?supplied-pmid 9681970?><pub-id pub-id-type="pmid">9681970</pub-id></mixed-citation>
    </ref>
    <ref id="c122">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyyti</surname><given-names>OM</given-names></name>, <name name-style="western"><surname>Portman</surname><given-names>MA</given-names></name></person-group><year>2006</year>. <article-title>Molecular mechanisms of cross-talk between thyroid hormone and peroxisome proliferator activated receptors: focus on the heart</article-title>. <source>Cardiovasc Drugs Ther</source><volume>20</volume>(<issue>6</issue>):<fpage>463</fpage>–<lpage>469</lpage>, PMID: 17171294, <pub-id pub-id-type="doi">10.1007/s10557-006-0643-z</pub-id>.<?supplied-pmid 17171294?><pub-id pub-id-type="pmid">17171294</pub-id></mixed-citation>
    </ref>
    <ref id="c123">
      <mixed-citation publication-type="book"><collab>ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods)</collab>. <year>2018</year><article-title>A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States</article-title>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Toxicology Program, ICCVAM</publisher-name><ext-link ext-link-type="uri" xlink:href="https://ntp.niehs.nih.gov/pubhealth/evalatm/natl-strategy/index.html">https://ntp.niehs.nih.gov/pubhealth/evalatm/natl-strategy/index.html</ext-link> [accessed <date-in-citation content-type="access-date">2 October 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c124">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishihara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nishiyama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sugiyama</surname><given-names>S-I</given-names></name>, <name name-style="western"><surname>Yamauchi</surname><given-names>K</given-names></name></person-group><year>2003</year>. <article-title>The effect of endocrine disrupting chemicals on thyroid hormone binding to Japanese quail transthyretin and thyroid hormone receptor</article-title>. <source>Gen Comp Endocrinol</source><volume>134</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>43</lpage>, PMID: 13129501, <pub-id pub-id-type="doi">10.1016/s0016-6480(03)00197-7</pub-id>.<?supplied-pmid 13129501?><pub-id pub-id-type="pmid">13129501</pub-id></mixed-citation>
    </ref>
    <ref id="c125">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jarque</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fetter</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Veneman</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Spaink</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Peravali</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Strähle</surname><given-names>U</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>An automated screening method for detecting compounds with goitrogenic activity using transgenic zebrafish embryos</article-title>. <source>PLoS One</source><volume>13</volume>(<issue>8</issue>):<elocation-id>e0203087</elocation-id>, PMID: 30157258, <pub-id pub-id-type="doi">10.1371/journal.pone.0203087</pub-id>.<?supplied-pmid 30157258?><pub-id pub-id-type="pmid">30157258</pub-id></mixed-citation>
    </ref>
    <ref id="c126">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>X</given-names></name>, <name name-style="western"><surname>He</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>Z</given-names></name></person-group><year>2012</year>. <article-title>Use of TSHβ:EGFP transgenic zebrafish as a rapid <italic>in vivo</italic> model for assessing thyroid-disrupting chemicals</article-title>. <source>Toxicol Appl Pharmacol</source><volume>262</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>155</lpage>, PMID: 22571824, <pub-id pub-id-type="doi">10.1016/j.taap.2012.04.029</pub-id>.<?supplied-pmid 22571824?><pub-id pub-id-type="pmid">22571824</pub-id></mixed-citation>
    </ref>
    <ref id="c127">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Idle</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><year>2012</year>. <article-title>Xenobiotic metabolomics: major impact on the metabolome</article-title>. <source>Annu Rev Pharmacol Toxicol</source><volume>52</volume>:<fpage>37</fpage>–<lpage>56</lpage>, PMID: 21819238, <pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010611-134748</pub-id>.<?supplied-pmid 21819238?><pub-id pub-id-type="pmid">21819238</pub-id></mixed-citation>
    </ref>
    <ref id="c128">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jomaa</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Aarts</surname><given-names>J</given-names></name>, <name name-style="western"><surname>de Haan</surname><given-names>LHJ</given-names></name>, <name name-style="western"><surname>Peijnenburg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bovee</surname><given-names>TFH</given-names></name>, <name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title><italic>In vitro</italic> pituitary and thyroid cell proliferation assays and their relevance as alternatives to animal testing</article-title>. <source>ALTEX</source><volume>30</volume>(<issue>3</issue>):<fpage>293</fpage>–<lpage>307</lpage>, PMID: 23861076, <pub-id pub-id-type="doi">10.14573/altex.2013.3.293</pub-id>.<?supplied-pmid 23861076?><pub-id pub-id-type="pmid">23861076</pub-id></mixed-citation>
    </ref>
    <ref id="c129">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Kavlock</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Knudsen</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Mortensen</surname><given-names>HM</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title><italic>In vitro</italic> screening of environmental chemicals for targeted testing prioritization: the ToxCast project</article-title>. <source>Environ Health Perspect</source><volume>118</volume>(<issue>4</issue>):<fpage>485</fpage>–<lpage>492</lpage>, PMID: 20368123, <pub-id pub-id-type="doi">10.1289/ehp.0901392</pub-id>.<?supplied-pmid 20368123?><pub-id pub-id-type="pmid">20368123</pub-id></mixed-citation>
    </ref>
    <ref id="c130">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name></person-group><year>2017</year>. <article-title>On selecting a minimal set of <italic>in vitro</italic> assays to reliably determine estrogen agonist activity</article-title>. <source>Regul Toxicol Pharmacol</source><volume>91</volume>:<fpage>39</fpage>–<lpage>49</lpage>, PMID: 28993267, <pub-id pub-id-type="doi">10.1016/j.yrtph.2017.09.022</pub-id>.<?supplied-pmid 28993267?><pub-id pub-id-type="pmid">28993267</pub-id></mixed-citation>
    </ref>
    <ref id="c131">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Magpantay</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Chickarmane</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Haskell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tania</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title>Integrated model of chemical perturbations of a biological pathway using 18 <italic>in vitro</italic> high-throughput screening assays for the estrogen receptor</article-title>. <source>Toxicol Sci</source><volume>148</volume>(<issue>1</issue>):<fpage>137</fpage>–<lpage>154</lpage>, PMID: 26272952, <pub-id pub-id-type="doi">10.1093/toxsci/kfv168</pub-id>.<?supplied-pmid 26272952?><pub-id pub-id-type="pmid">26272952</pub-id></mixed-citation>
    </ref>
    <ref id="c132">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juge-Aubry</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Gorla-Bajszczak</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pernin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lemberger</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wahli</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Burger</surname><given-names>AG</given-names></name>, <etal>et al.</etal></person-group><year>1995</year>. <article-title>Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat</article-title>. <source>J Biol Chem</source><volume>270</volume>(<issue>30</issue>):<fpage>18117</fpage>–<lpage>18122</lpage>, PMID: 7629123, <pub-id pub-id-type="doi">10.1074/jbc.270.30.18117</pub-id>.<?supplied-pmid 7629123?><pub-id pub-id-type="pmid">7629123</pub-id></mixed-citation>
    </ref>
    <ref id="c133">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karmaus</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Toole</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Filer</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name></person-group><year>2016</year>. <article-title>High-throughput screening of chemical effects on steroidogenesis using H295R human adrenocortical carcinoma cells</article-title>. <source>Toxicol Sci</source><volume>150</volume>(<issue>2</issue>):<fpage>323</fpage>–<lpage>332</lpage>, PMID: 26781511, <pub-id pub-id-type="doi">10.1093/toxsci/kfw002</pub-id>.<?supplied-pmid 26781511?><pub-id pub-id-type="pmid">26781511</pub-id></mixed-citation>
    </ref>
    <ref id="c134">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Haraguchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ikushiro</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>A possible mechanism for the decrease in serum thyroxine level by phenobarbital in rodents</article-title>. <source>Toxicol Appl Pharmacol</source><volume>249</volume>(<issue>3</issue>):<fpage>238</fpage>–<lpage>246</lpage>, PMID: 20932986, <pub-id pub-id-type="doi">10.1016/j.taap.2010.09.024</pub-id>.<?supplied-pmid 20932986?><pub-id pub-id-type="pmid">20932986</pub-id></mixed-citation>
    </ref>
    <ref id="c135">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavlock</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Ankley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Blancato</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Breen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Conolly</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dix</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Computational toxicology—a state of the science mini review</article-title>. <source>Toxicol Sci</source><volume>103</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>27</lpage>, PMID: 18065772, <pub-id pub-id-type="doi">10.1093/toxsci/kfm297</pub-id>.<?supplied-pmid 18065772?><pub-id pub-id-type="pmid">18065772</pub-id></mixed-citation>
    </ref>
    <ref id="c136">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitamura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jinno</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ohta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuroki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>N</given-names></name></person-group><year>2002</year>. <article-title>Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A</article-title>. <source>Biochem Biophys Res Commun</source><volume>293</volume>(<issue>1</issue>):<fpage>554</fpage>–<lpage>559</lpage>, PMID: 12054637, <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00262-0</pub-id>.<?supplied-pmid 12054637?><pub-id pub-id-type="pmid">12054637</pub-id></mixed-citation>
    </ref>
    <ref id="c137">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitamura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jinno</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sugihara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ohta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuroki</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group><year>2005</year>. <article-title>Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture</article-title>. <source>Toxicology</source><volume>208</volume>(<issue>3</issue>):<fpage>377</fpage>–<lpage>387</lpage>, PMID: 15695023, <pub-id pub-id-type="doi">10.1016/j.tox.2004.11.037</pub-id>.<?supplied-pmid 15695023?><pub-id pub-id-type="pmid">15695023</pub-id></mixed-citation>
    </ref>
    <ref id="c138">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hood</surname><given-names>AM</given-names></name></person-group><year>2001</year>. <article-title>Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism</article-title>. <source>Toxicol Pathol</source><volume>29</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>40</lpage>, PMID: 11215682, <pub-id pub-id-type="doi">10.1080/019262301301418838</pub-id>.<?supplied-pmid 11215682?><pub-id pub-id-type="pmid">11215682</pub-id></mixed-citation>
    </ref>
    <ref id="c139">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinstreuer</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Ceger</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Browne</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>Development and validation of a computational model for androgen receptor activity</article-title>. <source>Chem Res Toxicol</source><volume>30</volume>(<issue>4</issue>):<fpage>946</fpage>–<lpage>964</lpage>, PMID: 27933809, <pub-id pub-id-type="doi">10.1021/acs.chemrestox.6b00347</pub-id>.<?supplied-pmid 27933809?><pub-id pub-id-type="pmid">27933809</pub-id></mixed-citation>
    </ref>
    <ref id="c140">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knudsen</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Sipes</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <etal>et al.</etal></person-group><year>2011</year>. <article-title>Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets</article-title>. <source>Toxicology</source><volume>282</volume>(<issue>1–2</issue>):<fpage>1</fpage>–<lpage>15</lpage>, PMID: 21251949, <pub-id pub-id-type="doi">10.1016/j.tox.2010.12.010</pub-id>.<?supplied-pmid 21251949?><pub-id pub-id-type="pmid">21251949</pub-id></mixed-citation>
    </ref>
    <ref id="c141">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Köhrle</surname><given-names>J</given-names></name></person-group><year>1999</year>. <article-title>Local activation and inactivation of thyroid hormones: the deiodinase family</article-title>. <source>Mol Cell Endocr</source><volume>151</volume>(<issue>1–2</issue>):<fpage>103</fpage>–<lpage>119</lpage>, PMID: 10411325, <pub-id pub-id-type="doi">10.1016/S0303-7207(99)00040-4</pub-id>.<?supplied-pmid 10411325?><pub-id pub-id-type="pmid">10411325</pub-id></mixed-citation>
    </ref>
    <ref id="c142">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Köhrle</surname><given-names>J</given-names></name></person-group><year>2008</year>. <article-title>Environment and endocrinology: the case of thyroidology</article-title>. <source>Ann Endocrinol (Paris)</source><volume>69</volume>(<issue>2</issue>):<fpage>116</fpage>–<lpage>122</lpage>, PMID: 18440490, <pub-id pub-id-type="doi">10.1016/j.ando.2008.02.008</pub-id>.<?supplied-pmid 18440490?><pub-id pub-id-type="pmid">18440490</pub-id></mixed-citation>
    </ref>
    <ref id="c143">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kojima</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Uramaru</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sugihara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kitamura</surname><given-names>S</given-names></name></person-group><year>2009</year>. <article-title>Nuclear hormone receptor activity of polybrominated diphenyl ethers and their hydroxylated and methoxylated metabolites in transactivation assays using Chinese hamster ovary cells</article-title>. <source>Environ Health Perspect</source><volume>117</volume>(<issue>8</issue>):<fpage>1210</fpage>–<lpage>1218</lpage>, PMID: 19672399, <pub-id pub-id-type="doi">10.1289/ehp.0900753</pub-id>.<?supplied-pmid 19672399?><pub-id pub-id-type="pmid">19672399</pub-id></mixed-citation>
    </ref>
    <ref id="c144">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ikenaka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>SMM</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Mizukawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mitani</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>Uridine diphosphate-glucuronosyltransferase (UGT) 2B subfamily interspecies differences in carnivores</article-title>. <source>Toxicol Sci</source><volume>158</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>100</lpage>, PMID: 28453659, <pub-id pub-id-type="doi">10.1093/toxsci/kfx072</pub-id>.<?supplied-pmid 28453659?><pub-id pub-id-type="pmid">28453659</pub-id></mixed-citation>
    </ref>
    <ref id="c145">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konno</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Negishi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kodama</surname><given-names>S</given-names></name></person-group><year>2008</year>. <article-title>The roles of nuclear receptors CAR and PXR in hepatic energy metabolism</article-title>. <source>Drug Metab Pharmacokinet</source><volume>23</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>13</lpage>, PMID: 18305370, <pub-id pub-id-type="doi">10.2133/dmpk.23.8</pub-id>.<?supplied-pmid 18305370?><pub-id pub-id-type="pmid">18305370</pub-id></mixed-citation>
    </ref>
    <ref id="c146">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korevaar</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Muetzel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Medici</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chaker</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jaddoe</surname><given-names>VW</given-names></name>, <name name-style="western"><surname>de Rijke</surname><given-names>YB</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study</article-title>. <source>Lancet Diabetes Endocrinol</source><volume>4</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>43</lpage>, PMID: 26497402, <pub-id pub-id-type="doi">10.1016/S2213-8587(15)00327-7</pub-id>.<?supplied-pmid 26497402?><pub-id pub-id-type="pmid">26497402</pub-id></mixed-citation>
    </ref>
    <ref id="c147">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyono</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Subramani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ramadoss</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hollenberg</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Bonett</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Denver</surname><given-names>RJ</given-names></name></person-group><year>2016</year>. <article-title>Liganded thyroid hormone receptors transactivate the DNA methyltransferase 3a gene in mouse neuronal cells</article-title>. <source>Endocrinology</source><volume>157</volume>(<issue>9</issue>):<fpage>3647</fpage>–<lpage>3657</lpage>, PMID: 27387481, <pub-id pub-id-type="doi">10.1210/en.2015-1529</pub-id>.<?supplied-pmid 27387481?><pub-id pub-id-type="pmid">27387481</pub-id></mixed-citation>
    </ref>
    <ref id="c148">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lake</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Bhat</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Chorley</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Carswell</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Sey</surname><given-names>YM</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Dose and effect thresholds for early key events in a PPARα-mediated mode of action</article-title>. <source>Toxicol Sci</source><volume>149</volume>(<issue>2</issue>):<fpage>312</fpage>–<lpage>325</lpage>, PMID: 26519955, <pub-id pub-id-type="doi">10.1093/toxsci/kfv236</pub-id>.<?supplied-pmid 26519955?><pub-id pub-id-type="pmid">26519955</pub-id></mixed-citation>
    </ref>
    <ref id="c149">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaLone</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Villeneuve</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Burgoon</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Russom</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Helgen</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Berninger</surname><given-names>JP</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action</article-title>. <source>Aquat Toxicol</source><volume>144–145</volume>:<fpage>141</fpage>–<lpage>154</lpage>, PMID: 24177217, <pub-id pub-id-type="doi">10.1016/j.aquatox.2013.09.004</pub-id>.<?supplied-pmid 24177217?><pub-id pub-id-type="pmid">24177217</pub-id></mixed-citation>
    </ref>
    <ref id="c150">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landers</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>McKinnon</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Subramaniam</surname><given-names>VN</given-names></name>, <name name-style="western"><surname>Mortimer</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>K</given-names></name></person-group><year>2009</year>. <article-title>Carrier-mediated thyroid hormone transport into placenta by placental transthyretin</article-title>. <source>J Clin Endocrinol Metab</source><volume>94</volume>(<issue>7</issue>):<fpage>2610</fpage>–<lpage>2616</lpage>, PMID: 19401362, <pub-id pub-id-type="doi">10.1210/jc.2009-0048</pub-id>.<?supplied-pmid 19401362?><pub-id pub-id-type="pmid">19401362</pub-id></mixed-citation>
    </ref>
    <ref id="c151">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lans</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Spiertz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Brouwer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Koeman</surname><given-names>JH</given-names></name></person-group><year>1994</year>. <article-title>Different competition of thyroxine-binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBS, PCDDS and PCDFS</article-title>. <source>Eur J Pharmacol</source><volume>270</volume>(<issue>2–3</issue>):<fpage>129</fpage>–<lpage>136</lpage>, PMID: 8039542, <pub-id pub-id-type="doi">10.1016/0926-6917(94)90054-X</pub-id>.<?supplied-pmid 8039542?><pub-id pub-id-type="pmid">8039542</pub-id></mixed-citation>
    </ref>
    <ref id="c152">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kelts</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Banks</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cali</surname><given-names>JJ</given-names></name></person-group><year>2011</year>. <article-title>Automation and miniaturization of the bioluminescent UGT-Glo assay for screening of UDP-glucuronosyltransferase inhibition by various compounds</article-title>. <source>J Lab Autom</source><volume>16</volume>(<issue>1</issue>):<fpage>38</fpage>–<lpage>46</lpage>, PMID: 21609684, <pub-id pub-id-type="doi">10.1016/j.jala.2010.05.005</pub-id>.<?supplied-pmid 21609684?><pub-id pub-id-type="pmid">21609684</pub-id></mixed-citation>
    </ref>
    <ref id="c153">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lasley</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2011</year>. <article-title>Developmental thyroid hormone insufficiency reduces expression of brain-derived neurotrophic factor (BDNF) in adults but not in neonates</article-title>. <source>Neurotoxicol Teratol</source><volume>33</volume>(<issue>4</issue>):<fpage>464</fpage>–<lpage>472</lpage>, PMID: 21530650, <pub-id pub-id-type="doi">10.1016/j.ntt.2011.04.001</pub-id>.<?supplied-pmid 21530650?><pub-id pub-id-type="pmid">21530650</pub-id></mixed-citation>
    </ref>
    <ref id="c154">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lecat-Guillet</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Merer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pourcher</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rousseau</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ambroise</surname><given-names>Y</given-names></name></person-group><year>2008</year>. <article-title>Small-molecule inhibitors of sodium iodide symporter function</article-title>. <source>Chembiochem</source><volume>9</volume>(<issue>6</issue>):<fpage>889</fpage>–<lpage>895</lpage>, PMID: 18307189, <pub-id pub-id-type="doi">10.1002/cbic.200700682</pub-id>.<?supplied-pmid 18307189?><pub-id pub-id-type="pmid">18307189</pub-id></mixed-citation>
    </ref>
    <ref id="c155">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>H-S</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tae</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>G-U</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>YH</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Proteomic biomarkers for bisphenol A–early exposure and women’s thyroid cancer</article-title>. <source>Cancer Res Treat</source><volume>50</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>117</lpage>, PMID: 28279065, <pub-id pub-id-type="doi">10.4143/crt.2017.001</pub-id>.<?supplied-pmid 28279065?><pub-id pub-id-type="pmid">28279065</pub-id></mixed-citation>
    </ref>
    <ref id="c156">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewandowski</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Seeley</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Beck</surname><given-names>BD</given-names></name></person-group><year>2004</year>. <article-title>Interspecies differences in susceptibility to perturbation of thyroid homeostasis: a case study with perchlorate</article-title>. <source>Regul Toxicol Pharmacol</source><volume>39</volume>(<issue>3</issue>):<fpage>348</fpage>–<lpage>362</lpage>, PMID: 15135213, <pub-id pub-id-type="doi">10.1016/j.yrtph.2004.03.002</pub-id>.<?supplied-pmid 15135213?><pub-id pub-id-type="pmid">15135213</pub-id></mixed-citation>
    </ref>
    <ref id="c157">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>SY</given-names></name></person-group><year>2010</year>. <article-title>Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors</article-title>. <source>J Mol Endocrinol</source><volume>44</volume>(<issue>3</issue>):<fpage>143</fpage>–<lpage>154</lpage>, PMID: 19741045, <pub-id pub-id-type="doi">10.1677/JME-09-0107</pub-id>.<?supplied-pmid 19741045?><pub-id pub-id-type="pmid">19741045</pub-id></mixed-citation>
    </ref>
    <ref id="c158">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maglich</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Parks</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Goodwin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Billin</surname><given-names>AN</given-names></name>, <etal>et al.</etal></person-group><year>2003</year>. <article-title>Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes</article-title>. <source>J Biol Chem</source><volume>278</volume>(<issue>19</issue>):<fpage>17277</fpage>–<lpage>17283</lpage>, PMID: 12611900, <pub-id pub-id-type="doi">10.1074/jbc.M300138200</pub-id>.<?supplied-pmid 12611900?><pub-id pub-id-type="pmid">12611900</pub-id></mixed-citation>
    </ref>
    <ref id="c159">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchesini</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Meimaridou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Haasnoot</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Meulenberg</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Albertus</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mizuguchi</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Biosensor discovery of thyroxine transport disrupting chemicals</article-title>. <source>Toxicol Appl Pharm</source><volume>232</volume>(<issue>1</issue>):<fpage>150</fpage>–<lpage>160</lpage>, PMID: 18647617, <pub-id pub-id-type="doi">10.1016/j.taap.2008.06.014</pub-id>.<?supplied-pmid 18647617?><pub-id pub-id-type="pmid">18647617</pub-id></mixed-citation>
    </ref>
    <ref id="c160">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchesini</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Meulenberg</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Haasnoot</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Mizuguchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Irth</surname><given-names>H</given-names></name></person-group><year>2006</year>. <article-title>Biosensor recognition of thyroid-disrupting chemicals using transport proteins</article-title>. <source>Anal Chem</source><volume>78</volume>(<issue>4</issue>):<fpage>1107</fpage>–<lpage>1114</lpage>, PMID: 16478101, <pub-id pub-id-type="doi">10.1021/ac051399i</pub-id>.<?supplied-pmid 16478101?><pub-id pub-id-type="pmid">16478101</pub-id></mixed-citation>
    </ref>
    <ref id="c161">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markossian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Guyot</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Teixeira</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aguilera</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bouchet</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>CRISPR/Cas9 editing of the mouse <italic>Thra</italic> gene produces models with variable resistance to thyroid hormone</article-title>. <source>Thyroid</source><volume>28</volume>(<issue>1</issue>):<fpage>139</fpage>–<lpage>150</lpage>, PMID: 29205102, <pub-id pub-id-type="doi">10.1089/thy.2017.0389</pub-id>.<?supplied-pmid 29205102?><pub-id pub-id-type="pmid">29205102</pub-id></mixed-citation>
    </ref>
    <ref id="c162">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martignoni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Groothuis</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>de Kanter</surname><given-names>R</given-names></name></person-group><year>2006</year>. <article-title>Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</article-title>. <source>Expert Opin Drug Metab Toxicol</source><volume>2</volume>(<issue>6</issue>):<fpage>875</fpage>–<lpage>894</lpage>, PMID: 17125407, <pub-id pub-id-type="doi">10.1517/17425255.2.6.875</pub-id>.<?supplied-pmid 17125407?><pub-id pub-id-type="pmid">17125407</pub-id></mixed-citation>
    </ref>
    <ref id="c163">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Dix</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Kavlock</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Reif</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>AM</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA’s ToxCast program</article-title>. <source>Chem Res Toxicol</source><volume>23</volume>(<issue>3</issue>):<fpage>578</fpage>–<lpage>590</lpage>, PMID: 20143881, <pub-id pub-id-type="doi">10.1021/tx900325g</pub-id>.<?supplied-pmid 20143881?><pub-id pub-id-type="pmid">20143881</pub-id></mixed-citation>
    </ref>
    <ref id="c164">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClain</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Posch</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Bosakowski</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>JM</given-names></name></person-group><year>1988</year>. <article-title>Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital</article-title>. <source>Toxicol Appl Pharmacol</source><volume>94</volume>(<issue>2</issue>):<fpage>254</fpage>–<lpage>265</lpage>, PMID: 3388422, <pub-id pub-id-type="doi">10.1016/0041-008x(88)90267-0</pub-id>.<?supplied-pmid 3388422?><pub-id pub-id-type="pmid">3388422</pub-id></mixed-citation>
    </ref>
    <ref id="c165">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNabb</surname><given-names>FMA</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>CT</given-names></name></person-group><year>2004</year>. <article-title>Does thyroid function in developing birds adapt to sustained ammonium perchlorate exposure?</article-title><source>Toxicol Sci</source><volume>82</volume>(<issue>1</issue>):<fpage>106</fpage>–<lpage>113</lpage>, PMID: 15310858, <pub-id pub-id-type="doi">10.1093/toxsci/kfh247</pub-id>.<?supplied-pmid 15310858?><pub-id pub-id-type="pmid">15310858</pub-id></mixed-citation>
    </ref>
    <ref id="c166">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meerts</surname><given-names>I</given-names></name>, <name name-style="western"><surname>van Zanden</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Luijks</surname><given-names>EAC</given-names></name>, <name name-style="western"><surname>van Leeuwen-Bol</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Marsh</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jakobsson</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group><year>2000</year>. <article-title>Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin <italic>in vitro</italic></article-title>. <source>Toxicol Sci</source><volume>56</volume>(<issue>1</issue>):<fpage>95</fpage>–<lpage>104</lpage>, PMID: 10869457, <pub-id pub-id-type="doi">10.1093/toxsci/56.1.95</pub-id>.<?supplied-pmid 10869457?><pub-id pub-id-type="pmid">10869457</pub-id></mixed-citation>
    </ref>
    <ref id="c167">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendel</surname><given-names>CM</given-names></name></person-group><year>1989</year>. <article-title>The free hormone hypothesis: a physiologically based mathematical model</article-title>. <source>Endocr Rev</source><volume>10</volume>(<issue>3</issue>):<fpage>232</fpage>–<lpage>274</lpage>, PMID: 2673754, <pub-id pub-id-type="doi">10.1210/edrv-10-3-232</pub-id>.<?supplied-pmid 2673754?><pub-id pub-id-type="pmid">2673754</pub-id></mixed-citation>
    </ref>
    <ref id="c168">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2009</year>. <article-title>Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes</article-title>. <source>Environ Health Perspect</source><volume>117</volume>(<issue>7</issue>):<fpage>1033</fpage>–<lpage>1041</lpage>, PMID: 19654909, <pub-id pub-id-type="doi">10.1289/ehp.0800247</pub-id>.<?supplied-pmid 19654909?><pub-id pub-id-type="pmid">19654909</pub-id></mixed-citation>
    </ref>
    <ref id="c169">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mol</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Van der Geyten</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Darras</surname><given-names>VM</given-names></name></person-group><year>1999</year><article-title>Effects of experimental hypo- and hyperthyroidism on iodothyronine deiodinases in Nile tilapia, Oreochromis niloticus</article-title>. <source>Fish Physiol Biochem</source><volume>20</volume>(<issue>3</issue>):<fpage>201</fpage>–<lpage>207</lpage>, <pub-id pub-id-type="doi">10.1023/A:1007739431710</pub-id>.</mixed-citation>
    </ref>
    <ref id="c170">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moleti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Di Bella</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Giorgianni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mancuso</surname><given-names>A</given-names></name>, <name name-style="western"><surname>De Vivo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alibrandi</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>2011</year>. <article-title>Maternal thyroid function in different conditions of iodine nutrition in pregnant women exposed to mild-moderate iodine deficiency: an observational study</article-title>. <source>Clin Endocrinol (Oxf)</source><volume>74</volume>(<issue>6</issue>):<fpage>762</fpage>–<lpage>768</lpage>, PMID: 21521276, <pub-id pub-id-type="doi">10.1111/j.1365-2265.2011.04007.x</pub-id>.<?supplied-pmid 21521276?><pub-id pub-id-type="pmid">21521276</pub-id></mixed-citation>
    </ref>
    <ref id="c171">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montaño</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cocco</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Guignard</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Marsh</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>2012</year>. <article-title>New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors</article-title>. <source>Toxicol Sci</source><volume>130</volume>(<issue>1</issue>):<fpage>94</fpage>–<lpage>105</lpage>, PMID: 22859314, <pub-id pub-id-type="doi">10.1093/toxsci/kfs228</pub-id>.<?supplied-pmid 22859314?><pub-id pub-id-type="pmid">22859314</pub-id></mixed-citation>
    </ref>
    <ref id="c172">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriyama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tagami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Akamizu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Usui</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Saijo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanamoto</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><year>2002</year>. <article-title>Thyroid hormone action is disrupted by bisphenol A as an antagonist</article-title>. <source>J Clin Endocrinol Metab</source><volume>87</volume>(<issue>11</issue>):<fpage>5185</fpage>–<lpage>5190</lpage>, PMID: 12414890, <pub-id pub-id-type="doi">10.1210/jc.2002-020209</pub-id>.<?supplied-pmid 12414890?><pub-id pub-id-type="pmid">12414890</pub-id></mixed-citation>
    </ref>
    <ref id="c173">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morreale de Escobar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Obregon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Escobar del Rey</surname><given-names>F</given-names></name></person-group><year>2000</year>. <article-title>Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?</article-title><source>Clin Endocr Metabol</source><volume>85</volume>(<issue>11</issue>):<fpage>3975</fpage>–<lpage>3987</lpage>, PMID: 11095417, <pub-id pub-id-type="doi">10.1210/jcem.85.11.6961</pub-id>.<?supplied-pmid 11095417?><pub-id pub-id-type="pmid">11095417</pub-id></mixed-citation>
    </ref>
    <ref id="c174">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morreale de Escobar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ares</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Berbel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Obregón</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>del Rey</surname><given-names>FE</given-names></name></person-group><year>2008</year>. <article-title>The changing role of maternal thyroid hormone in fetal brain development</article-title>. <source>Semin Perinatol</source><volume>32</volume>(<issue>6</issue>):<fpage>380</fpage>–<lpage>386</lpage>, PMID: 19007674, <pub-id pub-id-type="doi">10.1053/j.semperi.2008.09.002</pub-id>.<?supplied-pmid 19007674?><pub-id pub-id-type="pmid">19007674</pub-id></mixed-citation>
    </ref>
    <ref id="c175">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morreale de Escobar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Obregón</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>del Rey</surname><given-names>FE</given-names></name></person-group><year>2004a</year>. <article-title>Maternal thyroid hormones early in pregnancy and fetal brain development</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source><volume>18</volume>(<issue>2</issue>):<fpage>225</fpage>–<lpage>248</lpage>, PMID: 15157838, <pub-id pub-id-type="doi">10.1016/S1521-690X(04)00022-3</pub-id>.<?supplied-pmid 15157838?><pub-id pub-id-type="pmid">15157838</pub-id></mixed-citation>
    </ref>
    <ref id="c176">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morreale de Escobar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Obregón</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Escobar del Rey</surname><given-names>F</given-names></name></person-group><year>2004b</year>. <article-title>Role of thyroid hormone during early brain development</article-title>. <source>Eur J Endocrinol</source><volume>151</volume>(<issue>Suppl 3</issue>):<fpage>U25</fpage>–<lpage>U37</lpage>, PMID: 15554884, <pub-id pub-id-type="doi">10.1530/eje.0.151u025</pub-id>.<?supplied-pmid 15554884?><pub-id pub-id-type="pmid">15554884</pub-id></mixed-citation>
    </ref>
    <ref id="c177">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morse</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Groen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Veerman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Amerongen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Koëter</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Smits van Prooije</surname><given-names>AE</given-names></name>, <etal>et al.</etal></person-group><year>1993</year>. <article-title>Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats</article-title>. <source>Toxicol Appl Pharmacol</source><volume>122</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>33</lpage>, PMID: 8378931, <pub-id pub-id-type="doi">10.1006/taap.1993.1168</pub-id>.<?supplied-pmid 8378931?><pub-id pub-id-type="pmid">8378931</pub-id></mixed-citation>
    </ref>
    <ref id="c178">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortimer</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Landers</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Balakrishnan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>2012</year>. <article-title>Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta</article-title>. <source>Placenta</source><volume>33</volume>(<issue>4</issue>):<fpage>252</fpage>–<lpage>256</lpage>, PMID: 22264585, <pub-id pub-id-type="doi">10.1016/j.placenta.2012.01.006</pub-id>.<?supplied-pmid 22264585?><pub-id pub-id-type="pmid">22264585</pub-id></mixed-citation>
    </ref>
    <ref id="c179">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Rijntjes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Blaauboer</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Clewell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Dingemans</surname><given-names>MML</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Mechanism-based testing strategy using <italic>in vitro</italic> approaches for identification of thyroid hormone disrupting chemicals</article-title>. <source>Toxicol In Vitro</source><volume>27</volume>(<issue>4</issue>):<fpage>1320</fpage>–<lpage>1346</lpage>, PMID: 23453986, <pub-id pub-id-type="doi">10.1016/j.tiv.2013.02.012</pub-id>.<?supplied-pmid 23453986?><pub-id pub-id-type="pmid">23453986</pub-id></mixed-citation>
    </ref>
    <ref id="c181">
      <mixed-citation publication-type="book"><collab>National Academies of Sciences, Engineering, and Medicine</collab>. <year>2007</year><source>Toxicity Testing in the 21st Century: A Vision and a Strategy</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c182">
      <mixed-citation publication-type="book"><collab>National Academies of Sciences, Engineering, and Medicine</collab>. <year>2018</year><source>Progress Toward Transforming the Integrated Risk Information System (IRIS) Program: A 2018 Evaluation</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c183">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nebert</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><year>1987</year>. <article-title>P450 genes: structure, evolution, and regulation</article-title>. <source>Annu Rev Biochem</source><volume>56</volume>:<fpage>945</fpage>–<lpage>993</lpage>, PMID: 3304150, <pub-id pub-id-type="doi">10.1146/annurev.bi.56.070187.004501</pub-id>.<?supplied-pmid 3304150?><pub-id pub-id-type="pmid">3304150</pub-id></mixed-citation>
    </ref>
    <ref id="c184">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Schroeder</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Ankley</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Blackwell</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Blanksma</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part I: fathead minnow</article-title>. <source>Aquat Toxicol</source><volume>173</volume>:<fpage>192</fpage>–<lpage>203</lpage>, PMID: 26852267, <pub-id pub-id-type="doi">10.1016/j.aquatox.2015.12.024</pub-id>.<?supplied-pmid 26852267?><pub-id pub-id-type="pmid">26852267</pub-id></mixed-citation>
    </ref>
    <ref id="c185">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neumann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>WW</given-names></name>, <name name-style="western"><surname>Titus</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Krause</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kleinau</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Alberobello</surname><given-names>AT</given-names></name>, <etal>et al.</etal></person-group><year>2009</year>. <article-title>Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>106</volume>(<issue>30</issue>):<fpage>12471</fpage>–<lpage>12476</lpage>, PMID: 19592511, <pub-id pub-id-type="doi">10.1073/pnas.0904506106</pub-id>.<?supplied-pmid 19592511?><pub-id pub-id-type="pmid">19592511</pub-id></mixed-citation>
    </ref>
    <ref id="c186">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nolte</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Wisely</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Westin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Kurokawa</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group><year>1998</year>. <article-title>Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ</article-title>. <source>Nature</source><volume>395</volume>(<issue>6698</issue>):<fpage>137</fpage>–<lpage>143</lpage>, PMID: 9744270, <pub-id pub-id-type="doi">10.1038/25931</pub-id>.<?supplied-pmid 9744270?><pub-id pub-id-type="pmid">9744270</pub-id></mixed-citation>
    </ref>
    <ref id="c187">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noyes</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Hinton</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Stapleton</surname><given-names>HM</given-names></name></person-group><year>2011</year>. <article-title>Accumulation and debromination of decabromodiphenyl ether (BDE-209) in juvenile fathead minnows (<italic>Pimephales promelas</italic>) induces thyroid disruption and liver alterations</article-title>. <source>Toxicol Sci</source><volume>122</volume>(<issue>2</issue>):<fpage>265</fpage>–<lpage>274</lpage>, PMID: 21546348, <pub-id pub-id-type="doi">10.1093/toxsci/kfr105</pub-id>.<?supplied-pmid 21546348?><pub-id pub-id-type="pmid">21546348</pub-id></mixed-citation>
    </ref>
    <ref id="c188">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noyes</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Lema</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Macaulay</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Stapleton</surname><given-names>HM</given-names></name></person-group><year>2013</year>. <article-title>Low level exposure to the flame retardant BDE-209 reduces thyroid hormone levels and disrupts thyroid signaling in fathead minnows</article-title>. <source>Environ Sci Technol</source><volume>47</volume>(<issue>17</issue>):<fpage>10012</fpage>–<lpage>10021</lpage>, PMID: 23899252, <pub-id pub-id-type="doi">10.1021/es402650x</pub-id>.<?supplied-pmid 23899252?><pub-id pub-id-type="pmid">23899252</pub-id></mixed-citation>
    </ref>
    <ref id="c189">
      <mixed-citation publication-type="book"><collab>NRC (National Research Council)</collab>. <year>2005</year><source>Health Implications of Perchlorate Ingestion</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c190">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Shaughnessy</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Oshiro</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2018a</year>. <article-title>Developmental thyroid hormone insufficiency induces a cortical brain malformation and learning impairments: a cross-fostering study</article-title>. <source>Toxicol Sci</source><volume>163</volume>(<issue>1</issue>):<fpage>101</fpage>–<lpage>115</lpage>, PMID: 29385626, <pub-id pub-id-type="doi">10.1093/toxsci/kfy016</pub-id>.<?supplied-pmid 29385626?><pub-id pub-id-type="pmid">29385626</pub-id></mixed-citation>
    </ref>
    <ref id="c191">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Shaughnessy</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Hotchkiss</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <etal>et al.</etal></person-group><year>2018b</year>. <article-title>Thyroid hormone disruption in the fetal and neonatal rat: predictive hormone measures and bioindicators of hormone action in the developing cortex</article-title>. <source>Toxicol Sci</source><volume>166</volume>(<issue>1</issue>):<fpage>163</fpage>–<lpage>179</lpage>, PMID: 30085217, <pub-id pub-id-type="doi">10.1093/toxsci/kfy190</pub-id>.<?supplied-pmid 30085217?><pub-id pub-id-type="pmid">30085217</pub-id></mixed-citation>
    </ref>
    <ref id="c192">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obregón</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ruiz de Oña</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Calvo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Escobar del Rey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Morreale de Escobar</surname><given-names>G</given-names></name></person-group><year>1991</year>. <article-title>Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate</article-title>. <source>Endocrinology</source><volume>129</volume>(<issue>5</issue>):<fpage>2663</fpage>–<lpage>2673</lpage>, PMID: 1935795, <pub-id pub-id-type="doi">10.1210/endo-129-5-2663</pub-id>.<?supplied-pmid 1935795?><pub-id pub-id-type="pmid">1935795</pub-id></mixed-citation>
    </ref>
    <ref id="c193">
      <mixed-citation publication-type="book"><collab>OECD (Organisation for Economic Co-operation and Development)</collab>. <year>2009</year><article-title>Test no. 441: Hershberger bioassay in rats: a short-term screening assay for (anti)androgenic properties</article-title>. In: <source>OECD Guidelines for the Testing of Chemicals</source>, <comment>Section 4</comment><publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264076334-en</pub-id> [accessed <date-in-citation content-type="access-date">20 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c194">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2014</year><article-title>New scoping document on <italic>in vitro</italic> and <italic>ex vivo</italic> assays for the identification of modulators of thyroid hormone signaling</article-title>. In: <source>OECD Environment, Health and Safety Publications Series on Testing and Assessment</source>. <comment>No. 207.</comment><comment>ENV/JM/</comment><comment>MONO(</comment><comment>2014)23</comment><publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><ext-link ext-link-type="uri" xlink:href="http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2014)23&amp;doclanguage=en">http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2014)23&amp;doclanguage=en</ext-link> [accessed <date-in-citation content-type="access-date">20 September 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c195">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018a</year><article-title>Amphibian metamorphosis assay (AMA) (OECD TG 231)</article-title>. In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-8-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c196">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018b</year><article-title>Combined chronic toxicity/carcinogenicity studies (OECD TG 451-3</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-24-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c197">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018c</year><article-title>Developmental neurotoxicity study (OECD TG 426</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-27-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c198">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018d</year><article-title>Extended one-generation reproductive toxicity study (EOGRTS) (OECD TG 443</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-34-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c199">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018e</year><article-title>Larval amphibian growth and development assay (LAGDA) (OECD TG 241</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-15-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c200">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018f</year><article-title>Prenatal developmental toxicity study (OECD TG 414</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-26-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c201">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018</year>g. <article-title>Repeated dose 28-day oral toxicity study in rodents (OECD TG 407)</article-title>. In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-22-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c202">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018</year>h. <article-title>Repeated dose 90-day oral toxicity study in rodents (OECD TG 408</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-23-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c203">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018</year>i. <article-title>Reproduction/developmental toxicity screening test (OECD TG 421) and combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (OECD TG 422</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-25-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c204">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018</year>j. <source>Revised guidance document 150 on standardised test guidelines for evaluating chemicals for endocrine disruption</source>. OECD Series on Testing and Assessment, No. 150. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c205">
      <mixed-citation publication-type="book"><collab>OECD</collab>. <year>2018</year>k. <article-title>Two-generation reproduction toxicity study (OECD TG 416</article-title>). In: <source>Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>OECD</publisher-name><pub-id pub-id-type="doi">10.1787/9789264304741-33-en</pub-id> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c206">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fukuda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sumida</surname><given-names>K</given-names></name></person-group><year>2018</year>. <article-title>Specific alteration of gene expression profile in rats by treatment with thyroid toxicants that inhibit thyroid hormone synthesis</article-title>. <source>J Appl Toxicol</source><volume>12</volume>:<fpage>1529</fpage>–<lpage>1537</lpage>, PMID: 30047161, <pub-id pub-id-type="doi">10.1002/jat.3693</pub-id>.<?supplied-pmid 30047161?><pub-id pub-id-type="pmid">30047161</pub-id></mixed-citation>
    </ref>
    <ref id="c207">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohnhaus</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Bürgi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Burger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Studer</surname><given-names>H</given-names></name></person-group><year>1981</year>. <article-title>The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man</article-title>. <source>Eur J Clin Invest</source><volume>11</volume>(<issue>5</issue>):<fpage>381</fpage>–<lpage>387</lpage>, PMID: 6800809, <pub-id pub-id-type="doi">10.1111/j.1365-2362.1981.tb02000.x</pub-id>.<?supplied-pmid 6800809?><pub-id pub-id-type="pmid">6800809</pub-id></mixed-citation>
    </ref>
    <ref id="c208">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olker</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Haselman</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Donnay</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Blanksma</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Evaluating iodide recycling inhibition as a novel molecular initiating event for thyroid axis disruption in amphibians</article-title>. <source>Toxicol Sci</source><volume>166</volume>(<issue>2</issue>):<fpage>318</fpage>–<lpage>331</lpage>, PMID: 30137636, <pub-id pub-id-type="doi">10.1093/toxsci/kfy203</pub-id>.<?supplied-pmid 30137636?><pub-id pub-id-type="pmid">30137636</pub-id></mixed-citation>
    </ref>
    <ref id="c209">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olker</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Denny</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Hartig</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Cardon</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Knutsen</surname><given-names>CN</given-names></name>, <etal>et al.</etal></person-group><year>2019</year>. <article-title>Screening the ToxCast phase 1, phase 2, and e1k chemical libraries for inhibitors of iodothyronine deiodinases</article-title>. <source>Toxicol Sci</source><volume>168</volume>(<issue>2</issue>):<fpage>430</fpage>–<lpage>442</lpage>, PMID: 30561685, <pub-id pub-id-type="doi">10.1093/toxsci/kfy302</pub-id>.<?supplied-pmid 30561685?><pub-id pub-id-type="pmid">30561685</pub-id></mixed-citation>
    </ref>
    <ref id="c210">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opitz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Maquet</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Huisken</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Antonica</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Trubiroha</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pottier</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group><year>2012</year>. <article-title>Transgenic zebrafish illuminate the dynamics of thyroid morphogenesis and its relationship to cardiovascular development</article-title>. <source>Dev Biol</source><volume>372</volume>(<issue>2</issue>):<fpage>203</fpage>–<lpage>216</lpage>, PMID: 23022354, <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.09.011</pub-id>.<?supplied-pmid 23022354?><pub-id pub-id-type="pmid">23022354</pub-id></mixed-citation>
    </ref>
    <ref id="c211">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oppenheimer</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>HL</given-names></name></person-group><year>1997</year>. <article-title>Molecular basis of thyroid hormone-dependent brain development</article-title>. <source>Endocr Rev</source><volume>18</volume>(<issue>4</issue>):<fpage>462</fpage>–<lpage>475</lpage>, PMID: 9267760, <pub-id pub-id-type="doi">10.1210/edrv.18.4.0309</pub-id>.<?supplied-pmid 9267760?><pub-id pub-id-type="pmid">9267760</pub-id></mixed-citation>
    </ref>
    <ref id="c212">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Landers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mortimer</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>K</given-names></name></person-group><year>2011</year>. <article-title>Thyroid hormones and fetal neurological development</article-title>. <source>J Endocrinol</source><volume>209</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>, PMID: 21212091, <pub-id pub-id-type="doi">10.1530/JOE-10-0444</pub-id>.<?supplied-pmid 21212091?><pub-id pub-id-type="pmid">21212091</pub-id></mixed-citation>
    </ref>
    <ref id="c213">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul Friedman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Hedge</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Tiered high-throughput screening approach to identify thyroperoxidase inhibitors within the ToxCast phase I and II chemical libraries</article-title>. <source>Toxicol Sci</source><volume>151</volume>(<issue>1</issue>):<fpage>160</fpage>–<lpage>180</lpage>, PMID: 26884060, <pub-id pub-id-type="doi">10.1093/toxsci/kfw034</pub-id>.<?supplied-pmid 26884060?><pub-id pub-id-type="pmid">26884060</pub-id></mixed-citation>
    </ref>
    <ref id="c214">
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Paul Friedman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name></person-group><year>2017</year><article-title>Screening the Tox21 10K library for thyroid stimulating hormone receptor agonist and antagonist activity [Abstract #3423]</article-title>. In: <conf-name>SOT Annual Meeting</conf-name>, <comment>12–16 March 2017</comment>, <publisher-loc>Baltimore, MD</publisher-loc>: <publisher-name>Society of Toxicology</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c215">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Hedge</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Macherla</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Filer</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat</article-title>. <source>Toxicology</source><volume>312</volume>:<fpage>97</fpage>–<lpage>107</lpage>, PMID: 23959146, <pub-id pub-id-type="doi">10.1016/j.tox.2013.08.006</pub-id>.<?supplied-pmid 23959146?><pub-id pub-id-type="pmid">23959146</pub-id></mixed-citation>
    </ref>
    <ref id="c216">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Hedge</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rotroff</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name></person-group><year>2014</year>. <article-title>Development of a thyroperoxidase inhibition assay for high-throughput screening</article-title>. <source>Chem Res Toxicol</source><volume>27</volume>(<issue>3</issue>):<fpage>387</fpage>–<lpage>399</lpage>, PMID: 24383450, <pub-id pub-id-type="doi">10.1021/tx400310w</pub-id>.<?supplied-pmid 24383450?><pub-id pub-id-type="pmid">24383450</pub-id></mixed-citation>
    </ref>
    <ref id="c217">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Vanden Heuvel</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>2013</year>. <article-title>Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors</article-title>. <source>Toxicol in Vitro</source><volume>27</volume>(<issue>7</issue>):<fpage>2049</fpage>–<lpage>2060</lpage>, PMID: 23899473, <pub-id pub-id-type="doi">10.1016/j.tiv.2013.07.008</pub-id>.<?supplied-pmid 23899473?><pub-id pub-id-type="pmid">23899473</pub-id></mixed-citation>
    </ref>
    <ref id="c218">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perkins</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Ankley</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Garcia-Reyero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>LaLone</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>MS</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Current perspectives on the use of alternative species in human health and ecological hazard assessments</article-title>. <source>Environ Health Perspect</source><volume>121</volume>(<issue>9</issue>):<fpage>1002</fpage>–<lpage>1010</lpage>, PMID: 23771518, <pub-id pub-id-type="doi">10.1289/ehp.1306638</pub-id>.<?supplied-pmid 23771518?><pub-id pub-id-type="pmid">23771518</pub-id></mixed-citation>
    </ref>
    <ref id="c219">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Politi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rusyn</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tropsha</surname><given-names>A</given-names></name></person-group><year>2014</year>. <article-title>Prediction of binding affinity and efficacy of thyroid hormone receptor ligands using QSAR and structure-based modeling methods</article-title>. <source>Toxicol Appl Pharmacol</source><volume>280</volume>(<issue>1</issue>):<fpage>177</fpage>–<lpage>189</lpage>, PMID: 25058446, <pub-id pub-id-type="doi">10.1016/j.taap.2014.07.009</pub-id>.<?supplied-pmid 25058446?><pub-id pub-id-type="pmid">25058446</pub-id></mixed-citation>
    </ref>
    <ref id="c220">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porreca</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ulloa Severino</surname><given-names>L</given-names></name>, <name name-style="western"><surname>D’Angelo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cuomo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ceccarelli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Altucci</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. “<article-title>Stockpile” of slight transcriptomic changes determines the indirect genotoxicity of low-dose BPA in thyroid cells</article-title>. <source>PLoS One</source><volume>11</volume>(<issue>3</issue>):<elocation-id>e0151618</elocation-id>, PMID: 26982218, <pub-id pub-id-type="doi">10.1371/journal.pone.0151618</pub-id>.<?supplied-pmid 26982218?><pub-id pub-id-type="pmid">26982218</pub-id></mixed-citation>
    </ref>
    <ref id="c221">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porterfield</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Hendrich</surname><given-names>CE</given-names></name></person-group><year>1993</year>. <article-title>The role of thyroid hormones in prenatal and neonatal neurological development—current perspectives</article-title>. <source>Endocr Rev</source><volume>14</volume>(<issue>1</issue>):<fpage>94</fpage>–<lpage>106</lpage>, PMID: 8491157, <pub-id pub-id-type="doi">10.1210/edrv-14-1-94</pub-id>.<?supplied-pmid 8491157?><pub-id pub-id-type="pmid">8491157</pub-id></mixed-citation>
    </ref>
    <ref id="c222">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Power</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Elias</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Mendes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>C</given-names></name></person-group><year>2000</year>. <article-title>Evolution of the thyroid hormone-binding protein, transthyretin</article-title>. <source>Gen Comp Endocrinol</source><volume>119</volume>(<issue>3</issue>):<fpage>241</fpage>–<lpage>255</lpage>, PMID: 11017772, <pub-id pub-id-type="doi">10.1006/gcen.2000.7520</pub-id>.<?supplied-pmid 11017772?><pub-id pub-id-type="pmid">11017772</pub-id></mixed-citation>
    </ref>
    <ref id="c223">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Power</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Llewellyn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Faustino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nowell</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Björnsson</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Einarsdottir</surname><given-names>IE</given-names></name>, <etal>et al.</etal></person-group><year>2001</year>. <article-title>Thyroid hormones in growth and development of fish</article-title>. <source>Comp Biochem Physiol C Toxicol Pharmacol</source><volume>130</volume>(<issue>4</issue>):<fpage>447</fpage>–<lpage>459</lpage>, PMID: 11738632, <pub-id pub-id-type="doi">10.1016/S1532-0456(01)00271-X</pub-id>.<?supplied-pmid 11738632?><pub-id pub-id-type="pmid">11738632</pub-id></mixed-citation>
    </ref>
    <ref id="c224">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramadoss</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Abraham</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Costa-e-Sousa</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group><year>2014</year>. <article-title>Novel mechanism of positive <italic>versus</italic> negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver</article-title>. <source>J Biol Chem</source><volume>289</volume>(<issue>3</issue>):<fpage>1313</fpage>–<lpage>1328</lpage>, PMID: 24288132, <pub-id pub-id-type="doi">10.1074/jbc.M113.521450</pub-id>.<?supplied-pmid 24288132?><pub-id pub-id-type="pmid">24288132</pub-id></mixed-citation>
    </ref>
    <ref id="c225">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>LH</given-names></name></person-group><year>2012</year>. <article-title>Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe</article-title>. <source>Environ Sci Technol</source><volume>46</volume>(<issue>8</issue>):<fpage>4633</fpage>–<lpage>4640</lpage>, PMID: 22482873, <pub-id pub-id-type="doi">10.1021/es2046074</pub-id>.<?supplied-pmid 22482873?><pub-id pub-id-type="pmid">22482873</pub-id></mixed-citation>
    </ref>
    <ref id="c226">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hoefig</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hiller</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Schomburg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Köhrle</surname><given-names>J</given-names></name></person-group><year>2012</year>. <article-title>Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay</article-title>. <source>Endocrinology</source><volume>153</volume>(<issue>5</issue>):<fpage>2506</fpage>–<lpage>2513</lpage>, PMID: 22434082, <pub-id pub-id-type="doi">10.1210/en.2011-1863</pub-id>.<?supplied-pmid 22434082?><pub-id pub-id-type="pmid">22434082</pub-id></mixed-citation>
    </ref>
    <ref id="c227">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schäche</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hoefig</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Welsink</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schwiebert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><year>2015</year>. <article-title>An improved nonradioactive screening method identifies genistein and xanthohumol as potent inhibitors of iodothyronine deiodinases</article-title>. <source>Thyroid</source><volume>25</volume>(<issue>8</issue>):<fpage>962</fpage>–<lpage>968</lpage>, PMID: 25962824, <pub-id pub-id-type="doi">10.1089/thy.2015.0058</pub-id>.<?supplied-pmid 25962824?><pub-id pub-id-type="pmid">25962824</pub-id></mixed-citation>
    </ref>
    <ref id="c228">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richard</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Flamant</surname><given-names>F</given-names></name></person-group><year>2018</year>. <article-title>Regulation of T3 availability in the developing brain: the mouse genetics contribution</article-title>. <source>Front Endocrinol (Lausanne)</source><volume>9</volume>:<fpage>265</fpage>, PMID: 29892264, <pub-id pub-id-type="doi">10.3389/fendo.2018.00265</pub-id>.<?supplied-pmid 29892264?><pub-id pub-id-type="pmid">29892264</pub-id></mixed-citation>
    </ref>
    <ref id="c229">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Ingbar</surname><given-names>SH</given-names></name></person-group><year>1959</year>. <article-title>Effects of propylthiouracil and perchlorate on the biogenesis of thyroid hormone</article-title>. <source>Endocrinology</source><volume>65</volume>(<issue>2</issue>):<fpage>198</fpage>–<lpage>207</lpage>, PMID: 13672142, <pub-id pub-id-type="doi">10.1210/endo-65-2-198</pub-id>.<?supplied-pmid 13672142?><pub-id pub-id-type="pmid">13672142</pub-id></mixed-citation>
    </ref>
    <ref id="c230">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Staskal</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Diliberto</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>DeVito</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name></person-group><year>2008</year>. <article-title>Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener</article-title>. <source>Toxicol Appl Pharmacol</source><volume>226</volume>(<issue>3</issue>):<fpage>244</fpage>–<lpage>250</lpage>, PMID: 17964624, <pub-id pub-id-type="doi">10.1016/j.taap.2007.09.015</pub-id>.<?supplied-pmid 17964624?><pub-id pub-id-type="pmid">17964624</pub-id></mixed-citation>
    </ref>
    <ref id="c231">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Van Herck</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Delbaere</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McAllan</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Darras</surname><given-names>VM</given-names></name></person-group><year>2018</year>. <article-title>The affinity of transthyretin for T<sub>3</sub> or T<sub>4</sub> does not determine which form of the hormone accumulates in the choroid plexus</article-title>. <source>Gen Comp Endocrinol</source><volume>264</volume>:<fpage>131</fpage>–<lpage>137</lpage>, PMID: 28919452, <pub-id pub-id-type="doi">10.1016/j.ygcen.2017.09.012</pub-id>.<?supplied-pmid 28919452?><pub-id pub-id-type="pmid">28919452</pub-id></mixed-citation>
    </ref>
    <ref id="c232">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Woodford</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Haggerty</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Tate</surname><given-names>EH</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Expression of the thyroid hormone transporters monocarboxylate transporter-8 (<italic>SLC16A2</italic>) and organic ion transporter-14 (<italic>SLCO1C1</italic>) at the blood-brain barrier</article-title>. <source>Endocrinology</source><volume>149</volume>(<issue>12</issue>):<fpage>6251</fpage>–<lpage>6261</lpage>, PMID: 18687783, <pub-id pub-id-type="doi">10.1210/en.2008-0378</pub-id>.<?supplied-pmid 18687783?><pub-id pub-id-type="pmid">18687783</pub-id></mixed-citation>
    </ref>
    <ref id="c233">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romanov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Medvedev</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gambarian</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Poltoratskaya</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Moeser</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Medvedeva</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors</article-title>. <source>Nat Methods</source><volume>5</volume>(<issue>3</issue>):<fpage>253</fpage>–<lpage>260</lpage>, PMID: 18297081, <pub-id pub-id-type="doi">10.1038/nmeth.1186</pub-id>.<?supplied-pmid 18297081?><pub-id pub-id-type="pmid">18297081</pub-id></mixed-citation>
    </ref>
    <ref id="c180">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rooney</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Boyles</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Bucher</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Thayer</surname><given-names>KA</given-names></name></person-group><year>2014</year>. <article-title>Systematic review and evidence integration for literature-based environmental health science assessments</article-title>. <source>Environ Health Perspect</source><volume>122</volume>(<issue>7</issue>):<fpage>711</fpage>–<lpage>718</lpage>, PMID: 24755067, <pub-id pub-id-type="doi">10.1289/ehp.1307972</pub-id>.<?supplied-pmid 24755067?><pub-id pub-id-type="pmid">24755067</pub-id></mixed-citation>
    </ref>
    <ref id="c234">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rootwelt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ganes</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Johannessen</surname><given-names>SI</given-names></name></person-group><year>1978</year>. <article-title>Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans</article-title>. <source>Scand J Clin Lab Invest</source><volume>38</volume>(<issue>8</issue>):<fpage>731</fpage>–<lpage>736</lpage>, PMID: 105401, <pub-id pub-id-type="doi">10.3109/00365517809104880</pub-id>.<?supplied-pmid 105401?><pub-id pub-id-type="pmid">105401</pub-id></mixed-citation>
    </ref>
    <ref id="c235">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosebrough</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>McMurtry</surname><given-names>JP</given-names></name></person-group><year>2006</year>. <article-title>Studies on doses of methimazole (MMI) and its administration regimen on broiler metabolism</article-title>. <source>Comp Biochem Physiol Part A Mol Integr Physiol</source><volume>143</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>41</lpage>, PMID: 16337159, <pub-id pub-id-type="doi">10.1016/j.cbpa.2005.10.019</pub-id>.<?supplied-pmid 16337159?><pub-id pub-id-type="pmid">16337159</pub-id></mixed-citation>
    </ref>
    <ref id="c236">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Paul Friedman</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dybdahl</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><year>2017</year><article-title>QSAR models for thyroperoxidase inhibition and screening of U.S. and EU chemical inventories</article-title>. <source>Comput Toxicol</source><volume>4</volume>:<fpage>11</fpage>–<lpage>21</lpage>, <pub-id pub-id-type="doi">10.1016/j.comtox.2017.07.006</pub-id>.</mixed-citation>
    </ref>
    <ref id="c237">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Vargas</surname><given-names>R</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Xie</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>RM</given-names></name></person-group><year>2003</year>. <article-title>Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor</article-title>. <source>Mol Endocrinol</source><volume>17</volume>(<issue>7</issue>):<fpage>1268</fpage>–<lpage>1282</lpage>, PMID: 12663745, <pub-id pub-id-type="doi">10.1210/me.2002-0421</pub-id>.<?supplied-pmid 12663745?><pub-id pub-id-type="pmid">12663745</pub-id></mixed-citation>
    </ref>
    <ref id="c238">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rotroff</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Beam</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Dix</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Farmer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals</article-title>. <source>J Toxicol Environ Health B Crit Rev</source><volume>13</volume>(<issue>2–4</issue>):<fpage>329</fpage>–<lpage>346</lpage>, PMID: 20574906, <pub-id pub-id-type="doi">10.1080/10937404.2010.483949</pub-id>.<?supplied-pmid 20574906?><pub-id pub-id-type="pmid">20574906</pub-id></mixed-citation>
    </ref>
    <ref id="c239">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Royland</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>ME</given-names></name></person-group><year>2008</year>. <article-title>A genomic analysis of subclinical hypothyroidism in hippocampus and neocortex of the developing rat brain</article-title>. <source>J Neuroendocrinol</source><volume>20</volume>(<issue>12</issue>):<fpage>1319</fpage>–<lpage>1338</lpage>, PMID: 19094080, <pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01793.x</pub-id>.<?supplied-pmid 19094080?><pub-id pub-id-type="pmid">19094080</pub-id></mixed-citation>
    </ref>
    <ref id="c240">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakane</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Iida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hasebe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fujii</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Buchholz</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Ishizuya-Oka</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Functional analysis of thyroid hormone receptor beta in <italic>Xenopus tropicalis</italic> founders using CRISPR-Cas</article-title>. <source>Biol Open</source><volume>7</volume>(<issue>1</issue>):<elocation-id>bio030338</elocation-id>, PMID: 29358165, <pub-id pub-id-type="doi">10.1242/bio.030338</pub-id>.<?supplied-pmid 29358165?><pub-id pub-id-type="pmid">29358165</pub-id></mixed-citation>
    </ref>
    <ref id="c241">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salvatore</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Harney</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>PR</given-names></name></person-group><year>1996</year>. <article-title>Type 2 iodothyronine deiodinase is highly expressed in human thyroid</article-title>. <source>J Clin Invest</source><volume>98</volume>(<issue>4</issue>):<fpage>962</fpage>–<lpage>968</lpage>, PMID: 8770868, <pub-id pub-id-type="doi">10.1172/JCI118880</pub-id>.<?supplied-pmid 8770868?><pub-id pub-id-type="pmid">8770868</pub-id></mixed-citation>
    </ref>
    <ref id="c242">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Vitti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ceccarini</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mammoli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rosellini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Pelosini</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2003</year>. <article-title><italic>In vitro</italic> assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity</article-title>. <source>J Endocrinol Invest</source><volume>26</volume>(<issue>10</issue>):<fpage>950</fpage>–<lpage>955</lpage>, PMID: 14759065, <pub-id pub-id-type="doi">10.1007/BF03348190</pub-id>.<?supplied-pmid 14759065?><pub-id pub-id-type="pmid">14759065</pub-id></mixed-citation>
    </ref>
    <ref id="c243">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vranckx</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rouaze-Romet</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nunez</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Tréton</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><year>1991</year>. <article-title>A senescence up-regulated protein: the rat thyroxine-binding globulin (TBG)</article-title>. <source>Biochim Biophys Acta</source><volume>1097</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>22</lpage>, PMID: 1907201, <pub-id pub-id-type="doi">10.1016/0925-4439(91)90017-4</pub-id>.<?supplied-pmid 1907201?><pub-id pub-id-type="pmid">1907201</pub-id></mixed-citation>
    </ref>
    <ref id="c244">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scanlan</surname><given-names>TS</given-names></name></person-group><year>2009</year>. <article-title>Minireview: 3-iodothyronamine (T<sub>1</sub>AM): a new player on the thyroid endocrine team?</article-title><source>Endocrinology</source><volume>150</volume>(<issue>3</issue>):<fpage>1108</fpage>–<lpage>1111</lpage>, PMID: 19116337, <pub-id pub-id-type="doi">10.1210/en.2008-1596</pub-id>.<?supplied-pmid 19116337?><pub-id pub-id-type="pmid">19116337</pub-id></mixed-citation>
    </ref>
    <ref id="c245">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Fiering</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Pallud</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Parlow</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Galton</surname><given-names>VA</given-names></name></person-group><year>2001</year>. <article-title>Targeted disruption of the type 2 selenodeiodinase gene (<italic>DIO2</italic>) results in a phenotype of pituitary resistance to T<sub>4</sub></article-title>. <source>Mol Endocrinol</source><volume>15</volume>(<issue>12</issue>):<fpage>2137</fpage>–<lpage>2148</lpage>, PMID: 11731615, <pub-id pub-id-type="doi">10.1210/mend.15.12.0740</pub-id>.<?supplied-pmid 11731615?><pub-id pub-id-type="pmid">11731615</pub-id></mixed-citation>
    </ref>
    <ref id="c246">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Fiering</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Thai</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>St Germain</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parlow</surname><given-names>AF</given-names></name>, <etal>et al.</etal></person-group><year>2006</year>. <article-title>Targeted disruption of the type 1 selenodeiodinase gene (<italic>Dio1</italic>) results in marked changes in thyroid hormone economy in mice</article-title>. <source>Endocrinology</source><volume>147</volume>(<issue>1</issue>):<fpage>580</fpage>–<lpage>589</lpage>, PMID: 16223863, <pub-id pub-id-type="doi">10.1210/en.2005-0739</pub-id>.<?supplied-pmid 16223863?><pub-id pub-id-type="pmid">16223863</pub-id></mixed-citation>
    </ref>
    <ref id="c247">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreiber</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Aldred</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Jaworowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nilsson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Achen</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Segal</surname><given-names>MB</given-names></name></person-group><year>1990</year>. <article-title>Thyroxine transport from blood to brain via transthyretin synthesis in choroid-plexus</article-title>. <source>Am J Physiol</source><volume>258</volume>(<issue>2 Pt 2</issue>):<fpage>R338</fpage>–<lpage>R345</lpage>, PMID: 2309926, <pub-id pub-id-type="doi">10.1152/ajpregu.1990.258.2.R338</pub-id>.<?supplied-pmid 2309926?><pub-id pub-id-type="pmid">2309926</pub-id></mixed-citation>
    </ref>
    <ref id="c248">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schriks</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vrabie</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Gutleb</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Faassen</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Rietjens</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Murk</surname><given-names>AJ</given-names></name></person-group><year>2006</year>. <article-title>T-screen to quantify functional potentiating, antagonistic and thyroid hormone-like activities of poly halogenated aromatic hydrocarbons (PHAHs)</article-title>. <source>Toxicol In Vitro</source><volume>20</volume>(<issue>4</issue>):<fpage>490</fpage>–<lpage>498</lpage>, PMID: 16219445, <pub-id pub-id-type="doi">10.1016/j.tiv.2005.09.001</pub-id>.<?supplied-pmid 16219445?><pub-id pub-id-type="pmid">16219445</pub-id></mixed-citation>
    </ref>
    <ref id="c249">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuur</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Legger</surname><given-names>FF</given-names></name>, <name name-style="western"><surname>van Meeteren</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Moonen</surname><given-names>MJH</given-names></name>, <name name-style="western"><surname>van Leeuwen-Bol</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>Å</given-names></name>, <etal>et al.</etal></person-group><year>1998</year>. <article-title>In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons</article-title>. <source>Chem Res Toxicol</source><volume>11</volume>(<issue>9</issue>):<fpage>1075</fpage>–<lpage>1081</lpage>, PMID: 9760282, <pub-id pub-id-type="doi">10.1021/tx9800046</pub-id>.<?supplied-pmid 9760282?><pub-id pub-id-type="pmid">9760282</pub-id></mixed-citation>
    </ref>
    <ref id="c251">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serrano</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Higgins</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Witthuhn</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Markowski</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Holcombe</surname><given-names>GW</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title><italic>In vivo</italic> assessment and potential diagnosis of xenobiotics that perturb the thyroid pathway: proteomic analysis of <italic>Xenopus laevis</italic> brain tissue following exposure to model T4 inhibitors</article-title>. <source>Comp Biochem Physiol Part D Genomics Proteomics</source><volume>5</volume>(<issue>2</issue>):<fpage>138</fpage>–<lpage>150</lpage>, PMID: 20452843, <pub-id pub-id-type="doi">10.1016/j.cbd.2010.03.007</pub-id>.<?supplied-pmid 20452843?><pub-id pub-id-type="pmid">20452843</pub-id></mixed-citation>
    </ref>
    <ref id="c252">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharlin</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Verrey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Olszewski</surname><given-names>RT</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)</article-title>. <source>Sci Rep</source><volume>8</volume>(<issue>1</issue>):<fpage>4403</fpage>, PMID: 29535325, <pub-id pub-id-type="doi">10.1038/s41598-018-22553-w</pub-id>.<?supplied-pmid 29535325?><pub-id pub-id-type="pmid">29535325</pub-id></mixed-citation>
    </ref>
    <ref id="c253">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sher</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Craft</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>SA</given-names></name></person-group><year>1998</year>. <article-title>The effects of thyroid hormone level and action in developing brain: are these targets for the actions of polychlorinated biphenyls and dioxins?</article-title><source>Toxicol Ind Health</source><volume>14</volume>(<issue>1–2</issue>):<fpage>121</fpage>–<lpage>158</lpage>, PMID: 9460173, <pub-id pub-id-type="doi">10.1177/074823379801400110</pub-id>.<?supplied-pmid 9460173?><pub-id pub-id-type="pmid">9460173</pub-id></mixed-citation>
    </ref>
    <ref id="c254">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Uramaru</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kuroki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ohta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kitamura</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Structure–activity relationships of 44 halogenated compounds for iodotyrosine deiodinase-inhibitory activity</article-title>. <source>Toxicology</source><volume>314</volume>(<issue>1</issue>):<fpage>22</fpage>–<lpage>29</lpage>, PMID: 24012475, <pub-id pub-id-type="doi">10.1016/j.tox.2013.08.017</pub-id>.<?supplied-pmid 24012475?><pub-id pub-id-type="pmid">24012475</pub-id></mixed-citation>
    </ref>
    <ref id="c255">
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Shobair</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nelms</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Deisenroth</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Patlewicz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Paul Friedman</surname><given-names>K</given-names></name></person-group><year>2019</year><article-title>A high-throughput approach to identify and prioritize putative thyroid-stimulating hormone receptor agonists and antagonists [Abstract #3154/P733]</article-title>. In: <conf-name>SOT Annual Meeting</conf-name>, <comment>10–14 March 2019</comment>, <publisher-loc>Baltimore, Maryland</publisher-loc>: <publisher-name>Society of Toxicology</publisher-name>.</mixed-citation>
    </ref>
    <ref id="c256">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>JE</given-names></name></person-group><year>1995</year>. <article-title>Thyroid hormone control of thermogenesis and energy balance</article-title>. <source>Thyroid</source><volume>5</volume>(<issue>6</issue>):<fpage>481</fpage>–<lpage>492</lpage>, PMID: 8808101, <pub-id pub-id-type="doi">10.1089/thy.1995.5.481</pub-id>.<?supplied-pmid 8808101?><pub-id pub-id-type="pmid">8808101</pub-id></mixed-citation>
    </ref>
    <ref id="c257">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sipes</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Kothiya</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Reif</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Richard</surname><given-names>AM</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling Assays</article-title>. <source>Chem Res Toxicol</source><volume>26</volume>(<issue>6</issue>):<fpage>878</fpage>–<lpage>895</lpage>, PMID: 23611293, <pub-id pub-id-type="doi">10.1021/tx400021f</pub-id>.<?supplied-pmid 23611293?><pub-id pub-id-type="pmid">23611293</pub-id></mixed-citation>
    </ref>
    <ref id="c258">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skeaff</surname><given-names>SA</given-names></name></person-group><year>2011</year>. <article-title>Iodine deficiency in pregnancy: the effect on neurodevelopment in the child</article-title>. <source>Nutrients</source><volume>3</volume>(<issue>2</issue>):<fpage>265</fpage>–<lpage>273</lpage>, PMID: 22254096, <pub-id pub-id-type="doi">10.3390/nu3020265</pub-id>.<?supplied-pmid 22254096?><pub-id pub-id-type="pmid">22254096</pub-id></mixed-citation>
    </ref>
    <ref id="c259">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>LQ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><year>2016</year>. <article-title>Exposure to 2,2ʹ,4,4ʹ-tetrabromodiphenyl ether (BDE-47) alters thyroid hormone levels and thyroid hormone-regulated gene transcription in manila clam <italic>Ruditapes philippinarum</italic></article-title>. <source>Chemosphere</source><volume>152</volume>:<fpage>10</fpage>–<lpage>16</lpage>, PMID: 26943874, <pub-id pub-id-type="doi">10.1016/j.chemosphere.2016.02.049</pub-id>.<?supplied-pmid 26943874?><pub-id pub-id-type="pmid">26943874</pub-id></mixed-citation>
    </ref>
    <ref id="c260">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Springer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dere</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>McDonnell</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Butt</surname><given-names>CM</given-names></name>, <etal>et al.</etal></person-group><year>2012</year>. <article-title>Rodent thyroid, liver, and fetal testis toxicity of the monoester metabolite of bis-(2-ethylhexyl) tetrabromophthalate (TBPH), a novel brominated flame retardant present in indoor dust</article-title>. <source>Environ Health Perspect</source><volume>120</volume>(<issue>12</issue>):<fpage>1711</fpage>–<lpage>1719</lpage>, PMID: 23014847, <pub-id pub-id-type="doi">10.1289/ehp.1204932</pub-id>.<?supplied-pmid 23014847?><pub-id pub-id-type="pmid">23014847</pub-id></mixed-citation>
    </ref>
    <ref id="c261">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>St Germain</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Schwartzman</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Croteau</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kanamori</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>DD</given-names></name>, <etal>et al.</etal></person-group><year>1994</year>. <article-title>A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>91</volume>(<issue>16</issue>):<fpage>7767</fpage>–<lpage>7771</lpage>, PMID: 8052658, <pub-id pub-id-type="doi">10.1073/pnas.91.16.7767</pub-id>.<?supplied-pmid 8052658?><pub-id pub-id-type="pmid">8052658</pub-id></mixed-citation>
    </ref>
    <ref id="c262">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinmaus</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pearl</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kharrazi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Blount</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Pearce</surname><given-names>EN</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Thyroid hormones and moderate exposure to perchlorate during pregnancy in women in Southern California</article-title>. <source>Environ Health Perspect</source><volume>124</volume>(<issue>6</issue>):<fpage>861</fpage>–<lpage>867</lpage>, PMID: 26485730, <pub-id pub-id-type="doi">10.1289/ehp.1409614</pub-id>.<?supplied-pmid 26485730?><pub-id pub-id-type="pmid">26485730</pub-id></mixed-citation>
    </ref>
    <ref id="c263">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stinckens</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Vergauwen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schroeder</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Maho</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Blackwell</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Witters</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part II: zebrafish</article-title>. <source>Aquat Toxicol</source><volume>173</volume>:<fpage>204</fpage>–<lpage>217</lpage>, PMID: 26818709, <pub-id pub-id-type="doi">10.1016/j.aquatox.2015.12.023</pub-id>.<?supplied-pmid 26818709?><pub-id pub-id-type="pmid">26818709</pub-id></mixed-citation>
    </ref>
    <ref id="c264">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stohn</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>A</given-names></name></person-group><year>2016</year>. <article-title>Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism</article-title>. <source>Psychoneuroendocrinology</source><volume>74</volume>:<fpage>46</fpage>–<lpage>56</lpage>, PMID: 27580013, <pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.08.021</pub-id>.<?supplied-pmid 27580013?><pub-id pub-id-type="pmid">27580013</pub-id></mixed-citation>
    </ref>
    <ref id="c265">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>OX</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XR</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhen</surname><given-names>SQ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XD</given-names></name></person-group><year>2009</year>. <article-title>Anti-thyroid hormone activity of bisphenol A, tetrabromobisphenol A and tetrachlorobisphenol A in an improved reporter gene assay</article-title>. <source>Toxicol In Vitro</source><volume>23</volume>(<issue>5</issue>):<fpage>950</fpage>–<lpage>954</lpage>, PMID: 19457453, <pub-id pub-id-type="doi">10.1016/j.tiv.2009.05.004</pub-id>.<?supplied-pmid 19457453?><pub-id pub-id-type="pmid">19457453</pub-id></mixed-citation>
    </ref>
    <ref id="c266">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szabo</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Diliberto</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Kodavanti</surname><given-names>PRS</given-names></name>, <name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name></person-group><year>2009</year>. <article-title>Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups</article-title>. <source>Toxicol Sci</source><volume>107</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>39</lpage>, PMID: 18978342, <pub-id pub-id-type="doi">10.1093/toxsci/kfn230</pub-id>.<?supplied-pmid 18978342?><pub-id pub-id-type="pmid">18978342</pub-id></mixed-citation>
    </ref>
    <ref id="c267">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Paules</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Simeonov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fitzpatrick</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Casey</surname><given-names>WM</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>The US Federal Tox21 Program: a strategic and operational plan for continued leadership</article-title>. <source>ALTEX</source><volume>35</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>168</lpage>, PMID: 29529324, <pub-id pub-id-type="doi">10.14573/altex.1803011</pub-id>.<?supplied-pmid 29529324?><pub-id pub-id-type="pmid">29529324</pub-id></mixed-citation>
    </ref>
    <ref id="c268">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Philbert</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Auerbach</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Wetmore</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Devito</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Cote</surname><given-names>I</given-names></name>, <etal>et al.</etal></person-group><year>2013a</year>. <article-title>Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework</article-title>. <source>Toxicol Sci</source><volume>136</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>18</lpage>, PMID: 23958734, <pub-id pub-id-type="doi">10.1093/toxsci/kft178</pub-id>.<?supplied-pmid 23958734?><pub-id pub-id-type="pmid">23958734</pub-id></mixed-citation>
    </ref>
    <ref id="c269">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Wesselkamper</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>JC</given-names></name>, <etal>et al.</etal></person-group><year>2013b</year>. <article-title>Temporal concordance between apical and transcriptional points of departure for chemical risk assessment</article-title>. <source>Toxicol Sci</source><volume>134</volume>(<issue>1</issue>):<fpage>180</fpage>–<lpage>194</lpage>, PMID: 23596260, <pub-id pub-id-type="doi">10.1093/toxsci/kft094</pub-id>.<?supplied-pmid 23596260?><pub-id pub-id-type="pmid">23596260</pub-id></mixed-citation>
    </ref>
    <ref id="c270">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tietge</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Butterworth</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Haselman</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Holcombe</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Hornung</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <etal>et al.</etal></person-group><year>2010</year>. <article-title>Early temporal effects of three thyroid hormone synthesis inhibitors in <italic>Xenopus laevis</italic></article-title>. <source>Aquat Toxicol</source><volume>98</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>50</lpage>, PMID: 20153061, <pub-id pub-id-type="doi">10.1016/j.aquatox.2010.01.014</pub-id>.<?supplied-pmid 20153061?><pub-id pub-id-type="pmid">20153061</pub-id></mixed-citation>
    </ref>
    <ref id="c271">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tietge</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Degitz</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Haselman</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Butterworth</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <etal>et al.</etal></person-group><year>2013</year>. <article-title>Inhibition of the thyroid hormone pathway in <italic>Xenopus laevis</italic> by 2-mercaptobenzothiazole</article-title>. <source>Aquat Toxicol</source><volume>126</volume>:<fpage>128</fpage>–<lpage>136</lpage>, PMID: 23178179, <pub-id pub-id-type="doi">10.1016/j.aquatox.2012.10.013</pub-id>.<?supplied-pmid 23178179?><pub-id pub-id-type="pmid">23178179</pub-id></mixed-citation>
    </ref>
    <ref id="c272">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tietge</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Holcombe</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Flynn</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kosian</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Korte</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>LE</given-names></name>, <etal>et al.</etal></person-group><year>2005</year>. <article-title>Metamorphic inhibition of <italic>Xenopus laevis</italic> by sodium perchlorate: effects on development and thyroid histology</article-title>. <source>Environ Toxicol Chem</source><volume>24</volume>(<issue>4</issue>):<fpage>926</fpage>–<lpage>933</lpage>, PMID: 15839568, <pub-id pub-id-type="doi">10.1897/04-105R.1</pub-id>.<?supplied-pmid 15839568?><pub-id pub-id-type="pmid">15839568</pub-id></mixed-citation>
    </ref>
    <ref id="c273">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Titus</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Neumann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Southall</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Michael</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Klumpp</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><year>2008</year>. <article-title>Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor</article-title>. <source>J Biomol Screen</source><volume>13</volume>(<issue>2</issue>):<fpage>120</fpage>–<lpage>127</lpage>, PMID: 18216391, <pub-id pub-id-type="doi">10.1177/1087057107313786</pub-id>.<?supplied-pmid 18216391?><pub-id pub-id-type="pmid">18216391</pub-id></mixed-citation>
    </ref>
    <ref id="c274">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trubiroha</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gillotay</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Giusti</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gacquer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Libert</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lefort</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>A rapid CRISPR/Cas-based mutagenesis assay in zebrafish for identification of genes involved in thyroid morphogenesis and function</article-title>. <source>Sci Rep</source><volume>8</volume>(<issue>1</issue>):<fpage>5647</fpage>, PMID: 29618800, <pub-id pub-id-type="doi">10.1038/s41598-018-24036-4</pub-id>.<?supplied-pmid 29618800?><pub-id pub-id-type="pmid">29618800</pub-id></mixed-citation>
    </ref>
    <ref id="c275">
      <mixed-citation publication-type="book"><collab>U.S. EPA (U.S. Environmental Protection Agency)</collab>. <year>1998a</year><source>Health Effects Test Guidelines: OPPTS 870.3100 90-Day Oral Toxicity in Rodents. EPA 712–C–98–199</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0010">https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0010</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c276">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>1998b</year><source>Health Effects Test Guidelines: OPPTS 870.3700 Prenatal Developmental Toxicity Study. EPA 712–C–98–207</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0017">https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0017</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c277">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>1998c</year><source>Health Effects Test Guidelines: OPPTS 870.6300 Developmental Neurotoxicity Study. EPA 712–C–98–239</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0042">https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0042</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c278">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>1998d</year><source>Series 870—Health Effects Test Guidelines, Group C, Chronic Toxicity Test Guidelines</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-870-health-effects-test-guidelines">https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-870-health-effects-test-guidelines</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c279">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2000a</year><source>Health Effects Test Guidelines: OPPTS 870.3050 Repeated Dose 28-Day Oral Toxicity Study in Rodents. EPA 712–C–00–366</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0009">https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0009</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c280">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2000b</year><source>Health Effects Test Guidelines: OPPTS 870.3650 Combined Repeated Dose Toxicity with the Reproduction/Developmental Toxicity Screening Test. EPA 712–C–00–368</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0016">https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0156-0016</ext-link> [accessed <date-in-citation content-type="access-date">15 September 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c281">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2005</year><source>Guidance for Thyroid Assays in Pregnant Animals, Fetuses and Postnatal Animals, and Adult Animals</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA, Office of Chemical Safety and Pollution Prevention, Office of Pesticide Programs</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/pesticide-registration/guidance-thyroid-assays-pregnant-animals-fetuses-and-postnatal-animals-and">https://www.epa.gov/pesticide-registration/guidance-thyroid-assays-pregnant-animals-fetuses-and-postnatal-animals-and</ext-link> [accessed <date-in-citation content-type="access-date">10 June 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c282">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2009</year><source>Series 890—Endocrine Disruptor Screening Program Test Guidelines</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA, Endocrine Disruptor Screening Program</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-890-endocrine-disruptor-screening-program">https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-890-endocrine-disruptor-screening-program</ext-link> [accessed <date-in-citation content-type="access-date">1 May 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c283">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2014</year><source>Integrated Bioactivity and Exposure Ranking: A Computational Approach for the Prioritization and Screening of Chemicals in the Endocrine Disruptor Screening Program. EPA-HQ-OPP-2014-0614-0003</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.regulations.gov/document?D=EPA-HQ-OPP-2014-0614-0003">https://www.regulations.gov/document?D=EPA-HQ-OPP-2014-0614-0003</ext-link> [accessed <date-in-citation content-type="access-date">1 June 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c284">
      <mixed-citation publication-type="web"><collab>U.S. EPA</collab>. <year>2015a</year><article-title>ToxCast and Tox21 Summary Files from invitrodb_v2</article-title>. October 2015 data release. <ext-link ext-link-type="uri" xlink:href="http://www2.epa.gov/chemical-research/toxicity-forecaster-toxcasttm-data">http://www2.epa.gov/chemical-research/toxicity-forecaster-toxcasttm-data</ext-link> [accessed <date-in-citation content-type="access-date">2 January 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c285">
      <mixed-citation publication-type="web"><collab>U.S. EPA</collab>. <year>2015b</year><article-title>Use of high throughput assays and computational tools: endocrine disruptor screening program; notice of availability and opportunity for comment</article-title>. Fed Reg 80:118 (19 June 2015). <ext-link ext-link-type="uri" xlink:href="https://www.federalregister.gov/articles/2015/06/19/2015-15182/use-of-high-throughput-assays-and-computational-tools-endocrine-disruptor-screening-program-notice">https://www.federalregister.gov/articles/2015/06/19/2015-15182/use-of-high-throughput-assays-and-computational-tools-endocrine-disruptor-screening-program-notice</ext-link> [accessed <date-in-citation content-type="access-date">7 March 2016</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c286">
      <mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2017</year><source>Continuing Development of Alternative High-Throughput Screens to Determine Endocrine Disruption, Focusing on Androgen Receptor, Steroidogenesis, and Thyroid Pathways</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA, Endocrine Disruptor Screening Program</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/sites/production/files/2017-09/documents/2017_edsp_white_paper_public.pdf">https://www.epa.gov/sites/production/files/2017-09/documents/2017_edsp_white_paper_public.pdf</ext-link> [accessed <date-in-citation content-type="access-date">15 January 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c287">
      <mixed-citation publication-type="book">U.S. EPA. <year>2018</year>
<article-title>Assessing and Managing Chemicals under TSCA; Alternative Test Methods and Strategies to Reduce Vertebrate Animal Testing</article-title>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>U.S. EPA</publisher-name>
<ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/alternative-test-methods-and-strategies-reduce">https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/alternative-test-methods-and-strategies-reduce</ext-link> [accessed <date-in-citation content-type="access-date">5 August 2018</date-in-citation>].</mixed-citation>
    </ref>
    <ref id="c288">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Raalte</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Wasan</surname><given-names>KM</given-names></name></person-group><year>2004</year>. <article-title>Peroxisome proliferator-activated receptor (PPAR)-α: a pharmacological target with a promising future</article-title>. <source>Pharm Res</source><volume>21</volume>(<issue>9</issue>):<fpage>1531</fpage>–<lpage>1538</lpage>, PMID: 15497675, <pub-id pub-id-type="doi">10.1023/b:pham.0000041444.06122.8d</pub-id>.<?supplied-pmid 15497675?><pub-id pub-id-type="pmid">15497675</pub-id></mixed-citation>
    </ref>
    <ref id="c289">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vansell</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><year>2002</year>. <article-title>Effect of microsomal enzyme inducers on the biliary excretion of triiodothyronine (T<sub>3</sub>) and its metabolites</article-title>. <source>Toxicol Sci</source><volume>65</volume>(<issue>2</issue>):<fpage>184</fpage>–<lpage>191</lpage>, PMID: 11812922, <pub-id pub-id-type="doi">10.1093/toxsci/65.2.184</pub-id>.<?supplied-pmid 11812922?><pub-id pub-id-type="pmid">11812922</pub-id></mixed-citation>
    </ref>
    <ref id="c290">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vermiglio</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lo Presti</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Moleti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sidoti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tortorella</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Scaffidi</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group><year>2004</year>. <article-title>Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries</article-title>. <source>J Clin Endocrinol Metab</source><volume>89</volume>(<issue>12</issue>):<fpage>6054</fpage>–<lpage>6060</lpage>, PMID: 15579758, <pub-id pub-id-type="doi">10.1210/jc.2004-0571</pub-id>.<?supplied-pmid 15579758?><pub-id pub-id-type="pmid">15579758</pub-id></mixed-citation>
    </ref>
    <ref id="c291">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villeneuve</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Angrish</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Fortin</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Katsiadaki</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Leonard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Margiotta-Casaluci</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Adverse outcome pathway networks II: network analytics</article-title>. <source>Environ Toxicol Chem</source><volume>37</volume>(<issue>6</issue>):<fpage>1734</fpage>–<lpage>1748</lpage>, PMID: 29492998, <pub-id pub-id-type="doi">10.1002/etc.4124</pub-id>.<?supplied-pmid 29492998?><pub-id pub-id-type="pmid">29492998</pub-id></mixed-citation>
    </ref>
    <ref id="c292">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villeneuve</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Crump</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garcia-Reyero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hecker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hutchinson</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>LaLone</surname><given-names>CA</given-names></name>, <etal>et al.</etal></person-group><year>2014</year>. <article-title>Adverse outcome pathway (AOP) development I: strategies and principles</article-title>. <source>Toxicol Sci</source><volume>142</volume>(<issue>2</issue>):<fpage>312</fpage>–<lpage>320</lpage>, PMID: 25466378, <pub-id pub-id-type="doi">10.1093/toxsci/kfu199</pub-id>.<?supplied-pmid 25466378?><pub-id pub-id-type="pmid">25466378</pub-id></mixed-citation>
    </ref>
    <ref id="c293">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villeneuve</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Garcia-Reyero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Martinović-Weigelt</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>ZH</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Orlando</surname><given-names>EF</given-names></name>, <etal>et al.</etal></person-group><year>2012</year>. <article-title>A graphical systems model and tissue-specific functional gene sets to aid transcriptomic analysis of chemical impacts on the female teleost reproductive axis</article-title>. <source>Mutat Res</source><volume>746</volume>(<issue>2</issue>):<fpage>151</fpage>–<lpage>162</lpage>, PMID: 22227403, <pub-id pub-id-type="doi">10.1016/j.mrgentox.2011.12.016</pub-id>.<?supplied-pmid 22227403?><pub-id pub-id-type="pmid">22227403</pub-id></mixed-citation>
    </ref>
    <ref id="c294">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Friesema</surname><given-names>ECH</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>TJ</given-names></name></person-group><year>2011</year>. <article-title>Thyroid hormone transporters: the knowns and the unknowns</article-title>. <source>Mol Endocrinol</source><volume>25</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>14</lpage>, PMID: 20660303, <pub-id pub-id-type="doi">10.1210/me.2010-0095</pub-id>.<?supplied-pmid 20660303?><pub-id pub-id-type="pmid">20660303</pub-id></mixed-citation>
    </ref>
    <ref id="c295">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Kaptein</surname><given-names>E</given-names></name>, <name name-style="western"><surname>van Toor</surname><given-names>H</given-names></name>, <name name-style="western"><surname>van Raaij</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>van den Berg</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Joe</surname><given-names>CT</given-names></name>, <etal>et al.</etal></person-group><year>1993</year>. <article-title>Glucuronidation of thyroid-hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions</article-title>. <source>Endocrinology</source><volume>133</volume>(<issue>5</issue>):<fpage>2177</fpage>–<lpage>2186</lpage>, PMID: 8404669, <pub-id pub-id-type="doi">10.1210/endo.133.5.8404669</pub-id>.<?supplied-pmid 8404669?><pub-id pub-id-type="pmid">8404669</pub-id></mixed-citation>
    </ref>
    <ref id="c296">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Biales</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Garcia-Reyero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Perkins</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Villeneuve</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Ankley</surname><given-names>GT</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Fish connectivity mapping: linking chemical stressors by their mechanisms of action-driven transcriptomic profiles</article-title>. <source>BMC Genomics</source><volume>17</volume>:<fpage>84</fpage>, PMID: 26822894, <pub-id pub-id-type="doi">10.1186/s12864-016-2406-y</pub-id>.<?supplied-pmid 26822894?><pub-id pub-id-type="pmid">26822894</pub-id></mixed-citation>
    </ref>
    <ref id="c297">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hallinger</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Murr</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Buckalew</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>SC</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>High-throughput screening and quantitative chemical ranking for sodium-iodide symporter inhibitors in ToxCast phase I chemical library</article-title>. <source>Environ Sci Technol</source><volume>52</volume>(<issue>9</issue>):<fpage>5417</fpage>–<lpage>5426</lpage>, PMID: 29611697, <pub-id pub-id-type="doi">10.1021/acs.est.7b06145</pub-id>.<?supplied-pmid 29611697?><pub-id pub-id-type="pmid">29611697</pub-id></mixed-citation>
    </ref>
    <ref id="c298">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>LQ</given-names></name>, <name name-style="western"><surname>James</surname><given-names>MO</given-names></name></person-group><year>2006</year>. <article-title>Inhibition of sulfotransferases by xenobiotics</article-title>. <source>Curr Drug Metab</source><volume>7</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>104</lpage>, PMID: 16454694, <pub-id pub-id-type="doi">10.2174/138920006774832596</pub-id>.<?supplied-pmid 16454694?><pub-id pub-id-type="pmid">16454694</pub-id></mixed-citation>
    </ref>
    <ref id="c299">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Lamoree</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Leonards</surname><given-names>PEG</given-names></name>, <name name-style="western"><surname>van Leeuwen</surname><given-names>SPJ</given-names></name>, <name name-style="western"><surname>Hamers</surname><given-names>T</given-names></name></person-group><year>2009</year>. <article-title>Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin</article-title>. <source>Toxicol Sci</source><volume>109</volume>(<issue>2</issue>):<fpage>206</fpage>–<lpage>216</lpage>, PMID: 19293372, <pub-id pub-id-type="doi">10.1093/toxsci/kfp055</pub-id>.<?supplied-pmid 19293372?><pub-id pub-id-type="pmid">19293372</pub-id></mixed-citation>
    </ref>
    <ref id="c300">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westholm</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Stenehjem</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Rumbley</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Drewes</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>GW</given-names></name></person-group><year>2009</year>. <article-title>Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs</article-title>. <source>Endocrinology</source><volume>150</volume>(<issue>2</issue>):<fpage>1025</fpage>–<lpage>1032</lpage>, PMID: 18845642, <pub-id pub-id-type="doi">10.1210/en.2008-0188</pub-id>.<?supplied-pmid 18845642?><pub-id pub-id-type="pmid">18845642</pub-id></mixed-citation>
    </ref>
    <ref id="c301">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Fenton</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Hines</surname><given-names>EP</given-names></name></person-group><year>2011</year>. <article-title>Endocrine disrupting properties of perfluorooctanoic acid</article-title>. <source>J Steroid Biochem Mol Biol</source><volume>127</volume>(<issue>1–2</issue>):<fpage>16</fpage>–<lpage>26</lpage>, PMID: 21397692, <pub-id pub-id-type="doi">10.1016/j.jsbmb.2011.03.011</pub-id>.<?supplied-pmid 21397692?><pub-id pub-id-type="pmid">21397692</pub-id></mixed-citation>
    </ref>
    <ref id="c302">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>GR</given-names></name></person-group><year>2008</year>. <article-title>Neurodevelopmental and neurophysiological actions of thyroid hormone</article-title>. <source>J Neuroendocrinol</source><volume>20</volume>(<issue>6</issue>):<fpage>784</fpage>–<lpage>794</lpage>, PMID: 18601701, <pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01733.x</pub-id>.<?supplied-pmid 18601701?><pub-id pub-id-type="pmid">18601701</pub-id></mixed-citation>
    </ref>
    <ref id="c303">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Lemieux</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Hassis</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Olshen</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Werb</surname><given-names>Z</given-names></name></person-group><year>2016</year>. <article-title>Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>113</volume>(<issue>10</issue>):<fpage>E1343</fpage>–<lpage>E1351</lpage>, PMID: 26903627, <pub-id pub-id-type="doi">10.1073/pnas.1600645113</pub-id>.<?supplied-pmid 26903627?><pub-id pub-id-type="pmid">26903627</pub-id></mixed-citation>
    </ref>
    <ref id="c304">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wittwehr</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aladjov</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ankley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>de Knecht</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heinzle</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>How adverse outcome pathways can aid the development and use of computational prediction models for regulatory toxicology</article-title>. <source>Toxicol Sci</source><volume>155</volume>(<issue>2</issue>):<fpage>326</fpage>–<lpage>336</lpage>, PMID: 27994170, <pub-id pub-id-type="doi">10.1093/toxsci/kfw207</pub-id>.<?supplied-pmid 27994170?><pub-id pub-id-type="pmid">27994170</pub-id></mixed-citation>
    </ref>
    <ref id="c305">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolff</surname><given-names>J</given-names></name></person-group><year>1998</year>. <article-title>Perchlorate and the thyroid gland</article-title>. <source>Pharmacol Rev</source><volume>50</volume>(<issue>1</issue>):<fpage>89</fpage>–<lpage>105</lpage>, PMID: 9549759.<?supplied-pmid 9549759?><pub-id pub-id-type="pmid">9549759</pub-id></mixed-citation>
    </ref>
    <ref id="c306">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lehman-McKeeman</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Grubb</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Grossman</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Bhaskaran</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Solon</surname><given-names>EG</given-names></name>, <etal>et al.</etal></person-group><year>2005</year>. <article-title>Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats</article-title>. <source>Toxicol Sci</source><volume>84</volume>(<issue>2</issue>):<fpage>232</fpage>–<lpage>242</lpage>, PMID: 15673846, <pub-id pub-id-type="doi">10.1093/toxsci/kfi094</pub-id>.<?supplied-pmid 15673846?><pub-id pub-id-type="pmid">15673846</pub-id></mixed-citation>
    </ref>
    <ref id="c307">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>YF</given-names></name>, <name name-style="western"><surname>Beland</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>JL</given-names></name></person-group><year>2016</year>. <article-title>Effect of triclosan, triclocarban, 2,2ʹ,4,4ʹ,-tetrabromodiphenyl ether, and bisphenol A on the iodide uptake, thyroid peroxidase activity, and expression of genes involved in thyroid hormone synthesis</article-title>. <source>Toxicol In Vitro</source><volume>32</volume>:<fpage>310</fpage>–<lpage>319</lpage>, PMID: 26827900, <pub-id pub-id-type="doi">10.1016/j.tiv.2016.01.014</pub-id>.<?supplied-pmid 26827900?><pub-id pub-id-type="pmid">26827900</pub-id></mixed-citation>
    </ref>
    <ref id="c308">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Hays</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Chopra</surname><given-names>IJ</given-names></name></person-group><year>2005</year>. <article-title>Alternate pathways of thyroid hormone metabolism</article-title>. <source>Thyroid</source><volume>15</volume>(<issue>8</issue>):<fpage>943</fpage>–<lpage>958</lpage>, PMID: 16131336, <pub-id pub-id-type="doi">10.1089/thy.2005.15.943</pub-id>.<?supplied-pmid 16131336?><pub-id pub-id-type="pmid">16131336</pub-id></mixed-citation>
    </ref>
    <ref id="c309">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>He</surname><given-names>W</given-names></name>, <name name-style="western"><surname>He</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group><year>2018</year>. <article-title>Generation and characterization of a hypothyroidism rat model with truncated thyroid stimulating hormone receptor</article-title>. <source>Sci Rep</source><volume>8</volume>(<issue>1</issue>):<fpage>4004</fpage>, PMID: 29507327, <pub-id pub-id-type="doi">10.1038/s41598-018-22405-7</pub-id>.<?supplied-pmid 29507327?><pub-id pub-id-type="pmid">29507327</pub-id></mixed-citation>
    </ref>
    <ref id="c310">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>PM</given-names></name></person-group><year>2001</year>. <article-title>Physiological and molecular basis of thyroid hormone action</article-title>. <source>Physiol Rev</source><volume>81</volume>(<issue>3</issue>):<fpage>1097</fpage>–<lpage>1142</lpage>, PMID: 11427693, <pub-id pub-id-type="doi">10.1152/physrev.2001.81.3.1097</pub-id>.<?supplied-pmid 11427693?><pub-id pub-id-type="pmid">11427693</pub-id></mixed-citation>
    </ref>
    <ref id="c311">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeo</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Bates</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Howe</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Ratcliffe</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Schardt</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Heath</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><year>1978</year>. <article-title>Anticonvulsants and thyroid function</article-title>. <source>Br Med J</source><volume>1</volume>(<issue>6127</issue>):<fpage>1581</fpage>–<lpage>1583</lpage>, PMID: 656820, <pub-id pub-id-type="doi">10.1136/bmj.1.6127.1581</pub-id>.<?supplied-pmid 656820?><pub-id pub-id-type="pmid">656820</pub-id></mixed-citation>
    </ref>
    <ref id="c312">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>York</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>J</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Brown</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Garman</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Mattie</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Dodd</surname><given-names>D</given-names></name></person-group><year>2004</year>. <article-title>A rat neurodevelopmental evaluation of offspring, including evaluation of adult and neonatal thyroid, from mothers treated with ammonium perchlorate in drinking water</article-title>. <source>Int J Toxicol</source><volume>23</volume>(<issue>3</issue>):<fpage>191</fpage>–<lpage>214</lpage>, PMID: 15204722, <pub-id pub-id-type="doi">10.1080/10915810490475835</pub-id>.<?supplied-pmid 15204722?><pub-id pub-id-type="pmid">15204722</pub-id></mixed-citation>
    </ref>
    <ref id="c313">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Gauger</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Bansal</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2006</year>. <article-title>4-hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells</article-title>. <source>Mol Cell Endocrinol</source><volume>257–258</volume>:<fpage>26</fpage>–<lpage>34</lpage>, PMID: 16930818, <pub-id pub-id-type="doi">10.1016/j.mce.2006.06.009</pub-id>.<?supplied-pmid 16930818?><pub-id pub-id-type="pmid">16930818</pub-id></mixed-citation>
    </ref>
    <ref id="c314">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Meyers</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Alex</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Braverman</surname><given-names>LE</given-names></name></person-group><year>1988</year>. <article-title>Thyroxine binding to serum thyronine-binding globulin in thyroidectomized adult and normal neonatal rats</article-title>. <source>Endocrinology</source><volume>122</volume>(<issue>5</issue>):<fpage>2318</fpage>–<lpage>2323</lpage>, PMID: 3129285, <pub-id pub-id-type="doi">10.1210/endo-122-5-2318</pub-id>.<?supplied-pmid 3129285?><pub-id pub-id-type="pmid">3129285</pub-id></mixed-citation>
    </ref>
    <ref id="c315">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>YH</given-names></name></person-group><year>2009</year>. <article-title>Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism</article-title>. <source>Environ Toxicol Chem</source><volume>28</volume>(<issue>5</issue>):<fpage>990</fpage>–<lpage>996</lpage>, PMID: 19045937, <pub-id pub-id-type="doi">10.1897/08-345.1</pub-id>.<?supplied-pmid 19045937?><pub-id pub-id-type="pmid">19045937</pub-id></mixed-citation>
    </ref>
    <ref id="c316">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Lazar</surname><given-names>MA</given-names></name></person-group><year>2000</year>. <article-title>The mechanism of action of thyroid hormones</article-title>. <source>Annu Rev Physiol</source><volume>62</volume>:<fpage>439</fpage>–<lpage>466</lpage>, PMID: 10845098, <pub-id pub-id-type="doi">10.1146/annurev.physiol.62.1.439</pub-id>.<?supplied-pmid 10845098?><pub-id pub-id-type="pmid">10845098</pub-id></mixed-citation>
    </ref>
    <ref id="c317">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y-X</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>C-H</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>Q-L</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>G-L</given-names></name>, <name name-style="western"><surname>Ming</surname><given-names>W-J</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>R-Y</given-names></name>, <etal>et al.</etal></person-group><year>2016</year>. <article-title>Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: a meta-analysis</article-title>. <source>Seizure</source><volume>35</volume>:<fpage>72</fpage>–<lpage>79</lpage>, PMID: 26803280, <pub-id pub-id-type="doi">10.1016/j.seizure.2016.01.010</pub-id>.<?supplied-pmid 26803280?><pub-id pub-id-type="pmid">26803280</pub-id></mixed-citation>
    </ref>
    <ref id="c318">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>DeVito</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KA</given-names></name></person-group><year>2002</year>. <article-title>Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption</article-title>. <source>Toxicol Sci</source><volume>66</volume>(<issue>1</issue>):<fpage>105</fpage>–<lpage>116</lpage>, PMID: 11861977, <pub-id pub-id-type="doi">10.1093/toxsci/66.1.105</pub-id>.<?supplied-pmid 11861977?><pub-id pub-id-type="pmid">11861977</pub-id></mixed-citation>
    </ref>
    <ref id="c319">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2005</year>. <article-title>Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals?</article-title><source>Mol Cell Endocrinol</source><volume>242</volume>(<issue>1–2</issue>):<fpage>10</fpage>–<lpage>15</lpage>, PMID: 16150534, <pub-id pub-id-type="doi">10.1016/j.mce.2005.07.006</pub-id>.<?supplied-pmid 16150534?><pub-id pub-id-type="pmid">16150534</pub-id></mixed-citation>
    </ref>
    <ref id="c320">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name></person-group><year>2010</year>. <article-title>New insights into thyroid hormone action in the developing brain: the importance of T<sub>3</sub> degradation</article-title>. <source>Endocrinology</source><volume>151</volume>(<issue>11</issue>):<fpage>5089</fpage>–<lpage>5091</lpage>, PMID: 20962056, <pub-id pub-id-type="doi">10.1210/en.2010-0926</pub-id>.<?supplied-pmid 20962056?><pub-id pub-id-type="pmid">20962056</pub-id></mixed-citation>
    </ref>
    <ref id="c321">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Bansal</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Parris</surname><given-names>C</given-names></name></person-group><year>2005</year>. <article-title>Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist <italic>in vitro</italic>, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain</article-title>. <source>Endocrinology</source><volume>146</volume>(<issue>2</issue>):<fpage>607</fpage>–<lpage>612</lpage>, PMID: 15498886, <pub-id pub-id-type="doi">10.1210/en.2004-1018</pub-id>.<?supplied-pmid 15498886?><pub-id pub-id-type="pmid">15498886</pub-id></mixed-citation>
    </ref>
    <ref id="c322">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Crofton</surname><given-names>KM</given-names></name></person-group><year>2005</year>. <article-title>Mode of action: developmental thyroid hormone insufficiency—neurological abnormalities resulting from exposure to propylthiouracil</article-title>. <source>Crit Rev Toxicol</source><volume>35</volume>(<issue>8–9</issue>):<fpage>771</fpage>–<lpage>781</lpage>, PMID: 16417044, <pub-id pub-id-type="doi">10.1080/10408440591007313</pub-id>.<?supplied-pmid 16417044?><pub-id pub-id-type="pmid">16417044</pub-id></mixed-citation>
    </ref>
    <ref id="c323">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoeller</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Rovet</surname><given-names>J</given-names></name></person-group><year>2004</year>. <article-title>Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings</article-title>. <source>J Neuroendocrinol</source><volume>16</volume>(<issue>10</issue>):<fpage>809</fpage>–<lpage>818</lpage>, PMID: 15500540, <pub-id pub-id-type="doi">10.1111/j.1365-2826.2004.01243.x</pub-id>.<?supplied-pmid 15500540?><pub-id pub-id-type="pmid">15500540</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
